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ABSTRACT 
The aims of this project were to investigate the binding characteristics of 
the cytosolic oestrogen receptor in the uterus, brain and thymus of immature 
Wistar rats. The specificities of the receptor in the uterus are well established. 
The specificities of the cytosolic receptor in the uterus and thymus of immature 
female Wistar rats were tested against a range of steroids and the values found 
for the thymus compared with those for the uterus. The concentrations and 
dissociation constant (Kd) of the cytosolic oestrogen receptor were determined 
in uterus, brain and thymus of male and female rats at 5,18 and 30 days of age. 
Clomiphene citrate (CC), an oestrogen antagonist/partial agonist, oestradiol 
(E2), CC+E2 or 4-hydroxyandrostenedione (4-OHA), an aromatase inhibitor, 
were administered to animals at 15 days in order to study the effects of these 
compounds on receptor binding characteristics at 30 days. Significant differences 
in specificity were found between the thymus and uterus, the cytosolic oestrogen 
receptor in the thymus exhibited significantly higher affinity for corticosterone 
than it did in the uterus. Male animals were heavier than females at 30 days. 
Uterus and thymus weights increased exponentially between 5 and 30 days. The 
tissue-to-body weight ratio increased in uterus between 18 and 30 days and 
increased in the thymus in both sexes between 5 and 18 days. In males at 30 
days, the tissue-to-body weight ratio of the thymus was significantly lower than 
in females of the same age. Cytosolic oestrogen receptor concentrations in the 
uterus, brain and thymus differed between some age and/or sex groups. 
Cytosolic oestrogen receptor concentrations increased exponentially in the uterus 
between the different age groups. Cytosolic oestrogen receptor concentrations in 
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both thymus and hypothalamus at 5 days were significantly higher in females than 
in males of the same age group. No differences in cytosolic oestrogen receptor 
concentrations were found between the sexes in the cortex at 5 and 18 days but 
at 30 days, receptors were not detectable in this brain area. The Kd for 
moxestrol, a synthetic oestrogen agonist that is not bound by alphafetoprotein 
present in the blood of immature rats, was similar in all tissues. E2 and CC+E'-' 
treatments resulted in decreased body and thymus weight in both sexes, increased 
uterus weight and decreased thymus weight in both sexes but led to increased 
uterus weight. CC treatment decreased the concentration of the receptors in the 
female thymus only-, E2 and CC+E2 treatments decreased the concentratIon of 
the receptor to levels that were undetectable in hypothalamus and thymus in both 
sexes, 4-OHA treatment increased thymus weight and cytosolic receptor 
concentrations in the hypothalamus and thymus of males only. 
These results suggest that cytosolic oestrogen receptors in uterus, brain 
and thymus are similar and that sex differences in these tissues are mediated by 
differential exposure to oestradiol during the early postnatal period. The thymus 
is crucial to the development of the immune response. The finding that the 
cytosolic oestrogen receptor differed from the uterus receptor in its affinity for 
corticosterone and that sex differences in cytosolic oestrogen receptor 
concentrations were present in the thymus at 5 days could be relevant to the sex 
dimorphisms that exist in autoirnmune disease manifestation. 
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Chapter one 
Introduction 
21 
w 
General introduction 
I. I: Comparative studies of developmental effects of oestrogen 
Oestrogen exerts a large number of subtle as well as dramatic effects in 
several tissues and organs in many species at different developmental stages. The 
brain and thymus of mammals as well as the uterus, the classical oestrogen target, 
are responsive to this hormone. Oestrogen alters brain development and 
behaviour in the adult animal (reviewed by Pilgrim and Hutchison, 1994) and 
causes changes in thymus structure and thymic cells (reviewed by Grossman el 
al, 1991). Moreover, the immune and neuroendocrine systems interact bý' the 
synthesis and release of thymic, hypothalamic, pituitary, adrenal and gonadal 
hormones. Stimulated T-cells and macrophages secrete lymphokines, which 
stimulate the hypothalamus to secrete corticotrophin-releasing hormone. The 
anterior pituitary is stimulated to release adrenocorticotrophic hormone which, at 
the adrenal level', stimulates the release of glucocorticolds. Glucocorticolds 
down-regulate the activity of T-cells and B-cells and also act on cells of the 
thymus epithelium to decrease the release of thymic hormones. The lower 
concentrations of thymic hormones, including thymosins, result in decreased 
activity of effector lymphocytes and at the level of the hypothalamus-pituitary 
may act to reduce the level of gonadotrophin-releasing hormone and luteinizing 
hormone (Rebar el al, 1981). Sex steroid levels are thereby reduced and the 
thymus responds by increased synthesis of thymic hormones. Homeostasis is 
thus maintained as thymic activity returns to its previous level (reviewed by. 
Grossman, 1991). 
There is much evidence that sex dimorphisms in brain and thymic 
structures, and in behaviour and immune function, may be due, in part, to the 
differential exposure of males and females to gonadal steroid hormones during 
perinatal development (Hutclýiison and Steimer, 1984; Keefer and Holdregger, 
22 
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1985; Grossman, 1984). Cells that express oestrogen receptors are likely to be 
closely involved in these phenomena. 
Comparative studies on the distribution of oestrogen-recepm, e cells in 
vertebrate brains show that many steroid- sensitive brain regions are conserved in 
birds (Balthazart et al, 1989. -, Gahr et al. ) 1987), fish and reptiles (Kim ef al, 
1978) and rats (MacLusky et al, 1979-- Vito and Fox, 1982; MacLusky ef al, 
1994). This finding suggests that there is an evolutionary advantage in the 
existence of differential brain development and the consequent differences in 
mating and maternalJoffspring rearing behaviour. Experimental administration of 
steroid hormones, and pregnancy with its associated changes in hormone levels, 
affect the thymus (Olsen and Kovacs, 1996) and T-cell development within that 
organ, as well as B-cell lymphopoiesis in bone marrow (Medina and Kincade, 
1994; Clarke and Kendall 1994; Rijhsinghani et al, 1996a). 
1.2: Sex steroids and the brain 
Oestrogens and testosterone exert several overall effects on rodent brain 
organisation during the early developmental period followed, in the adult, by 
activation of certain brain areas, such as the preoptic, by sex hormones. During 
the prenatal and early perinatal stage of development the relative difference 
between the sexes of the blood concentrations of these two hormones influences 
morphological differences in the brain (Garcia-Segura et al, 1986, McCormick et 
al, 1998). These alterations result in sex-related differences in male and female 
brains and on reproductive behaviour in the adult (reviewed by McCarthy, 1994). 
During the perinatal period, males are exposed to higher levels of oestrogen and 
testosterone than are females and this environmental difference results in sexual 
dimorphism of brain structure of the adult animals (Pang et al, 1978). Later, 
during development, the control of reproductive behaviour and gonadotrophin 
release is altered by this previous exposure (MacLusk-y ef al, 1994). 
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Brain development differs between the sexes in, for example, sý-naptic 
density, axon outgrowth and synaptic organisation (reviewed bV Pilgrim and 
Hutchison, 1994). Using in vitro studies with a PC 12 cell line (derived from rat 
pheochromocytoma), Lustig (1994) found that oestrogen and androgens induce 
inherent programmes in these cells. Androgens increased arborization and the 
receptive field of individual cells, thus increasing the likelihood of neuronal 
communication. Oestrogens induce the neuroarchitecture required for 
communication in the form of spines, synapses and gap-junction formation. The 
activities of androgens and oestrogens thus complement each other and hence 
modulate neural development and organisation in the various brain regions. 
1- Sex differences in neuron numbers and cell density in the brain 
In general, in those brain areas that are sexually dimorphic, neurons are 
larger in males than in females. In the preoptic area of the rat, neuron size and 
dendritic development are greater in males than in females (Gorski el al, 1980, 
Hammer and Jacobson, 1984. ). Male rats have a greater number of neurons and 
glial cells in the visual cortex than do females, although cell density is the same in 
both sexes (Reid and Juraska, 1992). Similar differences between the sexes are 
found in olfactory and limbic areas and in motor nuclei of the rat lumbar spinal 
cord (Breedlove, 1992). In contrast, there are some brain regions in which 
females have larger numbers of neurons. For example, females have hig-her 
numbers of doparninergic neurons in the penventricular area of the hypothalamus 
(Simerley el al, 1985). Moreover, although males have larger numbers of 
neurons in the preoptic nucleus of the hypothalamus, the specific cells in this area 
that are immunoreactive to calcitonin gene-related peptide are more numerous in 
females than in males (Herbison, 1992). Female mice also have higher numbers 
of immunoreactive oxytocin cells in vivo (Haussler el al, 1990) and of prolactin 
cells in vitro (Beyer el al, 1992) in the hypothalamus. In the latter case these 
24 
differences are not dependent on the presence of sex steroids 
surnmarised in Table 1.1. 
These findings are 
Table 1.1: Differences in brain neuron number and size in rodents 
Brain area Observation Species Male Female Reference 
Preoptic area neuron size and Rat > Hammer and Jacobson, 
dendritic 1984 
development 
Olfactory and neuron number Rat > Breedlove, 1992 
limbic areas 
Visual cortex neuron size and Rat > Reid and Juraska, 1992 
cell density 
Periventr1cular dopaminergic Rat > Simerley el al, 1985 
area of neurons 
hypothalamus 
Hypothalamus cells reactive to Rat > Herbison, 1992 
preoptic area calcitonin gene- 
related peptide 
Hypothalamus oxytocin Mouse > Haussler el al, 1990 
immunoreactive 
cells 
Hypothalamus prolactin cells Mouse > Beyer el al, 1992 
(> = more in this sex than in the other). 
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Regulation of neuron number and size in the brain 
Several mechanisms could be involved in the regulation of neuron 
numbers in developing mammals. There could be regulation of the production of 
neurons from precursor cells and of the migration of neuroblasts from deeper 
taelencaphalic cells in the cortex. There is evidence of continued cell 
proliferation in male brain in some groups of vertebrates (Goldman and 
Nottebohm, 1983-, Taylor and Truman, 1992), but in mammals there is no 
evidence of this phenomenon. 
While in many sexually dimorphic brain regions, neuron numbers are 
greater in one sex than in the other, average neuronal size, and hence dendritic 
branching possibilities, are greater in males in many vertebrate species. The 
preoptic area of early postnatal male rats shows this sex difference of greater 
neuron size (Hammer and Jacobson, 1984). Dopaminergic neurons in perinatal 
male rats show the same feature (Kolbinger el al, 1991). In females, however, 
some areas may show greater dendritic processes than in males. In female rats 
there is greater dendritic branching in the pre-frontal cortex than in males (Kolb 
and Stewart 1991). There is some evidence, in rats, that the cerebral cortex 
grows at a more uniform rate during early post-natal development in males than 
in females and this phenomenon could be due to movement of neurons, under the 
control of oestrogen, from deeper layers to the developing cortical area 
(Diamond, 1987). 
Sex-specific regulation of neuronal death might be analogous to the death 
of T-cells, during their passage in the thymus, giving rise to differential shaping 
of the adult brain. Neuronal death during ontogenesis of the brain could be due 
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to an external stimulus as a trigger of pre-programmed cell death, or due to the 
removal of factors that would alter the micro-environment of the neuron, for 
example, by removal of a specific growth factor. Raf-1, a protooncogene 
product, is a protein kinase factor with a key influence on the c- os gene (Rapp, 
1991) that is involved in programmed cell death (Smeyne ef al, 1993). The Raf- 
I level in the female hypothalamus is double that found in males during 
development, where the levels are regulated by testosterone (Whorf and Tobet, 
1992). It is possible that the presence of higher concentrations of testosterone in 
developing males protects them from the cell death that occurs in the 
hypothalamus of developing females. Oestrogen increases the transcription of 
mRNA for c-fos and for another protooncogene, c-myc, in non-neuronal cell 
lines (Loose-Nfitchell et al, 1989), but also increases the survival of one 
oestrogen receptor-bearing cell line in vitro although not in another (Rasmussen 
el al, 1990). In male rats, therefore, androgens may have a positive effect on 
neuronal survival (Wright ef al, 1988). 
Sex steroids and axon development 
It seems clear that testosterone and/or its metabolite oestradiol-170 
(oestradiol) are involved in observed differences in neuronal development of 
many species, though these effects differ between brain areas as well as between 
species (Toran-Allerand ef al, 1983). The pattern for synaptic input is more 
complex. Different research groups have observed sex differences, 
but have 
made different observations on the ratio of synaptic density in different 
brain 
nuclei (Matsumoto and Arai, 1986; Chen et al, 1990). 
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Effects of sex steroids additional to those involving dendritic branching 
and synaptic density are those that may influence connectivity between neurons 
due to axonal outgrowth. If sex steroids promote axonal growth dunng 
development, axons of neurons sensitive to these steroids are likely to reach their 
target post-synaptic neurons earlier than 'rival' neurons, though the target cell 
itself may not be steroid- sensitive (Wolff and Missler, 1992). Both androgens 
and oestrogens promote neuritic extensions of cultured hippocampal cells 
(Brinton, 1993). Androgens and oestrogens are involved in the genon-iic 
regulation of the production of specific proteins associated with axonal 
outgrowth during development in rats (Rogers el al, 1991 -, Shughrue and Dorsa, 
1993). As perinatal male rats are exposed to higher levels of these hormones, it 
would be expected that axon outgrowth would be unifom-fly higher in males than 
in females. As this is not the case (Simerley el al, 1985-, de Vries el al, 1981), 
other factors may play additional roles in axon growth regulation. 
1.2.4-. Testosterone metabolism in the brain 
The microenvironment of developing neurons is likely to depend upon the 
diverse metabolites of androgens present in the brain of perinatal male rats. 
The best studied example of the metabolism of testosterone in the brain is 
the conversion of testosterone to oestradiol- 170 (oestradiol) within brain cells by 
the activity of the cytochrome P450 enzyme, aromatase (Callard el al, 1978). 
The oestradiol made available to the brain by the catalytic action of this enzyme 
is crucial for the development of a 'male' brain. That oestrogen is required has 
been confirmed by recent studies using anti-sense nucleotides for the oestrogen 
receptor mRNA. Treatment of new-born male rats with these nucleotides results 
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in female-type differentiation of hypothalamus morpholog-v and beha-viour 
(McCarthy ef al, 1993). The critical development phase coincides With the 
testosterone surge during the perinatal period in male rats (Meaney el al, 1985) 
There may be additional direct effects of testosterone on the development of 
male behaviour. The fate of testosterone once inside the cell can be- 
binding to the cytosolic androgen receptors-) 
conversion to dihydrotestosterone which binds to androgen receptors,, 
iii) conversion to oestradiol through aromatase activity and subsequent 
binding to oestrogen receptors-, 
iv) conversion to other androgen metabolites that bind to neither receptor 
and may become inactivated. 
1.2.5. Role of aromatase in brain development 
The involvement of the sex hormones in brain development and on the 
sex differences that have been observed appears to depend, in part, on the 
aromatization of testosterone to oestradiol in the brain (McEwen et al, 1979) 
(Figure 1.1. ). The enzyme involved is a complex of cytochrome P 450 aromatase 
complexed with NADPH-cytochrome-reductase. 
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Two processes, masculinization and defeminization, occur during the pennatal 
period in mammals. Aromatase is active during brain development in limbic 
structures and in the hypothalamus, and is present in rat hypothalamic neurons 
and astroglia. Moreover , in rats, 
hypothalamus cells from males always have a 
higher aromatase activity than do female hypothalamus cells at embryonic day 15 
in both cultured cells and in explant hypothalamus cultures. This sex difference is 
observed in the absence of androgens, although the cells had exposure previouslv 
to androgens earlier in development (Hutchison el al, 1995). Levels of the 
pothalamus, preopti cytosolic receptor for androgens are similar in the hy ic area, 
amygdala and septum of neonatal male and female rats. In the preoptic area of 
male rats, there are higher levels of aromatase activity and the higher 
concentrations of oestrogen in this area might explain the lower levels of nuclear 
androgen receptor (Beyer et al, 1993) There appears to be one form only of 
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aromatase with tissue-specific gene expression as the control point. Regulation 
of aromatase activity is likely to play a part in development (Meanev et al, 1985). 
In general, oestrogen defeminizes and masculinizes the brain in 
developing males at different developmental stages. Oestrogens in mammals 
influence neurogenesis in the foetus,. and synapse formation in the perinatal and 
adult rat. Testosterone is metabolized to 5cc-dihydrotestosterone and it is this 
fonn of the steroid that is required for differentiation of the external male 
genitalia (Woodman, 1997). 5cc-dihydrotestosterone is also found in developing 
brain areas, where it appears to have a role in deferninizing and/or mascullnizing 
the developing brain. 
While the aromatase system has been well defined in many avian species 
(Hutchison and Steimer, 1984. ), regulation of aromatase activity is less clearly 
defined in mammalian species. Testosterone appears to induce aromatase in 
mammals-, however, testosterone may also be catabolized to biologically inactive 
forms and these forms may inhibit aromatase, thus regulating the concentration 
of testosterone available for conversion to oestrogens. Enzymes that are located 
in the same cells or brain nuclei as aromatase could also, by competing with 
aromatase for testosterone, limit the conversion of this hormone to oestrogen. 
Hutchison et al (1997) found sex differences in cultured mouse hypothalamus, 
though not in cultured cerebral cortex cells, with significantly higher aromatase 
activity in males at embryonic day 13 and 19 without apparent involvement of 
androgens at this early stage of development. 
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1-2.6: Other regulatory factors 
Neurons and glia are not exclusively sensitive to sex steroids, but receiv, e 
signals from other steroid hormones such as cortico steroids, neurosterolds and 
nerve growth factors. In some instances, oestrogens maV influence neuron 
growth as a direct effect on growth-related genes such as those for microtubule- 
associated protein (Ferreira and Caceres, 1991). Moreover, the distribution Of 
oestrogen receptors and of neurotrophin receptors in the brain overlaps (Toran- 
Allerand el al, 1992). The response to activation of both types of receptor could 
facilitate amplification of the activity of the hormones concerned. There Is 
enhanced neuron differentiation by interactions of oestrogens with insulin-related 
peptides (Toran-Allerand, 1988). This effect could be a factor In the 
development of the sex differences in sYnaptic connectivit-V (Garcia-Segura el al, 
1994. ). Steroid- sensitive and steroid-insensitive neurons could interact bv 
releasing growth inhibitory factors or neurotrophic factors. 
In addition to the effects of sex steroids and other factors originating 
from outside the brain, there may be direct effects on the development of neuron 
structure and brain organisation directed by genes on the X and Y chromosomes 
of neurons. Expression of regulatory genes carried on these chromosomes, and 
intrinsic to the neurons, could direct early neuronal. development before sex 
steroids were present. In Drosophila, sex-sPecific development of abdominal 
neuroblasts is dependent on genes of the sex-determining hierarchy (Taylor and 
Truman, 1992). In n-&e, the Sry genes encode the testis-determining factor and 
expression of these genes occurs as early as the two-cell stage, long before gonad 
development occurs (Zwingman et al, 1993). The same Sty gene effect may 
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occur in cells of the nervous system that maý,,, also express this gene at an early 
stage of development. The effect could be significant as the gene product 
recognises the promoter section of the gene for aromatase. 
Brain development in vertebrates is influenced by many factors, including 
sex hormones. Cell number, cell size, and synaptic connections are all regulated, 
at least in part, by the presence of sex steroids and their receptors. Enzymes 
regulate the metabolism of sex steroids in the brain and the effects of sex steroids 
appear to occur over several time periods, either directly or indirectly, on target 
cells. 
Sex steroids have an important, though not exclusive, role to play in brain 
development in mammals and in the differences between the sexes that have been 
observed during brain differentiation. The different concentrations of sex 
steroids present in the brain of perinatal male and female rodents as well as the 
activity of aromatase and the conversion of testosterone to oestrogen in males 
appears to affect the fate of brain cells in several brain areas (Hutchison, 1993)). 
if oestrogen does indeed influence the development of neurons, receptors for this 
hormone would be expected to be present in the cells that are affected. 
1.3: Development of T-cells and the thymic environment 
1.3.1: Thymic development of T-cells 
In common with other progenitors of other mammalian leukocytes, pre- 
T-cells originate in the bone marrow. Pre-T-cells migrate to the thymus, the 
major site for T-cell development in mammals (Ford ef al, 1966, 
Moore and 
Owenl 1967). The absence of an intact thymic microenvironment prevents the 
proper proliferation and differentiation necessary for 
building the peripheral T- 
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cell repertoire (Jenkinson and Owen, 1990). In the neonate mammal, the thymus 
represents a large tissue mass that continues to grow after birth until pubertv, 
after which it involutes while remaining functionally active. The thymus consists 
of lobules divided into an outer cell-dense area (cortex) surrounding an inner 
region (medulla). There is little evidence of any extrathymic site for normal T- 
cell maturation, although oestrogen administration activates extrathymic T-cell 
differentiation in the liver (Okuyama et al, 1992). The main role of the thymus is 
to provide a microenviron-ment suitable for the development of precursor T-cells 
into potentially mature, appropriately functional, T-cells. This environment is 
provided by an extracellular matrix of fibroblasts in the thymus and by the thymic 
stroma, which consists of reticulo-epithelial cells derved from the pharyngeal 
region during development. Macrophages and dendritic cells of bone marrow 
origin also contribute to the structure and environment (Aguila et al, 1997). 
Precursor thymocytes enter the thymus devoid of the mature cell differentiation 
(CD) antigens that will be exposed later on their cell surfaces. It is during the 
period of residence of T-cells in this tissue that the markers necessary for future 
T-cell function are expressed on their cell surfaces in response to signals ftom 
non-thymocvte cells. Moreover, this period also influences cell positioning, cell 
proliferation, and gene rearrangement for T-cell receptor specificities. As they 
mature, T-cells express cell-surface markers and there is positive and negative 
selection of T-cells for proliferation and apoptosis (Nfiller, 1994). 
Precursor cells that lack the surface markers, CD4 and CD8, travel 
through the cortex of the thymus to the cortico-medullary region guided 
by 
thymic epithelial cells in the cortex and medulla They first express the 
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polypeptide chains associated with the T-cell receptor (TCR) which assist 
thymocytes in binding to appropriate antigens. is passage they also During th I 
express the CD2 marker, which is involved in cell adhesion, as well as both the 
major T-cell surface marker antigens, CD4 and CD8. Immature CD4+ and 
CD8+ thymocytes are subject to positive and negative selection in the thymus. 
Those thymocytes bearing receptors for the recognition of foreign peptides 
complexed with appropriate self-antigens are allowed to mature, a process named 
positive selection (Anderson ef al, 1994). Thymocytes with a high affinity for 
self major histocompatibility antigens (MEC) on thymic stroma could become 
auto-reactive and undergo apoptosis followed by phagocVtosis bV local 
macrophages or epithelial cells (Ashton-Rickhardt ef al,, 1994; Sebzda ef al, 
1994). This process is termed negative selection. Interactions between the 
positively selected cells and stromal cells lead to down-regulation of either their 
CD4 or CD8 expression (Anderson el al, 1994. ). Thus, it is during their passage 
in the thymus that T-cells express their characteristic patterns of CD markers and 
antigen receptors and functional self-MEC restriction develops (reviewed by 
Aspinall, 1997. ). Peripheral T-cells may also undergo apoptosis and there is 
evidence that the Fas molecule (APO-1 or CD95) is associated with this 
regulatory mechanism for deletion of potentially auto-reactive T-cell clones that 
may have escaped earlier apoptosis in the thymus (Musette el al, 1994). The 
pattern of CD markers and antigen-receptors expressed on the surface of mature 
T-cells are crucial to the development of an effective and appropriate immune 
response (Davey, 1989). 
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Cells that migrate from the thymus account for oniv a small proportion of 
those that arrive at that organ from the bone marrow, the majority dying within 
the thymus by apoptosis. After emergence ftom the thymus, T-cells circulate and 
express further CD antigens and migrate through the secondary lymph tissue for 
a limited time. Unless they meet and interact with their specific antigens, T-cells 
remain functionally inactive-, interaction with correctly presented antigen leads to 
activation, clonal expansion, effector production/function and memorv cell 
development (reviewed by Anderson et al, 1996). 
1.3.2-. The thymic environment 
The thymus is a sizeable organ in young mammals. Within this organ, T- 
cell differentiation is controlled by the thyrnic microenvironment and in particular 
by the epithelial cells lying within the thymic cortex. Thymic epithelial cells 
secrete a large and heterogeneous group of hormones which include the 
thymosins (thymosin ccl, thymosin fraction 5, thymosin 04), thymulin, 
thymopoietin, as well as some other less-well characterised peptide hormones. 
These hormones are crucial for T-cell differentiation and hence immune function 
(Kendall, 1991). There is also increasing evidence that thyrnic peptides are an 
important humoral link between the immune system and the neuroendocrine 
system. That growth hormone and prolactin are necessary for normal thymus 
mass and thymocyte number was an early finding in mice (Bartke, 1964). In rats, 
prolactin stimulates the release of thymulin from thymic epithefial cells (Gala el 
al, 1991), while suppression of prolactin secretion reduces the level of circulating 
thymulin (Dardenne and Savino, 1990). Growth hormone mRNA is present in 
the thymus of neonatal rats (Binder et al, 1994) and stimulates the release of 
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thymulin from murine thymic epithelial cells iii vitro (Ban et al, 1991) 
Functional activity of receptors for growth hormone and prolactin are present on 
T-cells in rats (Gala, 1991 -, Dardenne and Bach, 1988) while the effects of these 
two hormones on thymic epithelium have been demonstrated in rats (Kelley et al, 
1986), dogs (Goff el al, 1987), humans (Mocchegiani et al, 1990), and mice 
(Dardenne and Savino, 1990). 
Lutenizing hormone-releasing hormone and thymus development may 
also be related. Treatment of neonatal female rats with luteinizing hormone- 
releasing hormone antagonist lowers thyrnocyte proliferation and thymus weight 
as well as inhibiting sexual maturation (Morale el al, 1991). While 
neuroendocrine hormones influence the thymus, communication is reciprocal and 
the thymus itself has a role in the regulation of hypothalamo-pituitary function. 
Surgical ablation of the thymus in new-born male and female mice (before 12 
hours postpartum) results in changes in the growth hormone and prolactin 
secreting cells of the pituitary. Several other endocrinopathies have been 
observed in congenitally athymic or thymus-deficient animals. Athymic mice also 
show low plasma concentrations of luteinizing hormone and follicle-stimulating 
hormone (Rouabhia ef al, 1989). 
1.3.3 - Autoirnmunity and sex differences 
Do oestrogens influence development of the thymus? Several aspects of 
immune responsiveness differ between males and females in many species 
including humans (Weetman ef al, 1981. ), mice (Weinstein ef al, 1984) and rats 
(Wilder ef al, 1982). In many mammalian species, females resist infection better 
than do males (Grossman, 1984; Ahmed et al, 1983), have higher background 
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immunoglobulin levels than males, (Butterworth ef al, 1967) and stronger cell- 
mediated immunity as demonstrated most effectively by their more rapid rejection 
of allografts (Graff et al, 1969). Moreover females of several species are more 
susceptible to naturally occurring and experimentally induced autoimmune 
diseases than are males (Olsen and Kovacs, 1996). For example, there is a higher 
incidence in women of many autoimmune diseases such as rheumatoid arthritis, 
Graves disease and systemic lupus erthymatosus (SLE); the incidence of SLE is 
9-13 times higher in women than in men (Ahmed et al, 1985). Moreover, 
Sanchez-Guerrero el al (1995) have reported an increased risk of the 
development of systemic lupus erythymatosus in postmenopausal women treated 
with oestrogen replacement therapy. In a spontaneous animal model of SLE, the 
Fl. female progeny of New Zealand Black (NZW) and New Zealand White 
(NZW) mice develop the disease earlier than the males and have a shorter life, 
with 100 per cent mortality at ten months. Males have less than 10 percent 
mortality in this period (Theofilopoulos and Dixon, 1985). Pre-pubertal 
castration of the males of this strain results in disease patterns indistinguishable 
from those found in females and with 100 percent mortality at eleven months 
(Theofilopoulos and Dixon, 1985. ). NML/MP-lpr/lpr rmce also manifest a disease 
similar to SLE and females have a shorter life-span than males with 50 per cent 
mortality at five months (Theofilopoulos ef al, 198 1). Among experimentally- 
induced autoimmune diseases, autoirnmune thyroiditis in normal PVG/c rats is 
more severe in females than in males (Ahmed et al, 1983) and male LEW/N rats 
are more resistant than are females to the development of induced polvarthritis in 
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response to injected peptidoglycan-polysaccharide ftagments of streptococc, 
(Allen ei al, 1983). 
Hormones of the hypothalamic-pituitary-gonadal and hvPothalamic- 
pituitary-adrenal axes play important roles in various animal models of 
autoimmunity such as systemic lupus erythymatosus and in mice , in collagen- 
induced arthritis in mice and rats and in streptococcal cell wall, adjuvant and 
avridine arthritis models in rats. Aut0immunity, through hormones, is closeiv 
linked with gender, sex chromosomes and age. In animal models of 
autoimmunity, manipulation of sex-hormone levels can influence the course of 
the disease. In mufine models of SLE, oestradiol is a potent accelerator of the 
disease on MRL mice (Carlsten et al, 1990). Female sex hormones are implicated 
in accelerated autoantibody production in (NZB/NZW. )(FI) rn1ce (Roubinian ei 
al, 1977; 1978; Theofilopoulos and Dixon, 1985). Castration of male mice 
results in the female age pattern of disease onset. However, oestrogens suppress 
T-cell dependent pathology in collagen-induced arthritis in mice and rats. 
Testosterone and dihydrotestosterone treatment of female and castrated male 
lupus-prone mice inhibits the onset of the disease (Roubinian et al, 1977; 1978); 5 11 
conversely, these two sex hormones enhance collagen-induced arthritis in n-ke 
though not in rats (reviewed by Wilder, 1996. ). Moreover, studies with Lewis 
and Fischer F344 rats demonstrate that corticosteroids and their releasing factors 
are important in regulation of inflammation and the onset of autoimmune disease 
(Dhabhar et al, 1993). The hyPothalan-k-pituitary-adrenal axis is sexuallv 
dimorphic and is linked to the hyPothalarnic-pituitary gonadal axis, and 
oestrogens are associated with higher corticosteroid responses in females than in 
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males. These findings in animal models of autolmmunity have major relevance to 
greater understanding of the causes of development of autoimmune conditions in 
humans. 
If oestrogens play a role in the development of the thymus, sex 
differences in oestrogen receptor concentrations in this tissue during the eark, 
postnatal period could account, in part, for some of the differences in 
autoimmunity that have been found in experimental animals and in humans. 
Oestrogen receptor studies 
1 -. Methodologies for receptor research- recent developments 
Advances in molecular biology have, in recent years, led to the 
development of many new techniques for the detection, measurement and 
distribution determination of hormone receptors and their mRNAs in tissues, 
cells and cell homogenates. 
Immunohistochemical techniques provide sensitive assays for the 
detection of protein (and other. ) antigens in frozen or fixed tissue sections or in 
viable cells. These techniques require an antibody, polyclonal or monoclonal, to 
link cellular antigen specifically to a stain that can be visualised by microscopy. 
The antibody can be conjugated to a fluorescent chromophore for illumination 
with ultraviolet light. In another refinement of the technique, enzyme-linked 
antibody is used to localize antigen and an insoluble coloured end-product of the 
enzyme catalysed reaction is precipitated for detection. Ferritin-labelled antibody 
probes can be used for locating antigens by electron nucroscopy. Immunogold 
probes are prepared by adsorbing a species- specific antibody to colloidal gold 
In of particles. Radioisotope-labelled antibody can also be used for the detectio 
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receptors by autoradiography. These methods tend to be semi -quant it ative and 
the use of polyclonal antibodies may lead to false-positive reactions (Cuello AC, 
1993). Western blot analysis permits the detection and separation of specific 
proteins in a tissue sample and, although it can quantify the tissue content of the 
protein, it does not measure the protein turnover. 
In situ hybridisation techniques, like those of immunocytochenustry, are 
carried out on tissue slices but are used to detect specific DNA and RNA 
sequences using DNA and RNA complementary to the sequence under 
investigation. Oligonucleotide probes are now more routinely available than 
previously and can be labelled with radioactive isotopes or, more safelv, using 
non-radioactive detection groups such as biotin. The technique is used chiefly to 
detect mRNA and to detect quantitative changes in gene expression after 
pharmacological interventions. The technique can be used in conjunction with 
Western blot analyses for protein to establish whether changes in mRNA 
concentrations may be associated with physiological changes in protein svnthesis 
in the tissue under investigation. Northern blot hybridisation is another method 
that permits the determination of size and relative amount of mRNA in a 
preparation of total RNA. The technique can give serni-quantitative estimates of 
gene expression in various tissues (reviewed by Cowell ef al, 1997). 
A major step forward in the techniques of molecular biology was the 
development of the polymerase chain reaction by Kary Mullis in 1983. The 
technique amplifies DNA by using temperature sensitive Taq polyrnerase, a DNA 
polymerase in the cellular DNA replication reaction. Multiple rounds of 
enzymatic replication increase exponentially the amount of a specIfic gene 
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sequence wit .na few hours. Reverse transcriptase-polymerase chal ion n react 
extends the technique to allow detection of mRNA. Initiallv, mRNA is 
transcribed to DNA, catalysed by reverse transcriptase. Random or specific 
primprs for the DNA fragment 4rý used to gqpqr4tý cpNA complemqnt4ry to thV 
RNA. The specific DNA fragments are selectively amplified in the polymerase 
step by using oligonucleotide primers flanking the target message. The specific 
amplified gene product (cDNA) is examined by agarose gel electrophoresis and 
verified by gene sequencing, Southern blot or restriction enzyme digest analysis. 
The sensitivity of the reverse transcription polymerase chain reaction is one 
thousand fold greater than earlier methods and very low concentrations of the 
mRNA in tissues can be detected by amplification of the m. RNA present. The 
onginal two-step procedure has been replaced by a simpler method that combines 
reverse transcriptase and DNA polymerase activity. This one-step procedure 
minimises handling and reduces the risk of contamination (reviewed by O'Leary 
el al, 1997). 
Receptors can also be detected in tissues by autoradiography using 
isotopes such as 
3H 
and 
14C 
. 
Animals can be treated with radiolabelled ligand 
and tissues removed for examination of ligand-labelled receptors. Alternatively, 
tissue sections removed from untreated animals are incubated with labelled ligand 
in vitro. The data can be quantified by recording the intensity of the image 
formed by the image of radioisotope decay on photographic emulsion. 
Radioligand binding studies are used in order to quantify the 
concentration of receptors in intact cells or tissue homogenates. The advantage 
of this technique is that the binding characteristics of the receptor (affinit, %, 
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constant of the receptor for specific ligands) can also be determined (see Section 
2.2.4). 
1.4.2: The oestrogen receptor 
Steroid receptors such as the oestrogen receptor act under the influence 
of their lipophilic ligands, which cross the cell membrane readily, ba regulate 
specific m RNA transcription. The receptor has a ligand-binding domain and a 
DNA-binding domain. The hormone-free receptor is associated with heat shock 
proteins sp), mainly hsp 90, which stabilises the receptor and prevents it 
binding to DNA. Upon binding of the ligand to receptor, the hsp dissociates and 
the ligand-receptor complex undergoes dimerisation (Pratt, 1993). The DNA 
binding site is exposed and the dimer is translocated to the nucleus where it binds 
to the oestrogen response elements in the promoter region of target genes to 
initiate and/or modulate gene transcription (Figure 1.2). However, steroids mav 
diffluse directly into the nucleus and exert their effects through binding to nuclear 
receptors. Such activation of steroid receptors by the ligand is followed by 
receptor binding to steroid response elements on the DNA, stable complex- 
formation at the DNA enhancer site, and recruitment of transcription factors and 
RNA polymerase to initiate gene transcription (reviewed by Greenstein, 1986). 
Moreover, many steroids (neurosteroids). such as progestins and oestrogens, can 
have non-genornic effects (Grazzini et al, 1998). These effects include 
I 
modulation of the y-aminobutyrinacid A receptor (GABAA), lordosis behaviour 
in female rats, oocyte maturation, LHRH release from the hypothalamus. 
depolarization of neurons in several brain areas and changes in membrane fluiditý, 
(reviewed by Brann et al, 1995). The recent discovery of a novel form of the 
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oestrogen receptor (. Kuiper el al, 1996), the oestrogen receptor-beta, to 
distinguish it from the oestrogen receptor-alpha, cloned from the uterus in 1986, 
has increased the complexity of possible oestrogen effects in different tissues (see 
also Chapter 4, Section 4.1). 
0 
> PP 
Pre-mRNA 
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mRNA 
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Figure 1.2: Model showing a theoretical mechanism of action of hypothetical 
steroid hormones. (S = steroid, R= receptor, HSP = heat shock protein, PP = 
polypeptide, mRNA:::::::::: messenger RNA. ). 
The observed differences between the sexes in brain development are 
associated with differential exposure to the sex hormones oestradiol and 
testosterone. Moreover the effects of these hormones can be blocked 
by 
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inhibition of aromatase activity in the brain. Oestrogen receptors are present in 
brains of perinatal mice (Keefer and Holdregger, 1985) and rats, where there are 
sex differences in their distribution and concentration in the hypothalamus 
(Kuhnemann et al, 1994, Don Carlos et al,, 1995). Manipulation of sex hormone 
levels in the thymus can result in alterations in thymus size and can influence the 
course of autoimmune disease. Evidence of oestrogen effects on thymus size, 
and of sex differences in immune function, would suggest that the oestrogen 
receptor must be involved in the underlying and interacting mechanisms of 
immune responsiveness. Specific, high-affinity receptors for oestrogen are 
present in the thymus of rats (Grossman, 1984), mice (Kawashima el al, 1992) 
and humans (Nilsson ef al, 1990). Grossman's work 0 984) showed that the 
thyrnic oestrogen receptor has a high affinity for oestradiol, although receptor 
concentration in this tissue is one-hundred-fold lower than in the uterus. The 
receptor appears to be confined mainly to the reticulo-epithelial cells in this 
tissue, although oestrogen receptors have been detected also in thvmocytes in 
humans (Weusten et al, 1986) and rats (Amir-Zaltzman ef al, 1993). 
What are the role of oestrogen and the binding characteristics of its 
receptor during early development of the thymus. I there is 9 As described earlier, 
good evidence of sex differences in the distribution of the oestrogen receptor in 
the brain and of its activity during development of that tissue. The activity of 
oestrogens in the uterus and brain, and the oestrogen receptor specificities and 
binding characteristics during development of these tissues is relativeIN- well 
established. The thymus grows rapidly in the immature rat. If, as in brain and 
uterus, oestrogens exert their effects on the thymus through the oestrogen 
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receptor, an important question to address is that of the receptor characteristics 
during the early development of the thymus. Does the cytosolic oestrogen 
receptor in the thymus have the same specificity as in the uterus, the classic site 
for oestrogen activity? Do the concentrations and dissociation constants of the 
oestrogen receptor in the thymus differ between the sexes and at specific, early 
developmental stages in the rat? Does thymus weight differ between the sexes 
during early development? Does treatment with oestrogen antagonists or with 
aromatase inhibitors effect changes in the receptor binding or II n thymus we*ght9 
Given the well known sex-related differences between males and females in the 
manifestation of autoimmune disease, it seemed relevant to seek to establish 
some of the properties of the oestrogen receptor and to try to find a means to 
manipulate its role, if any, in thymus development during this crItical early penod 
of differentiation. 
The aims of this project were to characterise the cytosolic oestrogen 
receptor in the uterus, brain and thymus of male and female rats during the 
postnatal penod from 5 to 30 days. 
Examination of the specificity of the oestrogen receptor for oestradiol, as 
well as the affinity of oestrogen receptor for a number of inhibitors, would be 
necessary in order to establish whether or not the oestrogen receptor in the 
uterus, the classic tissue target for oestradiol, and thymus are identical. The 
specificity of oestrogenic responses depends upon the initial binding of oestradiol 
to the receptor. Much is known about the specificity of the receptor in the uterus 
but little is known of its specificity in the thymus. There could be differences 
between its affinity for oestradiol and for putative inhibitors of binding These 
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differences, if present, could reflect receptor heterogeneitv or the existence of 
tissue specific oestrogens. This study is described in Chapter 3. 
The binding characteristics of the oestrogen receptor should be 
investigated in the uterus, brain and thymus of developing rats at an age when the 
thymus is still growing and when the levels of free circulating oestradiol are still 
low. There could be differences between the sexes and/or age groups in the 
expression of the receptor. Moreover differential exposure in the sexes to 
oestradiol could have developmental significance in the thymus as well as in the 
uterus and brain. This section of the project is reported in Chapter 4. 
If there are any differences between the sexes and age groups in the 
expression of oestrogen receptor, treatment with oestrogen antagonists could 
alter this expression and oestrogen effects on thymus weight. If the thymic 
environment can be marupulated by drugs, it could shed significant light on the 
mechanisms of autoimmune disease development. This work is discussed in 
Chapter 5. 
Each chapter has a short introduction, a brief section on the materials and 
methods specific to that study, results, and discussion. 
Chapter 6 includes a final discussion of the project and the conclusion. 
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Chapter two 
Materials and Methods 
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2.1: Materials 
2.1.1. Steroids and non-steroidal compounds 
Trivial name Systematic name 
Oestradiol- I 7(x 3,1 7(x-Dihydroxy- 1,3,5 [1 0]-oestratfiene 
Oestradiol- 170 3,170-Dihydroxy- 1,3,5 [I 0]-oestratriene 
Testosterone 170-hydroxv-4-androsten-3 -one 
Progesterone 4-Pregene-3,20-dione 
Corticosterone 4-Pregnene- 110,21 -diol-3,20-dione 
Oestfiol 3,16a, 1 70-Tfihydroxy- 1,3,5 [I 0]-oestratriene 
Oestrone 3-Hydroxy- 1,3,5 [1 0]-oestratrien- I 7-one 
Diethylstilboestrol trans-4,4-dihydroxy-ot, P-di ethyl stilbene 
Moxestrol 1,3,5-oestratriene, 3,170diol, II P-methoxy, I 7cc- 
ethyne (R 2858) 
4-OHA 4-Hydroxy-4-androstene-3,17-dione 
Clomiphene citrate I -[p(P-diethylaminoethox-y , 
)phenyl]-1,2- 
diphenylchloroethylene 
Tritiated oestradiol [2,4,6,7_3H-oestradiol] (specific activity 100 Ci/mmole) and 
(4-3H)-toluene reference standard were from Amersham. International p1c, UK,, 
tritiated moxestrol (3H-moxestrol, specific activity 80-88 Ci/mmole) and 
unlabelled moxestrol were purchased from NEN Research Products, Germany. 
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2.1.2- Other Materials 
Clomiphene, bovine serum albumin, (Sigma A7030) and Sigmacote were 
from Sigma Chemical Co., UK; Folin and Ciocalteu's phenol reagent, POPOP 
(1,4-di-2-(5-phenyloxazoyl)-benzene) and PPO (2,5-Diphenyloxazole) were from 
BDH Laboratory Supplies, UK, Sephadex G-50 (fine) and Sephadex LH-20 were 
from Pharmacia, UK; Diazeparn Injection B. P. was from Phoenix 
Pharmaceuticals Ltd., UK, Hypnorm was from Janssen Pharmaceuticals Ltd., 
LTK. All other chemicals and reagents were of 'Analar' grade obtained from BDH 
Laboratory Supplies, UK. Whatman No I filter paper was used throughout the 
experiments for gel filtration. Beekay Rat and Mouse Standard Diet was from 
Bantin and Kingman Universal, Hull, UK. 
2.1.3: Glassware 
The silica glass columns used for gel filtration and all glass test tubes 
were siliconized as follows. Clean, dry columns and test tubes were rinsed with 
Sigmacote, which forms a microscopically thin film of silicon on glass. Columns 
and tubes were drained of excess solution, allowed to dry overnight and finally 
rinsed with ethanol and distilled water. 
2.1.4: Buffer solutions 
The buffer solutions used for binding studies were prepared 24hr in 
advance, preserved with 0.2% (w/v) sodium azide and stored at 4'C. The buffer 
employed for estimating the free fraction of oestradiol in serum was prepared 
immediately before use. All buffers were made with dejorused, double distilled 
water and the pH standardized at 7.4 at 200C using a glass electrode and pH 
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meter. Mercaptoethanol was added to inhibit the oxidation of sulphydryl groups 
in the cytosolic preparations from uterus, brain and thymus. 
Buffer I (phosphate/sucrose/mercaptoethanoI pH 7-4) 
This buffer was used for preparing cytosolic receptors from uterus, 
thymus and brain. The composition was: 
Na2l-fPO4 lomm 
NaH2PO4 lomm 
sucrose 250mM 
sodium azide 0.2% (w/v) 
mercaptoethanol loomm 
Buffer 2 (phosphate/sucrose pH 7.4) 
Buffer 2 was used for determining the concentration of oestrogen binding 
sites in the various tissue cytosols and the dissociation constant (Kd) of the 
reaction between ligand and receptor. The composition was-. 
Na2HP04 lomm 
NaH2PO4 lomm 
sucrose 250mM 
sodium azide 0.2 % (w/v) 
Both buffers had previously been used for similar experiments in this laboratorý, 
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Buffer 3 (phosphate pH 7.4) 
This buffer was used for measuring the free fraction of oestradiol in 
serum. The composition was- 
Na2f-EP04 150mM 
NaIH2PO4 150mM 
2.1.5. Scintillation fluid 
Scintillation fluid, for estimation of radioactivity in the cytosolic and 
serum samples, was prepared by dissolving 6g PPO and 0.6g POPOP in 2L 
toluene. This fluid was used to convert the energy eTMtted by the P radioactivity 
in the ligand to energy emitted by the fluid as chemiluminescence. The counting 
efficiency of the counter, using the (4_3H)-toluene reference standard, was 48- 
50%. 
Animals 
For specificity studies (Chapter 3) and cytosol receptor studies 
undertaken on the binding of 3 H-moxestrol in 5,18 and 30-day-old Wistar rats 
(Chapter 4), male and female animals were obtained from a pathogen-free colony 
bred at St. Thomas's Hospital Medical Biological Services, London. For studies 
on the effects of treatment with oestradiol, clornIphene and 4-OHA on male and 
female Wistar rats (Chapter 5), animals were supplied by Bantin and Kingman 
Universal, Hull, UK. Animals from this latter group were allowed to settle for-24 
hours before treatment or sacrifice and were housed 4-8 per cage, with or 
without their mother depending upon age They were kept under conditions of 
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controlled lighting and heating (lights on, 08: 00h-22-00h,, lights off, 21-: 00h- 
08.00h, 21-22T) and were allowed free access to Beekay Rat and Mouse 
Standard diet and tap water. 
2.2: Methods 
2.2.1 - Anaesthesia 
Hypnorm (0.315mg fentanyl citrate and 10 mg fluanisone/ml) and 
Diazeparn (5mg Diazepam/ml) were used to anaesthetise rats pnor to any 
treatment or sacrifice. Hypnorm (I ml) and Diazepam (0.5 ml) were taken to 10 
ml with distilled sterilised water. The anaesthetic was administered 
intramuscularly at a dose of 0.2 ml per 100 gm body weight. All procedures 
were carried as specified by Home Office regulations., PrQject Licence 
No. 90/002004, Personal Licence No. 70/004825. 
2.2.2- Collection of blood and preparation of serum 
At 5,18 or 30 days of age, the animals were either decapitated (5 days) 
or anaesthetised (18 and 30 days) as described in Section 2.2.1. Trunk blood 
was collected from 5-day-old rats; blood from the other two age groups was 
collected by cardiac puncture using a heparinised needle. Blood was kept in vials 
on ice for one hour before centrifugation in an Eppendorf micro-centrifuge at 
14,000 rpm for 10 minutes at 4'C. The serum was frozen in I ml aliquots at 
-70'C. In the case of serum from 5-day-old rats, blood from two animals was 
pooled in order to obtain enough material for assay. Animals in the older age 
I- 
groups were sacrificed by cervical dislocation. The serum was assayed for the 
free fraction of oestradiol as described in Section 2.5. 
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2.2.3 - Procedure for preparation of cytosols 
The procedures used for measuring cytosolic oestrogen receptor were 
those described by Ginsburg et al (1974). 
2.2.3.1 - Dissection 
The uterus was removed via a ventral incision and the two homs were 
removed by a cut just above the bifurcation at the cervix and another cut at the 
oviduct-utero junction. The uterus was trimmed free of adhering tissue. The 
thymus was removed via a thoracic incision. In order to remove the brain the 
skin of the head was cut along the mid-line dorsally and the sk-ull-cap removed 
with scissors. The frontal lobes were raised, the exposed optic nerves were cut 
and the brain was lifted out and placed on an ice-cold Petri dish. The 
hypothalamus was dissected out using fine scissors. The area used extended 
from the optic chiasma rostrally to the marnmilary bodies caudally and 
hypothalamic fissures laterally. The hypothalamus was lifted by the optic nerve 
and a dorsal cut was made 2 mrn deep. Amygdala tissue was taken at the same 
time. Scissors were used to cut a slice 5 mm long and I mm. deep. Cortex tissue 
was taken in the same way. The time taken for the complete dissection of all 
tissues from one rat was approximately 5 minutes. Excised tissues were placed 
immediately in the appropriate amount of ice-cold Buffer 1. The number of 
tissues pooled varied according to the weight of the tissues; the tissue-volume 
ratio is shown in Table 2.1. 
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Table 2.1: Wet weight to buffer volume for studies of oestrogen receptors in 
female and male Wistar rats. 
Tissue Wet weight (mg/ml) 
thymus 150 
uterus 75 
cortex 150 
hypothalamus 150 
2.2.3.2- Tissue homogenisation 
Tissue preparation and procedures for the measurement of cytosolic 
oestrogen receptor employed the methods described by GinsbUFg et al (1974). 
Uterine tissues were minced with scissors and, because of their fibrous 
nature, were homogenized with two 5 second bursts using an Ultra-Turrex 
electrically driven mecharkal homogenizer (BDH, LJK). Thymus tissue was also 
minced with scissors and both brain and thymus tissues were homogenized 
manually using twenty strokes of a Jencons uniform ground-glass homogenizer 
and Teflon pestle at 0-4 0 C. The clearance between the pestle and the inner glass 
wall of the homogenizer was given by the manufacturer as 0.25mm. This 
clearance is required to avoid rupturing nuclei (Lovtrup-Rein and McEwen, 
1966). Brain tissue was not minced first, but was homogeruzed manually in the 
same way as the thymus. 
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2.2.3.3-. Centrifugation 
A Beckman L8-M ultracentrifuge with fixed-angle aluminium rotor xvas 
used. The homogenate was transferred to chilled centrifuge tubes and placed in a 
pre-cooled rotor at 4'C. Centrifugation was carried out at 105,0009 (42,000 
rpm) for I fir at 4'C. This process separated and deposited cell particulate 
matter, cell debris,, nuclei, mitochondria, lysosomes and microsomes and left a 
clear supernatant, which contained the cytosolic fraction of the cell. Uterine 
preparations had a variable layer of fat that was removed prior to storage. This 
procedure was essential in order to minimise the amount of non-specific low- 
affinity binding in this tissue. The supernatants were used as the cytosol 
preparations and were decanted into plastic tubes and frozen at -700C. An 
aliquot of each cytosol was taken for later determination of the protein content 
(Lowry ef al, 195 1). 
2.2.4: Assay of cytosols for steroid receptor-binding studies 
When a large amount of steroid is mixed with a relatively small 
population of receptors for that steroid, equilibrium is rapidly established. Under 
these conditions, a constant amount of steroid is bound to the receptor and most 
of the steroid present is unbound or free. 
Several techniques have been established for the separation and 
measurement of bound and free steroid. There are basically two types of 
technique. The amount of bound steroid can be measured without disturbing the 
equilibrium of the reaction or equilibrium conditions are not maintained as free 
steroid is removed from the system. Equilibrium dialysis is one example of the 
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former technique. This method was inappropriate for the present studies because 
the time taken to complete the dialysis could result in total loss of binding 
because of degradation of the receptors. Sucrose density-gradient centrifugation 
is another sensitive and well-proven method for separating specificalk, from non- 
specifically bound ligand. This method involves layering aliquots of incubate 
onto sucrose gradients followed by centrifugation at high speed and low 
temperature. Sucrose density-gradient centrifugation was unsuitable. though, for 
the measurement of large numbers of samples and the length of time of 
centrifugation (up to 24 hr) could cause dissociation of any complex present. 
Measurements of binding that disturb the equilibrium can be carried out using, 
adsorbents such as dextran charcoal and this technique has been used to measure 
oestrogen binding in hypothalamus and pituitary (Ginsburg ef al, 1974). 
However, this material adsorbs a small, but significant, proportion of the binding 
proteins as well and this amount has to be accounted for. Moreover, this method 
is not sensitive enough to detect oestradiol receptors in tissues where the 
concentration of these proteins is small. Another method that can be used for 
measuring oestrogen receptors is the enzyme immunoassay technique. Although 
it is sensitive for measuring the human oestrogen receptor and could be adapted 
to rat studies, it measures only receptor concentration and gives no idea about its 
binding affinity. 
The high-affinity oestrogen binding-protein from cytosol of brain, uterus 
and thymus can be measured using the technique of gel filtration, a method which 
does not involve disturbing the equilibrium (Ginsburg et al, 1974). The gel used 
was the small pore lipophilic gel Sephadex LH-20. This method separates 
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molecules according to their size. Substances are eluted from the columns of 
Sephadex in order of decreasing molecular weight. Moreover, Sephadex LH-A. 0 I 
is lipophilic and hinders the elution of free oestradiol by adsorption. The 
technique has been used widely in studies involving small amounts of cytosol, it 
is sensitive, and is convenient for handling large numbers of small samples. An 
additional practical advantage is that, while most gels must be disposed of after 
each experiment, LH-20 can be regenerated by careful washing and rinsing with 
ethanol and distilled water and thus reused three times. 
Gel filtration was chosen, therefore, as the most appropriate method for 
this study for four main reasons: 
(i) it had been used successfully in this laboratory for many years to detect 
and measure oestrogen-binding components in rat brain and uterus (Greenstein, 
1978). 
(ii) the method accommodated the need for simultaneous examination of up 
to 12 different cytosols without the need for large amounts of tissue. 
(iii) Up to 72 cytosol samples could be handled at any one time. 
(iv) The low background value obtained in the void volume when -H- 
moxestrol was applied to the column was particularly important when working 
with low protein concentrations and contributed to the relatively 
high sensitiv, tN,, 
of the method. 
2.2.4.1 - Preparation of steroids for binding studies 
The tritiated steroids were supplied by the manufacturer, 
dissolved in 
toluene. The carrier was evaporated under a stream of nitrogen and 
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reconstituted to the required concentration in absolute ethanol. All steroids were 
kept at 4'C. Preparation of the steroids and of the cytosols with steroids for 
Scatchard analysis was carfied out on ice. 
Tubes 1-5 were prepared for use in the measurement of the total binding 
in the cytosol preparations and Tube E, for the measurement of the non-specific 
binding in the cytosol preparations. Buffer 2 (3.92n-ý) was placed in a siliconized 
glass tube labelled T I, and I ml of the same buffer was placed in each of 5 other 
tubes labelled T2-T5 and E. 80 ýil 5x 10-7M 'H-moxestrol was added to TI 
(final concentration, IxI 0-'M) and mixed. 2ml of the contents of TI were 
transferred to Tube E and 40ýd 5x 10-'M unlabelled moxestrol in absolute 
ethanol added to the tube. 40ýtl absolute ethanol (less than 1% of the volume) 
was added to TI and the contents of Tube I were serially two-fold diluted 
through Tubes 2-5 to give a range of final concentrations from 5x 10-9 - 6.25 
10-10 
2.2.4.2- Incubation of the cytosols 
All prepared cytosols were assayed within two months of their 
preparation. Incubations were performed in 96-well polypropylene round- 
bottomed plates (Costar, Cambridge, Mass, USA) and sealed with Titerex Plate 
Sealers (ICN Biornedicals Ltd. UK). These trays had been tested and shown not 
to bind the steroids to their surface (Dhaher, 1992). 
6041 cytosol was incubated with 6041 of the appropriate radioactive 
steroid from one of Tubes 1-5 or Tube E. Aliquots (60ýtl) of the various 
concentrations of steroid were also incubated with 60ýtl Buffer 2 in the same 
rder to mi *' due to trays for estimation of the total radioactivity, in o nimise errors 
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evaporation dufing the process. Incubations were carried out for I hr in a 
shaking water bath at 25T, conditions that were determined to allow equilibrium 
to be established between the high-affinity receptor and the steroid (section 
2.4.1). For assays in which moxestrol was employed, the final concentrations in 
the incubation were from 5.0 x 10-9M to 3.1 x 10-'OM in the presence or absence 
of aI 00-fold excess of unlabelled moxestrol (Figure 2.1). 
60 ul 
sample 1 
Silo 
2 
S1000 
.... etc 
2 3 4 5 6 7 8 9 10 11 12 
60 ul TI 
4 0 0 0 0 0 0 0 0 0 0 0 0 A 
60 ul T2 
0 0 0 0 0 0 0 0 0 0 0 0 
60 ul T3 
0 0 0 0 0 0 0 0 0 0 0 0 
60 ul T4 
0 0 0 0 0 0 0 0 0 0 0 0 
60ulT5--> 
0 0 0 0 0 0 0 0 0 0 0 0 E 
60ulE--> 
0 0 0 0 0 0 0 0 0 0 0 0 F 
0 0 0 0 0 0 0 0 0 0 0 0 G 
60 ul buffer 2 --> 
0 0 0 0 0 0 0 0 0 0 0 0 
t t t tt t 
60 ul TI T2 T3 T4 T5 E 
Figure 2.1: Schematic diagram illustrating the incubation of cytosolic samples 
with the different concentrations of moxestrol. Samples were placed in the trays 
in columns 1-12 (for 12 samples) and, in rows A-F, the different dilutions of the 
ligand were added. Row H was used to estimate the total counts per ryunute 
for 
each of the different dilutions of figand. 
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In the case of 3H-oestradiol- 170, the five dilutions were from 3xI 0-ý'M to 1.88 
x 10- 
10 M in the presence and absence of a 100-fold excess of unlabelled 
oestradiol. 
2.2.4.3 - Preparation of Sephadex LH-20 columns 
Silica glass columns 17 cm in length, 0.45 cm in internal diameter were used in 
this method. (Figure 2.2). 
0.45 cm 
cm 
Stainless steel tube 
Figure 2.2: Schematic diagram showing the Sephadex column used in 
separating the bound and free moxestrol. 
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One end of each column was plugged with a small rubber bung through 
which was inserted a short piece of stainless steel tubing of internal diameter 
Imm. Small (0.45 cm) circles of Whatman No I filter paper were passed down 
the glass columns, onto the inner surface of the rubber bung to support the bed 
of gel. 
The columns were then mounted in a water bath designed to allow the 
simultaneous handling of six samples of each of twelve different cytosols. 
Sephadex LH-20 was equilibrated in Buffer 2 overnight before use. The swollen 
gel was run into the columns until the desired height (9 cm) was reached. During 
use, the columns were maintained at 0.5-2.0'C by a pump which circulated ice- 
water from a reservoir. This was necessary to minimise the dissociation of high- 
affinity binding components in contact with the gel (Figure 2.3). 
lee &N 
S 
Figure 2.3-, Schematic diagram showing the apparatus and the Sephadex 
columns used in the separation of saturated receptor molecules from the excess 
ligand in the column. 
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2.2.4.4: Separation of bound and free moxestrol 
The samples were cooled following the I hr incubation. I 00pI of 
the incubate was allowed to run into the column and was immediatelv washed 
into the column with 200[il of Buffer 2. The sample remained on the column for 
not more than lhr to ensure that no dissociation occurred during the elution 
(section 2.4.2). At the end of this time, bound 'H-moxestrol was eluted into a 
scintillation vial with 700ýtl of Buffer 2, a volume that was sufficient to elute all 
bound hormone leaving the free hormone in the column (section 2.3.1). 
2.2.4.5-. Measurement of radioactivity. 
Scintillation fluid (10ml) was added to the samples and the vials were 
kept in the dark overnight to allow extraction of the radioactivity. Radioactivity 
was measured using a Wallac 1409 scintillation counter. 
2.2.5: Investigation of binding isotherms and binding parameters 
2.2.5.1 - Binding isotherms 
When cytosol is incubated with -'H-moxestrol alone, the steroid binds to 
both saturable (specific) and non-saturable (non-specific) binding sites. Adding a 
100-fold concentration of unlabelled moxestrol saturates all the specific sites and 
H-moxestrol binds only to the non-specific sites. 
Upon Iincreasing the concentration of 
3 H-moxestrol, the amount of 
specifically-bound hormone increases until saturation is achieved; however, when 
aI 00-fold concentration of unlabelled moxestrol is added, saturation with the 
tritiated hormone Arill not be achieved because ý'H-moxestrol is displaced 
from 
the limited number of specific binding sites. 
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The binding isotherm was established by plotting the total binding. and the 
non-specific binding (unsaturable) against the total amount of "H-moxestrol 
added to the incubate. The non-specific binding produced a straight line xvith a 
positive slope. The total binding produced a logarithmic curve, which eventuallv 
reached a steady rate of increase parallel to the slope of the straight line 
describing the non-specific binding. By subtracting the non-specific binding ftom 
the total binding, the specific (saturable) binding curve was produced that 
increased initially and then produced a plateau. An example of an isotherm of 
specific binding is given in Figure 2.4. 
140 - 
120 - 
loo 
80 
60 
40 
20 - 
0 
0 50 loo 150 200 
Total cpm (x 10 
3) 
250 
* SB 
Figure 2.4: Isotherm (affinity) of the specific binding (SB) of moxestrol to 
oestrogen receptor in the thymus. 
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2.2.5.2. Determination of the factor to convert cpm moxestrol to molar 
concentration 
If the amount of 'H-moxestrol separated from 100 [t] of incubate 
I 
gave X cpm, then the amount of 'H-moxestrol in the cytosol is 2X because the 
volume of cytosol is one-half the volume of incubate. The 100 ýd of cytosol 
gives 2X cpm and IL of cytosol gives 2x 104 cpm. This figure is equivalent to- 
2 X104X 
dpm 
efficiency 
but since I Curie (Ci) gives 2.22 x 1011 dpm, then IL of cytosol would contain. 
2xl 04X Cl 
efficiency x 2.22 x 1012 
and the number of moles of 'H-moxestrol per litre of cytosol would be given by ý 
2 X104X 
efficiency x 22.2222 x 10" x specific. activity(O I mole) 
2.2.5.3- Transformation of binding isotherms to Scatchard plots 
The parameters of the reaction between a ligand and a class (or classes) 
of binding sites are most readily determined from exanuning binding isotherm 
data. This information consists of measurements made at a fixed temperature of 
the amounts of bound ligand present under conditions of apparent equilibrium 
between a fixed concentration of binding sites and a range of concentrations of 
free ligand. 
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Such data, which is defived from the Law of Mass Action, were 
interpreted mathematically by Scatchard (1949). If each receptor binds a single 
ligand molecule the model for the ligand-receptor combination is given by- 
k+i 
L+R I'Al 
Where, 
(2 1) 
L- Ligand 
R: Receptor 
k+i The rate of the association reaction 
k- i The rate of the dissociation reaction 
At equilibrium, the rate of the forward reaction (association) equals the 
rate of the backward reaction. The rate of the association reaction (Vj) is given 
by the equation: 
VI =k+ i [L] [R] 
And the rate of the dissociation reaction(V2) is given by the equation- 
V2= k- i [LR] 
At equilibfium, Vl-:::: V2. therefore- 
K+i[L][R]=k-i[LR] 
(2.2) 
(2.3) 
(2.4) 
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By rearranging the equation 
k-ilk+i represents the molar equilibrium constant for the dissociation reaction- 
[L][R] 
_ki= Kd .................................... . 
(2.5) 
[LR] k+i 
[L][R] 
= Kd ..................................... (2.6) [LR] 
Where 
[LI: is the concentration of free ligand which equals the total figand 
less [LR] 
[RI: is the concentration of unoccupied receptor which equals the total 
concentration of receptor binding sites less the bound receptors 
[n-LR] 
[LR] - is the concentration of ligand-bound receptor 
k+ the association rate constant, 
k-i the dissociation rate constant. 
Taking reciprocals from equation 2.6 and substituting [n-LR] for [R] 
[LR] 1- (2.7) 
[L][n-LR] Kd 
[LR] 
-In - 
LRI (2.8) 
[L] Kd 
[LR] 
nI -[LR] 
1 (2.9) 
[L] Kd Kd 
If [LR] = B, the concentration of the ligand-bound receptor 
[L] = F, the concentration of the free ligand 
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=n -B ** ....... ******''*'****''**'**'**'* ...... ** ..... 3.0 F Kd Kd 
This equation represents the equation of a straight line of negative slope 
Y=c -mx 
where C is the intercept on the Y axis and M is the slope of the line. 
The Scatchard equation predicts that, at a constant temperature, a plot of 
the ratio B/F versus B for binding of a ligand to a single class of non-interacting 
sites will be a straight line if the ligand molecule and binding sites are acting 
independently. The plot results in a straight line that has a slope of -I/Kd and 
when extrapolated it will intercept the Y axis at n/Kd and the X axis at n (Figure 
2.5). 
B/F 
B 
Figure 2.5: The Scatchard Plot which represents the equation B/F = 
n/Kd-B/Kd. 
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When such a linear relationship is shown it is indicative (though not 
conclusive evidence) of the presence of such independent behaviour of the 
reactants. This relationship may, indeed, not be independent. For example, 
allosteric effects may exist in which binding to one site on the macromolecule 
influences the probability of binding at other sites on the macromolecule. In such 
cases a linear relationship will not be shown between B/F and B. When the 
relationship is linear, then extrapolation to the Y axis Vields the value of n/Kd and 
to the ordinate yields the value of n (or Bmax), the concentration of binding sites 
in the preparation, and nKa, from which Ka, the equilibrium constant, can be 
calculated. 
The slope of the line is a quantitative measure of the affinity of the 
binding sites for the ligand. The value of Ka describes the amount of bound 
complex which will form between any particular combination of binding sites and 
free ligand. 
Certain assumptions must be made when using this model for this 
project-- 
(1) the ligand present is in an homogeneous form-, 
(2) the ligand is univalent, 
(3) equilibrium is reached during the incubation period and bound and free ligand 
can be separated without disturbing this equilibrium,, 
the response shows a direct proportionality with the number of occupied 
receptors*, 
(5) binding sites themselves do not interact., 
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(6) the reaction between ligand and receptor is simple and reversible. 
If the data from the binding isotherm does not produce a straight line 
upon plotting B/F against B, then this indicates either 
I) the presence of more than one class of receptor, each of whIch bInds 
specifically with the ligand at a different affinit-V or- 
2) there is more than one binding site on the same allosteric molecule so that 
when the ligand binds to the first binding site it induces a configurational 
change, which results in a change the affinity of ligand at the other 
binding site. 
2.2.5.4- Calculation of the molar dissociation constant (Kd) and the number of 
binding sites (. n. ). 
Each set of results of each sample was calculated by linear regression 
using an BP 48SX Scientific Expandable Calculator to produce the best-fit line 
for the Scatchard plot. The intercept of the line with the X axis gave the n value 
and the Y axis gave the nKa value from which Kd was calculated by dividing n 
over the Y intercept. The programme is given in Appendix A. 
The number of binding sites was expressed as fi-noles per mg protein and 
the amount of protein was expressed as mg/ml of cytosol. 
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2.2.6: Protein Estimation 
2.2.6.1: Reagents 
Reament A: 
Na2CO3 
NaOH 
gm 
0.4gm 
NaOH and Na2CO3 were dissolved in double distilled water and the volume 
made up to 100 ml. 
Reagent B: 
Sodium potassium tartrate I gm 
CUS04.5H20 0.5 gm 
The sodium potassium tartrate was dissolved in 80 n-fl double distilled water, the 
copper sulphate was added and the whole made up to 100 ml with double 
distilled water. 
Reagent C- 
Reagent A was mixed with Reagent B in the proportion 50A 
Reagent D: 
Folin and Ciocalteu's reagent was diluted I -. I with distilled water. 
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2.2.6.2-. Protein standard: 
Bovine serum albumin (BSA 100mg) was dissolved in 100 ml of double 
distilled water. 
2.2.6.3. Procedure 
Standard protein concentrations were prepared by adding 25ýtl, 50ýtl, 
75ýil, 100ýtl, 125ýtl, 150ýtl, and 200ýd of I mg/ml BSA to 175ýtl, 150ýtl, 125pl, 
100ýtl, 75ýtl, 50ýtl, and Oýtl of distilled water. Samples (10ýtl) were each diluted 
with 190ýil of distilled water. The blank was 200[d of distilled water. 
ml of reagent C were added to each tube (sample, standard or blank) 
and, after mixing, the tubes were left at room temperature for 10 minutes. 300 ýtl 
of reagent D were added to each tube, with rapid nuxing, after which the 
solutions were left overnight at 4'C. The optical density was measured at 750 
nm. The concentration of the protein in the samples was determined from a 
standard curve which was established by plotting the known standard protein 
concentrations against the optical density at 750nm (Figure 2.6). 
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2.3: Calibration of the Sephadex column 
200 
Experiments were performed in order to determine the void volume of 
the Sephadex column and in order to establish the rates of association and 
dissociation of the 3 H-moxestrol in the column. 
2.3.1: Elution of specifically bound moxestrol 
In order to establish the efficiency of the Sephadex columns for the 
separation of bound and free ligand it was essential to establish that the amount 
of buffer needed to elute the bound receptor was less than the amount needed to 
250 
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elute the free hormone. The procedure for determination of the -,,, old volume was 
carried out as follows: 
To I ml Buffer 2,1 Oýtl 5x I 0-7M 3 H-moxestrol were added. To 0.5 ml of 
this solution 5ýil ethanol was added in order to measure the total binding (TB)(A, 
TB,, Figure 2.7). In order to measure non-specific binding (NS). 5ýil 5x]0-5M 
unlabelled-moxestrol was added to the remaining 0.5 ml (B, NSB, Figure 2.7). 
To each of two siliconized glass test tubes 100ýtl of thymus cytosol was added 
with 100ýtl of either A or B and incubated for I hr at 300C. At the end of this 
time, the tubes were placed on ice for 10 minutes and 100ýd of each incubate was 
placed into a 0.45 x9 cm LH-20 Sephadex column at 1-20C. When the incubate 
had run into the column, 1.5n-d Buffer 2 was added in order to elute the column. 
Fifteen I 00ýtl fractions of eluate were collected into scintillation vials and I Oml 
of scintillation fluid was added to each vial, which were kept in the dark 
overnight before the radioactivity was counted. Most of the radioactivity 
appeared before the 9th fraction with a peak at the 6th fraction and background 
level was reached by the 9th fraction. A typical elution profile is shown in Figure 
2.7. 
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Figure 2.7: Elution of bound moxestrol. (TB = total bound, NSB = non- 
specific bound). 
2.3.2: Elution of free moxestrol 
To IH Buffer 2,10ýd 5xl 0-7M 3 H-moxestrol was added. 100ýd of this 
preparation were put into a 0.45 x 9cm LH-20 column at 1-20C. The column was 
eluted with 3 n-d of Buffer 2 and 301 OOpI fractions of the eluate were collected 
into scintillation vials. Scintillation fluid (10 ri-A) was added to each vial and the 
vials were kept in the dark overnight and the radioactivity was counted. 
The radioactivity in the eluate was within the background range of the 
counter at fraction number 10 when all the bound tracer would have been eluted. 
However, free moxestrol was eluted from fractions 15-30 (Figure 2.8). These 
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experiments established that the column technology clearly separated bound and 
free moxestrol. 
90 - 
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60 - 
50 - 
40 - 
30 - 
20 - 
10 - 
0 
10 15 20 
Fraction Number 
25 30 35 
Figure 2.8: Elution curve of the free hormone from fractions eluted after the 
ligand-bound hormone had been eluted. 
76 
2.4: Determination of association and association rates of the binding of 
moxestrol to the oestrogen receptor. 
2.4.1: Association study 
Association studies were carried out in order to establish the time 
needed for equilibrium to be established in the incubation. Cytosol preparation 
(I ml) was placed in each of two silconized glass tubes, A and B. 15.4 ml 5x] 0-7 
'H-moxestrol and 15.4 ml ethanol were added to tube A in order to measure total 
binding. To tube B 15.4 ml 5x I O-IM 3 H-moxestrol and 15.4 ml 5xlO-' unlabelled 
moxestrol were added in order to estimate the non-specific binding. The tubes 
were incubated at 30'C for 10,20,30,40,50,60,70,80,90, and 120 nunutes. 
At the end of each incubation period, 100 ýd of the incubate was placed on the 45 
x 9cm Sephadex LH-20 column at 1-2'C and 200 ýtl Buffer 2 was added. After 
30 minutes, the column was eluted with 800 [d of the same buffer and the eluate 
collected into a scintillation vial. When all the samples had been collected, 10 ml 
scintillation fluid was added to each vial The radioactivity was counted after 
overnight storage in the dark. 
Specific binding to oestrogen receptor reached a plateau after 40 
minutes incubation and lasted for at least 2 hr. Observations were made three 
times each in the uterus, thymus, and hyPothalamus (Figure 2.9. ). 
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Figure 2.9: Typical association curves for cytosolic specific binding in uterus, 
thymus and hypothalamus. 
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2.4.2. Dissociation studies 
Dissociation studies were also performed. Conditions for saturable 
binding of the oestrogen receptor with moxestrol required incubation of the 
samples at 30T. The Sephadex columns used for the Scatchard analysis were 
kept at 1-2'C. In order to establish that the eluate collected from the columns 
contained all the receptor molecules saturated with the labelled ligand, the time 
period that the preparation could stay in the column before dissociation of ligand 
and receptor was investigated. 
To each of two siliconized glass tubes were added 650 ýtl of the cytosol 
preparation. To one of the two tubes (A) was added I Oýd 5x 1 0-7 M H-moxestrol 
and 10ýtl ethanol in order to measure total binding. To the other tube (B) was 
added 10ýtl 5xl 0-7 M 'H-moxestrol and lOpl 5xlO-'M unlabelled moxestrol to 
measure non-specific binding. The tubes were incubated for I hr at 30T. I 00pl 
of the incubate from either tube A or tube B was placed in each of 8 Sephadex 
columns and washed in with 200ýtl Buffer 2. These samples were left on the 
column for 5,155 30, or 60 minutes before being eluted with 800 ýtl Buffer I into 
scintillation vials. Scintillation fluid (10ml) was added to each volume of eluate 
and the radioactivity was counted after overnight extraction in the dark. 
The amount of specific binding remained constant over the I hr period 
examined (Figure 2.10) and three observations for each were made for uterus, 
thymus and hypothalamus. The animals used for the association and dissociation 
studies were 30 days old and no binding was detectable in the cortex of this age 
group. 
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Figure 2.10: Typical dissociation curves of cytosolic specific binding in the 
uterus, thymus and hypothalamus. 
These results established that no significant dissociation occurred during 
the period that the eluted hormone-bound receptor remained in the column. 
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2.5: Measurement of the free fraction of oestradiol in serum 
The method used that of Greenstein et al (1977) 
2.5.1: Incubation of the serum 
Serum (0.8 ml) was incubated with 5pl (5x] 0-7M) 
3 
H-oestradiol for I hr 
at 3 70C. 
2.5.2: Collection of fractions of serum 
Sephadex G50 (Ifine) was suspended in Buffer 3 (previously degassed by 
evacuation) and allowed to equilibrate for I hr at room temperature. Columns of 
the gel (10.45cm x 7cm) were prepared. The volume of 3 drops of Buffer 3 eluted 
from each column was measured. This volume was used to estimate the total 
radioactivity in 3 drops of eluate when separation of alphafetoprotein-bound 3 H- 
oestradiol and the free hormone occurred by gel filtration. 
The serum sample was placed on the column (maintained at 3 VC) and 
allowed to permeate the gel. The column was eluted with Buffer 3 from a 
Marriott flask to maintain constant pressure. For each sample, 30 three-drop 
samples were collected into scintillation vials. 10 nil scintillation fluid were 
added and the samples were kept in the dark overrught before counting the 
radioactivity. 
The steroid-bound protein eluted in fractions 4-9, and the free hormone 
appeared in fractions 15-22 (Figure 2.11). 
81 
100000 
10000 
1000 
100 
10 
I 
0 10 20 30 40 
Fractions 
Figure 2.11 The elution. profile of alphafetoprotein-bound 3 H-oestradiol and 
free 'H-oestradiol in serum. 
The ratio of the free hormone to the bound hormone was determined from this 
elution profile by dividing the counts per minute of the second plateau (ftee 
hormone, fractions 15-22) by the counts per minute of the first plateau 
(alphafetoprotein-bound hormone, fractions 4-9). 
2.6: Statistical Analyses 
Statistical analyses of the results obtained in all the experiments were 
undertaken using Sigmaplot. Initially, tests were run to show that variances of 
individual groups were equal before Two-way Analysis of Variance. Where the 
variances of individual groups were not equal, ANOVA on Ranks and Student- 
Newman-Keuls tests were used. 
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Chapter three 
Specificity of oestrogen- binding protein for its ligand in uterus 
and thymus of females Wistar rats at 30 days 
83' 
Introduction 
Oestradiol, in common with other steroid hormones, exerts its effects on 
its target tissues through a primary association reaction with a specific 
intracellular receptor. The hormone-receptor complex binds to specIfic 
oestrogen-responsive elements to initiate transcription of the target genes 
(reviewed by Greenstein, 1978). In the uterus, the classic site for oestrogen 
activity, many studies have shown that this hormone-binding protein is a high- 
affinity, low capacity receptor that is highly specific for its ligand, oestradiol. 
(Jensen el al, 1968). 
Several studies have established the specificity of the oestrogen receptor 
in uterus and in brain in many species (Korenman 1968; 1969; 1970,; de Sombre 
et al, 1971; Sholl and Kim., 1989; Handa et al, 1991). The specificity of the 
receptor in these tissues has been tested against a range of steroidal and non- 
steroidal compounds in order to establish whether there may be heterogeneity of 
oestrogen receptor in different tissues or tissue-specific oestrogens or anti- 
oestrogens (Ginsburg el al, 1977). Similar work has not been camed out, thus 
far, on the specificity of oestrogen receptor in the thymus of immature rats, 
although many studies have confirmed the presence of a high-affinIty, low 
capacity oestrogen-binding protein in thymus from humans (Nilsson et al, 1984), 
rats, mice and cattle (Grossman ef al, 1979a). Numerous observations suggest 
that this organ is responsive to oestradiol (Stimson, 1980; Grossman ef al, 1982, 
Pearce et al, 1983). The specificity of the receptor for the different competitors 
exam-ined was assessed as the ability (potency) of the competitor to alter the 
apparent affinity the receptor for oestradiol. The greater the apparent lowering 
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of the affinity constant of the receptor for oestradiol, the greater the specificit-v of 
the receptor for the competitor in question. If, for example, the receptor had no 
affinity for the putative inhibitor/competitor, the apparent affinity of the receptor 
for oestradiol would not be altered in the presence of the compound in question. 
It is well known that the female of various mammalian species has 
enhanced immunological reactivity relative to the male (Rhodes el al, 1969-, 
Imnan, 1978, Masi and Kaslow, 1978). Moreover, the reticuloepithelial stroma 
cells in the thymus of rats produce immunoregulatory factors whose synthesis is 
influenced by oestrogens, progesterone, corticosteroids and androgens (Stimson 
el al, 1980). Oestradiol adn-ýnistration causes thymic regression in male and 
female rats, an effect that can be blocked by inhibition of aromatase (Greenstein 
el al, 1988b, 1992b). As the thymus is responsive to steroid hormones, this 
study was undertaken in order to deterrmne whether the oestrogen-binding 
protein in the thymus shows the same or sin-filar specificities as the oestrogen 
receptor in uterus of immature female Wistar rats. 
3.2: Materials and Methods 
3.2.1 - Animals 
Immature female Wistar rats, aged 27 days, were purchased from Bantin 
and Kingman and kept 5 per cage (56 x 38 x 20 cm) in the Biological Research 
Services Facility in the Rayne Institute, St. Thomas's Hospital. They were kept 
under conditions of controlled lighting and temperature, (lights on, O&OOh- 
22.00h, lights off, 22: 00h-08: 00h; 19-20T) and were allowed free access to BK 
rodent diet which is steroid free, and to tap water. The concentration of 
oestrogens in tap water was 1.47pmole (0.004 ppm) (Thames Water Authority). 
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This concentration was below the level that would be likely to have an effect on 
the animals in these studies (Beigel el al, 1998). 
3.2.2- Preparation of the cytosols 
When the rats reached 30 days, they were anaesthetised and sacrificed by 
cervical dislocation, in accordance with United Kingdom Home Office 
regulations and as described in Sections 2.1 and 2.2. Uteri and thymi were 
dissected as described in Section 2.2.3. Individual tissues were placed in 1.0 and 
1.5 ml, respectively, of ice-cold Buffer 1. Tissues were not further separated into 
subtypes (e. g. thymocytes and thymic epithelial cells). The tissues were 
homogenized as described in Section 2.2.3 and the resulting homogenate was 
centrifuged at 105,000g (42,000 rpm) in a Beckman L8-M ultracentnfuge using 
a fixed angle aluminium rotor for I hr at 4'C. The supernatant, which contained 
the soluble cell proteins, was decanted into plastic tubes and frozen at -70T 
prior to assay which occurred within two months of preparation. Nuclei 
remained intact during the separation (tested by microscopy) but were not 
collected. 
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3.2-3: Preparation of non-radioactive steroids for competition studies 
Stock solutions of the steroids were made up in absolute ethanol in the 
following concentrations (Table 3.1). 
Table 3.1 -. Concentrations of stock solutions of the steroids used in 
competition studies. 
Compound Concentration (M) 
Oestradiol- 170 (Oestradiol) Ix 10-9 
Oestradiol- 1 7cc 10 X 10 -6 
Oestrone lox lo -,, 
Oestriol 10 X 10-6 
Diethylstilboestrol 20 x 10 -6 
Testosterone 20x 10-6 
Corticosterone 20x 10-6 
Progesterone 20x 10-6 
3.2.4- Measurement of the binding of oestradiol in the presence of competitors 
Cytosols were incubated with 3H-oestradiol in the presence and the 
absence of aI 00-fold excess of unlabelled oestradiol. Cytosol (0.1 ml) was 
incubated with 0.1 ný of Buffer 2 (Section 2.1.4) together with one of a range of 
final concentrations of 3H-oestradiol (0.03-1.0 x 10-9M) 1hr at 250C. Parallel 
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incubations were carried out in the presence of aI 00-fold excess of unlabelled 
oestradiol. In order to keep the ethanol content of the incubations equal, ethanol 
was substituted for unlabelled oestradiol in those incubations which contained 
only the tritiated steroid. 
In order to measure the binding of unlabelled competitors in the high- 
affinity oestradiol binding system, parallel incubations were carried out in the 
presence of competitors in final concentrations listed in Table 3.2- These 
concentrations were chosen because previous work by Ginsburg el al (1977) had 
established that these concentrations produced only partial inhibition of the high- 
affinity binding of 3H-E2 to any uterus or brain cytosol fraction at concentrations 
Up to 10-6 M (Table 3.2). 
Incubations were carried out in a shaking water bath at 250C for I hr. 
Separation of bound and free 3H-E2 was achieved using gel filtration as 
described in Section 2.2.4. In this case, however, because tritiated oestradiol 
was used, 6 cm columns of Sephadex LH 20 were used (Ginsburg et al, 1974) 
and on1v 5 n-d scintillation fluid was added to the vials before overnight extraction 
and counting. 
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Table 3.2: Final concentrations in the incubations of steroids used in 
competition studies. 
Compound Concentration (M) 
Oestradiol-170 5x 10 -10 
Oestradiol- I 7ot 2.5 x 10-8 
Oestrone 2.5 x 10-8 
Oestriol 2.5 x 10 -8 
Diethylstilboestrol Ix 10 -10 
Testosterone IX 10 -7 
Corticosterone IX 10 -7 
Progesterone IX 10 -7 
3.2.5-. Construction of binding isotherms for ['H]-oestradiol in the absence and 
in the presence of other steroids. 
The Edsall and Wyman (1958) equation states that for competitive 
interaction between a ligand and an inhibitor at a single class of binding site, 
I= 
nKi ................................ I+ Kil 
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where B= the concentration of ligand / macromolecule complex 
Ka = the equilibrium association constant of the reaction 
F= the concentration of free ligand 
Ki = the equilibrium association constant of the 
receptor-inhibitor 
I= the concentration of free inhibitor 
By rearrangement, an expression similar in forrn to the Scatchard 
equation can be obtained- 
B_ 
_Ka 
(n - B) 
FI+ Kil 
Comparison of this expression with the Scatchard equation - 
B= 
Ka(n - B) ...................... F 
shows that the sole effect of a fixed concentration of competitive binding 
inhibitor on the binding of a ligand to a single class of non-interacting binding 
sites will be to decrease the slope of the plot by a factor of 
I 
The 
I+ Kil 
rectilinear nature of the plot and the intercept where B/F=O, at the binding 
capacity of the system, will not be affected. If, however, binding inhibition is due 
to non-competitive interaction, the Scatchard plot in the presence of the inhibitor 
will be curvilinear as - 
Ka 
will vary with ligand concentration. I+ Kil 
At least four experiments were carried out with each inhibitor in which 
Scatchard plots were constructed from five values of bound and free oestradiol in 
the presence and in the absence of fixed concentrations of the inhibitors. In each 
case, the compounds inhibited the binding of oestradiol. and the Scatchard plot 
was shifted by a linear reflection about the intercept on the abscissa according to 
the prediction for competitive interaction. 
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The dissociation constant for the inhibitor (Kdi) can be calculated if Ka 
and n are known together with values of F and B in the presence of inhibitor 
from the following equation derived from the Edsall and Wyman equationý 
Kdi= 
FI 
nKa B- 
(KaF + 1) 
......................... 
The intercept on the ordinate, nKi, is related to nKa by the same factor therefore, 
n Ka 
I +Kil 
This plot represents the two equations- 
a) B/F=Ka (n - B) 
b) B/F=Ki (n - B) 
nKj 
and the relationship between these two given is given above in equation 5. 
3.2.6- Statistical analyses. 
Regression analysis was used to obtain a measure of the slope and 
the coefficient of correlation for each Scatchard plot obtained. Plots for which 
the correlation coeffecient was less than 0.75 were not used in the results. 
Statistical analyses of the results were undertaken, using Sigmaplot, testing that 
there were no significant differences in the intercept (n) on the x axes of the data 
obtained. 
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3.3: Results 
Tissues from immature female rats were used for this study since, in these 
animals, the concentration of circulating oestrogen that might interfere in the 
experiments was low and the thymus was large. Moreover, atrophy of this 
tissue, which is associated with increasing levels of steroids in older aniM#I$, hqj 
not begun and circulating oestrogen-binding protein, alphafetoprotein, which 
would interfere in the binding reaction, has disappeared from the bloodstream by 
this age (Raynaud et al, 197 L Greenstein et al, 1992). 
At the concentration of each putative competitor used in this study, 
Ginsburg el al (1977) showed that only partial inhibition of the high-affinity 
binding of ['H]-Oestradiol occurred in cytosol incubate at a concentration of 1.0 
x 10-9M. Isotherms were constructed for the binding of ['H]-oestradiol to the 
high-affinity sites in uterus and in thymus tissue cytosols in the presence and 
absence of these chosen concentrations of the compounds. 
The Scatchard analysis obtained from both thymus and uterus yielded 
straight lines, a result that is consistent with the presence of only one class of 
binding site. Figure 3.1 a and b are representative plots from which it can be seen 
that the inhibitor depressed the slope of the Scatchard plots. Nevertheless, the 
line passed through the abscissa at a point that was not apparently different from 
that obtained in the absence of the inhibitor. This point is the binding capacity 
(n) and gives a measure of the concentration of bound receptors at full binding 
capacity of the system. The result (no change in value of n, alteration of Kd) 
provides evidence that the tested steroid was showing inhibition that was 
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competitive in nature. All of the steroids tested exhibited competitive 
antagonism to binding of tritiated oestradiol. 
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Figure 3.1 a: Inhibition of 'H-oestradiol binding by oestriol (2.5 x 10-8 M) in 
female Wistar rat uterus cytosols. 
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Figure 3.1 b: Inhibition of 3 H-oestradiol binding by oestriol (2.5 x 10-' M) in 
female Wistar rat thymus cytosols. 
93 
0 2000 4000 6000 
bowid cpiii (X 102) 
The mean value of the Kdi values obtained using thymus and uterus 
cytosols are shown in Table 3.3. 
Table 3.3: Molar dissociation constants of oestrogen agonists and antagonists in 
reaction with cytosolic high-affinity receptor for [3 H]-oestradiol- 170 from uterus 
and thymus of 30-day old female Wistar rats. 
Test Compound Order of 
magnitude 
Uterus Thymus 
Oestradiol- 170 10 -10 4.2 1.6 3.8+- 1.7 
Oestradiol- I 7a 10-9 12.2 4.4 8.3 ± 1.2 
Oestrone 10-1 13.0 3.0 12.0 ± 4.3 
Oestriol 10-9 14.3 3.3 8.1 + 1.2 
Diethylstilboestrol -10 10 2.7 1.1 0.5--+O. l 
Testosterone 10 5.5 1.6 4.4+- 
Corticosterone 10-1 33.3 1.1 4.4 1.9* 
Progesterone 10-7 1-5 0.2 1.1 0.7 
Each value is the mean (± SEM) of 4 or 5 determinations. 
* Significant difference from uterus p<0.05. 
The spectrum of affinities indicated clearly that of all the compounds 
tested, only the oestrogens, oestradiol and diethylstibestrol, exhibited a high 
affinity for the binding protein in both thymus and uterus. This pattern of 
steroidal specificities in uterus cytosols was in agreement with results obtained by 
others (Ginsburg el al, 1977). The dissociation constants of the compounds for 
the receptor ranged from 10-IOM to 10-7M in uterus and in thymus. In both 
tissues, the order of dissociation constants, ftom lowest to highest was, 
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oestradiol =- diethylstilbestrol (thymus and uterus), < oestradiol-17(x =- oestrone =- 
oestriol (thymus and uterus), < corticosterone (thymus), < corticosterone 
(uterus), < progesterone =- testosterone (thymus and uterus ). In both thymus 
and uterus, the dissociation constant for oestradiol and diethylstilbestrol showed 
similar values of the order of I 0-'OM which is consistent with known circulating 
concentrations of the hormone (Brown-Grant el al, 1970). The dissociation 
constants of oestrone, oestriol, and oestradiol- I 7cc, which has a hydroxyl group 
at position 17 oriented in the opposite plane from that of oestradiol, were of the 
order of 10-9M. This value was the same for both tissues and was significantly 
higher than those for oestradiol and diethylstilbestrol. The dissociation constants 
for testosterone and progesterone were of the order of I 0-'M and 
10-7 M and 
appeared higher in uterus and thymus than those of the other compounds. 
However, these values were significantly different (p < 0.05) only from those of 
oestradiol and diethylstilbestrol in both tissues. The affinity of corticosterone for 
the thymus receptor was significantly higher (p<O. 05), (Kdi =33.3 xI 0-'M), than 
the value obtained for the uterus (Kdi = 4.4 xI 0-'M). The differences in the 
relative affinities of the receptor for the compounds tested could reflect 
differences in the expression of the two oestrogen receptor sub-types, alpha and 
beta, in these two tissues 
3.4: Discussion 
The receptor for the compounds tested in this study was oestrogen- 
selective in the thymus and in the uterus and appeared to be similar though not 
necessarily identical in both tissues. The results obtained were consistent with 
the possibility that the thymus does possess high-affinity oestrogen receptors 
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although this study could not distinguish between alpha and beta subtypes of the 
receptor in the thymus or in the uterus. The molar dissociation constant for 
oestradiol in the thymus was of the order of 10-IOM which was compatible with 
the known physiological concentrations of circulating hormone (Brown-Grant et 
al, 1970). This value was similar to oestradiol binding in adult male (Brodie et 
al, 1980) and adult female rat thymus (Morgan and Grossman, 1985. ). Nilsson et 
al, (. 1984), characterising the receptor in human tissue, showed that the Kd for 
oestrogen in the thymus and uterus are similar and also of the order of I 0-'ý'M. 
In contrast to the results in rats in this present study, they found that in human 
thymus, diethylstilbestrol has a lower affinity for the oestrogen receptor than 
does oestradiol, although the affinity in uterus of these two compounds is similar. 
Studies of the specificity of the oestrogen-binding protein in the thymus have not 
previously been undertaken in the immature rat, but the pattern of steroidal 
specificities in uterus cytosols was in broad agreement with results obtained by 
others in rats (Ginsburg ef al, 1977. ) and New Zealand B/W FI mice (Athreva ef 
al, 1989). 
Similarities were found in uterus and thymus in the rank orders (that is to 
say, the potency of the compound to cause a decrease in the apparent Kd of the 
receptor for oestradiol) of the affinities of the steroids studied. The molar 
10 
dissociation constant for oestradiol in the uterus was 4.2 ± 1.6 x 10- M, the 
10 
value for thymus was 3.8 ± 1.7 x 10- M. The values found were also in 
agreement with earlier reports of specificities of receptor binding in uterus 
(Ginsburg el al, 1977) and in the thymus of male rats for oestradiol (Brodie el al, 
1980). 
96 
From this evidence it could be argued that circulating oestradiol of 
gonadal origin may act directly on the thymus. The dissociation constant for the 
binding reaction was in good agreement with the values reported by others for 
oestrogen receptors (Grossman, et al 1979a) and was sufficiently low to exclude 
the possibility that an alphafetoprotein-like molecule was involved (Radanyi el al, 
1977). That oestrogen can stimulate the thymus to release a humoral factor is 
confirmed because this effect is abolished in oestradiol-treated, thymectomized 
rats (Brodie et al, 1980). Moreover, cytosolic oestradiol receptors are locallsed 
in the thymic medulla, a site commonly associated with the synthesis of immuno- 
regulatory hormones (Grossman et al, 1979b, Grossman ef al, 1982). The target 
for oestrogen action could be the reticuloepithelial cells of the thymus. Plasma 
concentrations of oestradiol in the physiological range inhibit thymus 
development in immature rats, alter thymocyte responsiveness to mitogens 
(Gilbody el al, 1992), and inhibit thymus regeneration after orchiedectomy of 
ageing male rats (Greenstein and Fitzpatrick, 1988a). The effects of oestradiol 
are probably complex since it may actually cause proliferation of certain cortical 
elements of the thymus (Glucksman and Cherry, 1968). 
The results of this study showed that the thymus and uterus had sIMIlar 
spectra of affinities for all of the compounds tested with the surprising exception 
of corticosterone. For this compound, the thymus cytosolic receptor had an 
affinity which was ten-fold higher than that of the uterus. Possible experimental 
artefacts should be considered in seeking to explain the observed difference 
between the binding constant of the receptor for corticosterone in the uterus and 
thymus. It is possible that endogenous inhibitors were present in uterus cytosols 
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that interfered with the binding reaction of corticosterone in this tissue. This 
source of artifact seems unlikely, however, because the effect should have been 
present in all estimates for uterine binding and should have affected all the 
estimates of uterus Kdi in a similar way. The same argument can be used to 
discount the influence of errors in the estimation of unbound oestradiol for the 
basis of the calculation of Kdi rests on the assumption that equilibrium between 
receptor and inhibitor had been reached within the period known to be adequate 
for the attainment of oestradiol-receptor equilibrium. This period had been 
established in preliminary experiments (Section 2.4.1). 
There may be tissue-specific factors in thymus or in uterus that modify 
the affinity of corticosterone for the receptor in each of these tissues. Thus, the 
apparent specificity of the oestrogen receptor would differ slightly in the two 
tissues. This phenomenon is not unknown in other receptor systems. For 
example, alterations to androgen receptor affinity caused by mutations have been 
found in human prostate patients with complete or partial androgen insensitivity 
syndrome (Lubaka et al, 1989) and the affinity of androgens for their receptors 
differs between brain and prostate (Barley el al, 1975). 
The result that the thymus receptor exhibited a higher affinity for 
corticosterone, the steroid for which the only significant difference was found, 
than did the uterus receptor cannot be explained at present. The method of 
erence, although this preparation of the cytosols may have contributed to the diff 
cause seems unlikely since the same buffer was used for both tissues, and both 
tissues were processed in parallel during the same assay procedures. It is also 
possible that the receptor may not be the same in the two tissues. There may also 
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be heterogeneity of oestrogen receptors since a variant oestrogen receptor 
mRNA has been described in human mammary tumours (Garcia el al, 1988) and 
a mutated oestrogen receptor has been reported in a murine transformed Leydig 
cell line (Hirose ef al, 1991). The discovery of a second oestrogen receptor 
(ERP) (Kuiper el al, 1996) could also have implications for the observed 
differences in corticosterone affinity in the two tissues. These differences may 
reflect different structures for the receptors, and different responses to the ligand. 
Differential oestrogen receptor subtype distribution in reproductive, brain and 
immune tissues could account for the ability of oestrogens to exert tissue specific 
effects. In addition to distribution ratio differences between oestrogen receptor 
subtypes, there could be differences in the oestrogen response elements in the 
DNA that might respond differently to the alpha or beta homodimers or 
heterodimers of the oestrogen receptors. The mediation of gene transcription via 
the AP I enhancer site might also differ depending upon receptor sub-type (Paech 
et al, 1997). Paech et al showed that the oestrogen receptor-alpha (ERu) and 
oestrogen receptor-beta (ERP) subtypes signal in opposite ways when complexed 
with natural oestradiol at an AP I site. The oestradiol-bound alpha receptor 
activated transcription while the beta receptor had the opposite effect and 
inhibited transcription. Moreover, tamoxiphen, an anti-oestrogen, was a potent 
activator vAth the beta receptor at the API site. Further experiments using 
Western and Northern blot techniques might clarify whether there are indeed 
differences in the molecular structure of the oestrogen receptor in the thymus 
that could account for the observed differences in the affinity of the cytosolic 
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oestrogen receptor in this tissue compared with the values found for uterus and 
those reported for brain tissues. 
The relatively high affinity of the thymus receptor for corticosterone maV 
be significant in view of the well known immuno suppressive actions of the 
glucocorticoids. Determination of the development of autoimmune and 
inflammatory conditions such as systemic lupus erythymatosus and rheumatoid 
arthritis depend, in part, upon interactions between the immune system and the 
hypothalarno-pituitary-adrenal axis. The response to acute stress, cojyýtive or 
non-cognitive, is the release of corticosterone from the adrenals in the rat 
(cortisol in humans) and these steroids are potent immunosupressive hormones. 
(reviewed by Harbuz ef al, 1997). The Lewis strain of rat * is susceptible to 
experimental allergic encephalomyelitis after challenge with guinea pig basic 
myelin protein. This strain shows defects which include a lower response to 
stress in the hypothalamo-pituitary-adrenal aXis. In this animal model of 
autoimmune disease, the progress of the condition can be stopped by treatment 
with corticosterone. Evidence from studies of Lewis rats suggests that 
autoimmune disease may result from a hyPoresponsive hyPothalamo-pituitary- 
adrenal axis (Derijk and Sternberg, 1994). Adrenalectomy can also increase the 
severity of induced disease in autoimmune-prone rats (Macphee et al, 1989). 
Thus stress, by increasing glucocorticoids in circulation, maintains immune 
homeostasis in the face of infection when an immune response has been 
generated by this stressor. Glucocorticoid activity in the brain is associated with 
modulation of protein synthesis (Nfileusnic el al, 1986) and this finding could be 
significant for alterations in the thymus in response to stress. 
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Reductions in basal (early morning) serum cortisol levels in humans with 
rheumatoid arthritis, reductions in adrenal function in patients with multiple 
sclerosis, and glucocorticoid resistance in patients with systemic lupus 
erythymatosus have been observed. These findings suggest that the 
hypothalarno-pituitary-adrenal axis may be compromised in a variety of 
autoirnmune disorders (Harbuz et al, 1997). Dehydroepaniandrostenedione may 
also have a physiological role in regulating the immune response. This adrenal 
steroid may oppose effects of glucocorticoids although the mechanism of such a 
role has not been elucidated. 
Communication between the hyPothalamo-pituitary-adrenal axis and the 
hypothalamo-pituitary-gonadal axis also modulates the expression of 
autoirnmune disease. The effects of sex steroids are inhibited by glucocorticoids, 
conversely sex steroids modulate the hypothalamo-pituitary-adrenal axis. 
Paradoxically, the hypothalamo-pituitary-adrenal axis is more active in females 
(human) than in males and should predispose females to lower rather than higher 
incidence of autoimmune conditions. Testosterone may have a protective effect 
in males; oestrogens have effects that vary between different diseases. Oestrogen 
in some cases increases B-cell mediated immunity but decreases cell-mediated 
immune responses. Thus, oestradiol suppresses experimental arthritis in animal 
models of the disease but increases the severity of systemic lupus erythymatosus. 
Cells of the immune system express genes for stress peptides but locally 
expressed corticotrophin releasing hormone appears to have the opposite effect 
to the centrally released hormone in that the locally released hormone has an 
enhancing effect on the immune response (reviewed by Harbuz et al, 1997). 
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There is, moreover, evidence that stress-induced centrally released corticotrophin 
releasing hormone activates the sympathetic nervous system which influences 
immune activity in the periphery independently of glucocorticoids themselves 
(reviewed by Downing and Kendall, 1997). The mechanisms for this regulation 
include neurotransmitter synthesis and release, expression of receptors for these 
compounds and effects of their activity such as alterations to cell proliferation 
and activity of cells of the immune system. Evidence thus far on the role of 
autonomic system modulation of the immune response suggests that sympathetic 
activation depresses T-cell immunity but enhances antibody production. Further 
studies, using molecular biological techniques such as Western blot (for m. RNA 
differences for oestrogen receptor sub-types) or Northern blot (for molecular 
weights of oestrogen receptor sub-types) might identify the presence of ERcc and 
ERP receptors in the thymus and enable the relative concentrations of the sub- 
types, if they are present, to be detected. 
In summary, the thymus, a primary lymphoid tissue, may via interactions 
of glucocorticoids, sex hormones and sympathetic innervation respond and 
possibly develop differently in males and females. The finding of the present 
study, that oestrogen receptor affinity for corticosterone was one order of 
magnitude higher in the thymus than in uterus, could provide additional 
mechanistic explanations of autoimmune susceptibility in individuals in whom the 
stress response axis might be altered. This alteration could result in altered ratios 
of oestrogen receptor sub-types in individuals. There could be differential 
expression of receptor subtypes between the sexes in thymus although there is no 
evidence at present of such a difference. The expression of different sub-types of 
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oestrogen receptors could be modulated by corticosterone itself or by alterations 
of innervation of the thymus itself either genetically programmed and/or induced 
by stress during development. 
Although there may be structural differences between the cytosolic 
oestrogen receptor in uterus, brain and thymus, there may also be differences 
during ontogeny in cytosolic oestrogen receptor characteristics in the tissues 
and/or in their response to oestradiol or to agonists and antagonists of this 
hormone. Further studies of these tissues were undertaken in order to investigate 
oestrogen receptor concentrations and binding constants in developing rats as 
well as responses to oestrogen agonists and antagonists in uterus, thymus and 
brain. 
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Chapterfour 
The development of oestrogen receptors in uterus, brain and 
thymus in female and male Wistar rats from 5 to 30 days 
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4.1: Introduction 
1.1 - Steroid metabolism in the brain 
A variety of steroid metabolic pathways appear to co-exist in the brain. 
Active and inactive metabolites of corticosterone, oestradiol and testosterone are 
formed, there may be completing pathways; and stress and social stimuli also 
affect the activity of sex steroids in this tissue. The pathway for steroid synthesis 
from acetate,, cholesterol, and pregnenolone is common to the adrenal cortex,, 
testis and ovary. Hence, neuroactive steroids may originate from these organs 
(Gore-Langton and Armstrong, 1994). Steroids may also be synthesIzed de novo 
in the brain from cholesterol or derive from the metabolism of steroid hormones 
present in the blood. Moreover, steroids may also be available from various 
nutritional or environmental sources. 
Dehydroepiadrosterone (DHEA. ) is produced in the adrenal cortex ftom 
the pregnenolone precursor and, in some species, this hormone may be secreted 
in amounts that exceed cortisol and corticosterone (Goulding and Flower, 1997). 
However, DHEA, pregnenolone, and their sulphates are also synthesized locally 
in the central nervous system and have therefore been termed neurosterolds. 
The mammalian brain contains 5alpha-reductase, 3-alpha-hydroxvsterold 
dehydrogenase and aromatase, enzymes involved in the conversions of 
testosterone, progesterone and corticosterone metabolism. 
5alpha-reductase occurs as two isoforms and both forms reduce 
androgens, progestagens and corticosteroids although the affinities of the two 
isoforms for the substrates differ. The type I isoenzyme form of 5alpha- 
reductase is more abundant in the brain than the type 2 form. There is some 
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evidence that 5alpha-reduced metabolites formed as a result of 5alpha-reductase 
activity are necessary for the process of myelination in developing rats at three 
weeks (reviewed by Celotti et al, 1997), 5alpha-reductase is widely distributed 
in various brain areas including the hypothalamus. It is present in glial and 
ependymal cells of different areas, in oligodendrocytes and, in perinatal rats, in 
germinal zones and differentiating fields although no sex differences in its 
expression have been identified thus far. The formation of dihydrotestosterone,, 
the 5alpha-reduced metabolite of testosterone, is high in white matter structures 
in the brain and appears to have a role in the development of functions associated 
with modulation of GABA-operated chlofide channels. 5alpha-reductase in the 
spinal cord may be associated, through the formation of dihydrotestosterone with 
motorneuron growth (Matsumoto et al, 1988) and in masculinization of the 
sexually dimorphic spinal nucleus of the bulbocavenosus in the rat lumbar spinal 
cord (Goldstain and Sengelaub, 1992). Its association with the development of 
secondary male sex characteristics is well characterised and it also acts 
synergistically with oestradiol in the induction of male sexual behaviour in 
castrated male rats. Moreover, administration of dihydrotestosterone to female 
rats can cause organisational changes in brain and in behaviour (Celottl el al, 
1997). 
The conversion of 5alpha-reduced steroids to the 3alpha-hydroxylated 
derivatives is catalysed by 3alpha-hydroxysteroid dehydrogenase in astrocytes. 
The products of these reactions (dihvdrotestosterone to 3alpha-hydroxvsterold, 
dihydroprogesterone to tetrahydroprogesterone, dihydrodeoxycorticosterone to 
tetrahvdrodeoxycorticosterone. ) may be active by non-genomic interactions at the 
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plasma membrane in regulation of the amount of intracellular 5alpha-reduced 
hormones available for genon-k interactions (Melcangi et al, 1990). 
Pregnenolone sulphate interacts with the y-aminobutyric acid receptor 
(GABAA, the ionotrophic GABA receptor), as do steroids such as 
corticosterone, tetrahydroprogesterone, and tetrahydrodeoxycorticosterone. 
Pregnenolone sulphate and corticosterone interact with the GABAAreceptorin a 
mixed GABA-agonist/ antagonist manner and this interaction is inhibited by the 
neurosteroid., DHEA sulphate (MýJewska and Schwartz, 1987). There is much 
evidence that GABAergic steroids modify the functioning of central GABAN 
receptors in vivo and may participate in the physiological control of central 
nervous system excitability (reviewed by Alonso and Lopez-Coviella, 1998). 
The precursors of GABA-enhancing steroids, 5cc-pregnan-3cc-ol-2-one 
(TITP) and tetrahydrodeox-ycorticosterone (THDOC) are the ovarian and adrenal 
hormones, progesterone and corticosterone respectively. Conversion of the 
precursors of THP and THDOC takes place in the ovaries and adrenal cortex 
(respectively) through activity of 5-alphareductase and 3-alphaoxidoreductase. 
These reactions also occur in the central nervous system, primarily in glial cells 
(reviewed by Celotti et al, 1997). 
Effects of the neurosteroids, progesterone, corticosterone and their 
reduced metabolites may include potentiation of GABAergic inhibition in 
neurons involved in the lordotic response of female rats (Schwartz-Giblin and 
Pfaff, 1987). Pregnenolone sulphate may alter male sexual behaviour through its 
GABA-antagonistic properties (Baulieu el al, 1997). 
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Neurosteroid concentrations vary in the brain according to environmental 
and behavioural circumstances such as stress sex recognition or aggressiveness. 
A physiological function of neurosteroids in the nervous system has been 
suggested by the association of pregnenolone with memory formation in the 
hippocampus of ageing rats, progesterone, synthesized in Schwann cells in the 
peripheral nervous system may have a role in myelin repair (Mayo ef al, 1993). 
The enzymatic activity necessary for progesterone synthesis in the brain 
has been found in the hypothalamus, hippocampus, olfactory bulb, striatum, 
septum, cerebellum and cortex (Martini ef al, 1993) mainly in glial cells (Jung- 
Testas et al, 1989) and oligodendrocytes (Akwa et al, 1993. ) but also in neurons 
Arnold and Breedlove, 1985). 
Aromatase is expressed in a wide variety of tissues in males and females 
including the uterus, brain and thymus. Activity of this enzyme converts 
testosterone to oestradiol. The regional distribution of the enzyme has been 
investigated in rats by methods that include immunohistochemistry, enzymatic 
activity assays and in situ hybidization techniques (Roselli and Resko, 1993; 
Lauber and Lichtensteiger, 1994). While 5-alphareductase is widely distributed 
in the brain, aromatase is expressed chiefly in brain areas concerned with 
reproductive function, that is to say in neurons of the hypothalamus, preoptic., 
limbic,, and amygdala. The role of 5alpha-reductase and clihydrotestosterone in 
the brain remain controversial, those of aromatase, testosterone and oestradiol 
are relatively well established (reviewed by Celotti el al 1997). 
The characterisation and distribution of aromatase M the brain and the 
significance of its role in brain differentiation are relatively well understood. 
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Aromatase catalyses the conversion of testosterone to oestradiol. The secretion 
of testicular testosterone peaks in male rats during the late pre-natal and earlv 
post-natal period (up to 10 days after birth). Blood testosterone concentrations 
then fall to low levels characteristic of the pre-pubertal period in males and as 
puberty is reached, the concentration in blood of testosterone and other 
androgens rise rapidly to adult levels (Balthazart, 1997). 
In perinatal rats, testosterone appears to be necessary for the 
differentiation of aromatase-containing neurons, that is to say for masculinization 
of the neural anatomy necessary for the differentiation of oestrogen- synthesi sin v, 
neurons in the male brain. Androgens also enhance the growth of aromatase- 
containing neurons in the brain. Testosterone, converted to oestradiol by the 
activity of aromatase, deferninizes brain areas such as the hypothalamus. That 
oestradiol is necessary for this process is demonstrated by the finding that 
deferninization of the brain in androgen-receptor deficient mutant nUce is induced 
by administration of oestradiol. Early exposure to oestradiol and testosterone in 
males appears to lead to desensitisation in males to later (adult) exposure to 
oestradiol. In female rats, in the perinatal and early post-natal period, very low 
concentrations of testosterone and available oestradiol are present in the blood 
and in their absence, a female brain develops (reviewed by Pilgnm and 
Hutchison, 1994). Castration of perinatal male rats results in the development of 
a feminized brain and a female pattern of response to oestradiol and progesterone 
in later adult mating behaviour. Conversely, females given testosterone 
perinatally develop into androgenized fernales. The concentration of free 
oestradiol in the blood of perinatal rats is low because the maternally 
derived 
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hormone is bound to alphafetoprotein. In perinatal and early postnatal (up to 15 
days) females, therefore, only very low doses of oestradiol are available for brain 
and other oestradiol- sensitive tissues at this stage. In male, testicular 
testosterone is present in high concentrations in the perinatal and early postnatal 
period and its aromatization to oestradiol in the brain is a key event in the 
development of this tissue. In other tissues such as the thymus, aromatization 
may contribute to differential development in males and females of this primary 
organ of the immune system. 
Whether neurosteroid and/or non-genomic sex steroid activity exert any 
effects on the establishment of sex differences during brain development remains 
to be established. Effects of neurosteroids on glial cell growth and differentiation 
have been observed in the central and peripheral nervous system; in particular, in 
the role of pregnenolone in memory and in progesterone-enhanced growth of 
myelin basic protein- synthesi sing oligodendrocytes (Baulieu, 1997). Possible 
non-genomic effects could include alterations by steroid hormones on cell 
membrane fluidity, binding of steroids to membrane-bound receptors, regulation 
of GABAA receptors on plasma membranes and activation of steroid receptors 
by factors such as doparnine (Brann et al, 1995). 
4.1.2-. Steroid receptors 
The biological effects of steroid hormones are mediated by specific 
receptors. At least two types of steroid receptor have been identified in cells 
responsive to steroids. Genornic (classical) activity is mediated by nuclear 
receptors specific for the effect; non-genomic (non-classical) effects are 
mediated by steroid binding of membrane-bound receptors and are characterised 
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by rapid effects of short duration. The boundaries between effects of the two 
types of receptor are not sharp and overlapping effects due to interactions of the 
two types of receptor are known (reviewed by Tuohimaa el al, 1996). 
1- Intracellular steroid receptors 
The classical oestrogen receptor belongs to a superfan-ffly of protein 
transcription factors whose activity depends upon the binding of specific ligand 
and interaction with nucleotide sequences known as hormone-response elements 
on target genes. This type of response generally results in long-lasting effects 
(Arnold and Gorski, 1984). Members of the superfamily bind various ligands 
including vitamin D, retinoic acid, thyroid hormones, as well as steroid hormones 
such glucocorticoids, and the sex hormones. Transcriptional activation is 
mediated by the AF- I region in the N-terminal domain of the receptor and mav 
be regulated by epidermal growth factor and insulin-like growth factor, the 
structure of AF-I varies considerably between receptors. Steroid binding, in the 
ligand-binding AF-2 domain , is 
highly conserved in the superfamily. Steroids 
bind to a common hydrophobic fold in a ligand-binding fold of the protein 
structure of the receptor. Steroid binding causes a conformational change of a 
C-terininal helix in the receptor and creates an interacting surface to which co- 
activators can bind (reviewed by Parker, 1998). 
DNA binding is associated with two zinc fingers in the AF- I domain. 
Steroids bind as homodimers (although binding of heterodimers of the alpha- and 
beta-oestrogen receptors is known) to steroid response elements on the DNA. 
The first zinc finger determines the specificity of the DNA binding. Two types of 
steroid response element have been identified- both are palindromic half-sites 
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made up of 6 base-pair half sites with a3 base-pair spacer. The oestrogen 
response element is the more conserved of the two types of element, the second 
type is common to the glucocorticoid, progesterone, androgen, and 
mineralocorticoid response elements. A third type of response element has been 
identified for thyroid hormone, retinoic acid and vitamin D. The second zinc 
finger is associated with receptor dimerization. Heat shock proteins (hsp), such 
as hsp 90 bind to specific sequences in the AF-I domain (see Figure 1.2). 
Between the AF- I and AF-2 domain lies a hinge region that permits rotation of 
the receptor. The N-terminal of the AF- I region appears to be more active in 
gene transcription than the AF-2 region (Ing and O'Malley, 1995). Ligand 
binding and phosphorylation-induced conformational changes of the steroid 
receptor trigger transcriptional activation/repression. Moreover, proteolysis of 
ligand-bound receptor and new synthesis of ligand-free steroid receptor appear to 
be involved in termination of transcription activation and/or repression (reviewed 
by Tuohimaa et al, 1996). 
In some circumstances, intranuclear steroid receptors can be activated in 
the absence of ligand binding. Dopamine, through physiological activation of the 
membrane neurotransmitter receptor can mediate the activation of progesterone 
receptor (Power ef al, 1991). Moreover, there is some evidence that the nuclear 
oestrogen receptor may bind to specific DNA sequences in the absence of 
oestradiol binding to the receptor (Gorski ef al, 1993). 
More recently described, are membrane receptors for steroids whose 
activation by ligand may be coupled to membrane ion channels or second 
messenger systems which result in rapid and transitory changes in neuron 
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excitability (Brann ef al, 1995). For example, possible mechanisms for non- 
classica steroid-induced effects include changes in membrane fluidity, and 
hormone actions on the plasma membrane on GABAAreceptors and activation of 
a cascade of second messenger systems. 
There are, moreover, interactions between the responses of the two types 
of receptor, genomic and non-genon-uc since activation of intracellular steroid 
receptors may alter conductance and membrane receptor actIvation may also 
regulate gene expression through regulation of transcription factor signal 
transductance (reviewed by Alonso and Lopez-Coviella, 1998). 
4.1.2.2- Membrane-bound steroid receptors 
Membrane receptors for progesterone are found in hypothalamus where 
hormone binding to the receptor is effective in causing the release of luteinizing- 
hormone-releasing hormone (Ke and Ramirez, 1987) and in cloparrune release by 
the corpus striaturn where it can have stimulatory or inhibitory effects (Dluzen 
and Ramirez, 1991). Moreover, there are sex differences in that male rats have 
lower specific binding for progesterone in the hypothalamus and central nervous 
system than do females (reviewed by Alonso and Lopez-Coviella, 1998). 
Oestrogens can also have rapid non-genomic effects on hypothalamus where the 
inhibitory effect of oestradiol on luteinizing hormone release from the pituitar-v 
may be due to non-genomic control of the release luteinizing hormone releasing 
hormone by the hypothalamus. Oestradiol also has rapid (and therefore 
membrane receptor-mediated) effects on the spontaneous and induced firing rate 
of hypothalamic neurons during the oestrus cycle, on changes in the membrane 
internalisation process, on pituitary prolactin release, and on striatal and 
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dopamine and hypothalamic norepinephrine release in the hypothalamus. In 
other areas of the central nervous system, oestradiol causes depolansation in 
neurons in the hippocampus and cerebellum,, areas assoclated lArith memory and 
learning (Vanderwolf and Cain, 1994). 
Membrane binding of testosterone is less well characterised than that of 
oestradiol but membrane receptors for testosterone have been identified in the 
olfactory bulb of adult male rats where its role may be in the detection of 
chemical cues from females and/or in memory processes of an olfactory nature 
(reviewed by Ramirez and Zheng, 1996. ). 
In general, steroid-induced actions can take place very rapidly (seconds 
or minutes) or over longer periods (hours or days). Permanent effects mediated 
by steroids are attributed to intracellular receptor activity-, conversely, shot-term 
effects are generally ascribed to activation of membrane-bound hormone 
receptors. The timing, perinatal and prepubertal versus adult, of receptor 
activation seems to be an important determinant of whether permanent or 
transitory changes in the brain result from activation of intracellular or membrane 
receptors in target areas of responsive tissues (reviewed by Alonso and Lopez- 
Coviella, 1997). 
4.1.2.3 - Alpha and beta oestrogen receptors 
The actions of oestradiol were though to be mediated by a single 
oestrogen receptor until the recent cloning of a novel oestrogen receptor, 
oestrogen receptor-beta (ERP) in prostate tissue (Kuiper et al, 1996). The 
oestrogen receptor exists as two sub-types, oestrogen receptor-alpha (ER(x) and 
the beta receptor, ERO. ERO is highly homologous to ERct (95 percent) in the 
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DNA-binding domain (AF-1) but 55 percent homologous in the C-terminal 
ligand-binding domain (AF-2. ). The two sub-types differ in slightly in their 
affinity for oestrogenic substances or antagonists. The order for the ERcc isý 
diethylstilbestrol > hexestrol > dinestrol > 4-OH-tamoxiphen > 17beta-oestradiol 
> coumestrol, > ICI-164384 > estrone, > 17alpha-oestradiol > nafoxidine > 
moxestrol > clomiphene > oestriol, > 4-OH-oestradiol > tamoxiphen, > 2-OH- 
oestradiol, > 5androstene-3beta, l7beta-diol, genisteln. The order for the ERý 
is. dinestrol > 4-OH-tamoxiphen > DES > hexestrol > coumestrol, > ICI- 1643 84 
> 17beta-oestradiol > oestrone, genistein > oestfiol > nafoxidine, 5androstene- 
3beta, 17beta-diol > 17alpha-oestradiol, clonuphene, 2-OH-oestradiol > 4-OH- 
oestradiol, tamoxiphen, moxestrol. 
The tissue distribution and/or relative level of ERct and ERP expression 
differs markedly. There is moderate to high expression of ER(x in uterus, testis, 
pituitary, ovary, kidney, epididyn-ýs and adrenal. Expression of ERP is moderate 
to high in prostate, ovary, lung, bladder, brain, uterus and testis. Saturation 
ligand binding analysis of the two sub-types with 16alpha-iodo- I 7beta-oestradiol 
shows a single binding site with high affinity (Kd = 0.1 rM for ERcc, Kd = 0.4nM 
for ERP) (Kuiper et al, 1997). ERu. and ERP are differentially expresse in 
discrete sub-regions of the amygdala in females rats. The sub-types differ in their 
response to oestradiol treatment which results in decreased ER(x mRNA 
expression in the arcuate ventromedial hypothalamus but increased expression of 
ERO mRNA in the arcuate (Osterlund et al, 1998). Further studies confirm the 
presence of ER(x and ERP mRNA throughout the rostral-caudal extent of the 
brain and spinal cord. Some areas, such as the olfactory bulb in females, neurons 
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of the cerebellum, and some nuclei of the hypothalamus express only ERP. In 
contrast, ERa mRNA only is found in the ventromedial hypothalamus. Neurons 
of other areas including the bed nucleus of the stria terminalis and cortical 
amygdala express both forms of the oestrogen receptor. While neurons of the 
cerebral cortex and hippocampus also express mRNA for both sup-types of the 
oestrogen receptor, ERP is much more highly expressed than ERct (Shughrue ef 
al, 1997). 
The distribution of ERcc and ERP differs in the ovary of the rat. ER(x is 
highly expressed in stromal cells while ERP is concentrated in granulosa cells of 
developing follicles. In the uterus, ER(x is abundantly expressed in stromal and 
epithelial cells of the endometrium. In male rats, ERP but not ERct expressing- 
cells are found in prostate and Sertoli cells (Shughrue el al, 1998a). 
The ERP has been identified in mice (Shughrue ef al, 1998b) and 
monkeys (Register el al, 1998) as well as in humans and rats. Moreover, studies 
using ERa knock-out mice, deficient specifically for ERct but not ERP confirm 
that ERP is localised in many brain areas, including those associated with 
teaming and memory (Shughrue el al, 1998b). 
These new findings, of differential specificity and tissue distribution of the 
two forms of the oestrogen receptor, may provide new insights in oestrogen 
action during the development of the brain, reproductive tissues and in other 
tissues such as the thymus. 
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4.1.3 - Oestrogen receptors in the brain 
Oestrogen receptors are present in rat brain and they are concentrated in 
regions that are known to be responsive to oestradiol. These areas include the 
preoptic area, hypothalamus, cerebral cortex and amygdala (MacLusky ei al, 
1987-, Yokosuka el al, 1995). Aromatase, which catalyses the conversion of 
testosterone to oestradiol, is also present in the preoptic area, hypothalamus, and 
hippocampus (. MacLusky el al, 1994). 
The preoptic area of the brain is associated with many sexuallv 
differentiated reproductive functions (Arnold and Gorski, 1984, Meisal and 
Sachs, 1994). During development of the limbic-hypothalamic circuit, chemical 
and morphological differences in males and females appear to depend upon 
differential exposure to sex steroids during the prenatal period (Nficevych and 
Ulibarri, 1992). Circulating testosterone in prenatal and postnatal male rats is 
aromatized to oestrogen in the brain where it effects its deferninizing properties 
through activation of oestrogen receptors (Greenstein, 1978, MacLusky el al, 
1987). These effects include sexual dimorphism of specific neural areas and 
sexual behaviour in adult mammals such as the rat (Fox et al, 1978, MacLusky 
and Naftolin,, 1981). In the preoptic area of the brain, several binding studies 
have not detected sex-related differences in levels of cytosolic oestrogen-binding 
receptors (Fox ef al, 1978, McLusky el al, 1979). AutoradlographIc studies 
similarly found no sex difference in the number of oestrogen-concentrating cells 
in the preoptic area of neonatal rats (Friedman et al, 1983a; Sheridan el al, 
1974). On the other hand, the levels of mRNA for the oestrogen receptor In this 
area co-vary with levels of oestrogen receptor and are lower in male rats at birth 
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than in females. Moreover, higher concentrations of oestrogen receptors in the 
preoptic area of female rats were found in other studies (Kuhnemann et al, 
1994). At this age males have higher levels than do females of circulating 
testosterone, which is available for aromatization to oestrogen (Don Carlos et al, 
1996). 
There is an apparent paradox in the role of oestrogen in the development 
of a defeminized brain in males. It may be that oestrogen acts in synergy with 
androgens in this developmental process and 'primes' the brain in males for 
testosterone-dependent structure formation and for the later characteristic male 
response to oestradiol. At puberty, the concentration of cytosolic oestrogen 
receptors in the preoptic area in female rats decreases at the same time as levels 
of nuclear oestrogen receptor and cytosolic progesterone receptor increase. This 
is the period of increased levels of circulating oestrogen produced in the 
developing ovaries and is associated with vaginal opening and the first pre- 
ovulatory gonadotrophin surge that heralds the start of reproductive activity 
(Woodman, 1997). 
Early studies on the differences between levels of oestrogen receptor in 
the hypothalamus and pituitary of immature male and female rats suggested that 
there were no differences in nuclear binding between the anterior pituitary of 
males and females. In some studies, the hypothalamus of the female shows a 
limited ability (compared with the uterus) to bind oestradiol, but the male 
hypothalamus has no capacity to bind this hormone (Clark et al, 1972). 
Kuhnemann ef al (1994) used in vitro autoradiographic analysis of oestrogen 
binding in the rat brain between ages 2 -10 days. They found sex differences in 
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the number of oestrogen receptors present in the periventricular preoptic area, 
medial preoptic area and bed nucleus of the stria terminalis, though not in the 
nucleus or ventromedial, nucleus of the hypothalamus nor in the cortical or medial 
nucleus of the amygdala. Sex differences in the density of oestrogen receptors 
have also been identified in rat hypothalamus using oestrogen receptor- 
immunochemical methods (Yokosuka el al, 1995). 
Sexually dimorphic brain functions include the hypothalamic activity of 
the inhibitory neurotransmitter, y-aminobutyfic acid (GABA), although sex 
steroids have no direct effect on the cell numbers or on GABA uptake by 
GABAergic neurons. Efferent or afferent connections with other dimorphic 
neurons as well as neurosteroid. interactions may be responsible for the observed 
sex dimorphism in this group of cells (Lieb et al, 1994). Timing of the critical 
period for the effects of androgens and their metabolites on sexually dimorphic 
development appears to be related to developmental differences in the ability of 
cells to bind these hormones. 
The function of elevated oestrogen receptor concentrations in the 
developing cortex is not fully understood. Oestrogen concentrations in this area 
of the brain of developing rats reach a maximum during the first post-natal week 
and this period coincides with rapid growth and development of neurones. 
Administration of oestrogen during this period has long been known to enhance 
the process of brain myelination in cortex (Curry and Hein, 1966) and this 
finding 
supports a physiological role for oestrogen in brain development. In vitro studies 
in dissociated cortex cultures (Uchibori and Kawashima, 1985) and in cortical 
explant cultures (Toran-Allerand ef al, 1988) have also demonstrated that 
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oestrogen enhances neurite outgrowth, either directly or by interaction with other 
growth factors. Recent studies have detected oestrogen receptors in auditorv, 
somatosensory and visual cortices of neonatal rats with a peak at post-natal day 
3, although there were no sex differences (Yokosuka ef al, 1995). This study 
gave similar results to the autoradiographic studies by Shughrue ef al (1990), 
which showed high concentrations of oestrogen receptors in mouse cortex with a 
peak at ten days after birth. In other brain areas, such as the hippocampus, 
development differs between males and females and is regulated by the binding of 
oestradiol to the oestrogen receptor (Diamond et al, 1982, O'Keefe and Handa, 
1990). 
4.14: Oestrogen receptors in the thymus 
There is good evidence that, in many species, oestrogen receptors are 
present in the thymus. The dissociation constant for oestradiol in these tissues is 
of the order of 10-10-10-9M. Moreover, the receptor is similar to that in the 
uterus in its specificity for oestradiol and in its dissociation constant in humans 
(Nilsson ef al, 1984, Weusten ef al, 1986), rats (Morgan and Grossman, 1985) 
and mice (Aubrey-Thompson, 198 1) (Section 1.4). 
It is mainly cells of the reticuloepithelial cell population within the thymus 
that express receptors for oestrogen in rats (Imanishi et al, 1980). Using 
monoclonal antibodies to the oestrogen receptor and the progesterone receptor, 
and polyclonal antibodies to thymulin, Kawashima et al (1991) identified the 
reticuloepithelial cells and Hassall's corpuscles as the sex steroid- sensitive and 
thymulin-producing cells in the medulla of rat thymus. Furthermore, oestrogen 
receptors are present in the nucleus and in the cytoplasm of this group of cells. 
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They propose that sex steroids exert their effects on developing thvmocvtes 
through reticuloepithelial cells whose response to oestrogen is the production 
and release of thymulin as a regulator of T-cell differentiation. 
Oestradiol and dexamethasone in vivo alter the relative numbers of T- 
cells at their different developmental stages in thymus. While the overall effects 
of these compounds on the relative changes are similar in the shorter term, the 
oestradiol effects take longer (by 48 hours) to appear. This finding suggests that 
dexamethasone may act directly on the thymocytes while the oestradiol effects 
are mediated via the reticuloepithelial cell population (Screpanti et al, 1989). 
Oestrogen receptors are present in thymocytes and oestrogen receptor niRNA is 
also found in the cytosol of these cells in mice, although in lower concentrations 
than in reticuloepithelial cells (Kawashima ef al, 1992). 
Thymocyte sub-population ratios are altered by treatment with oestradiol 
(Novotny ef al, 1983) with a significant increase in mature T-cells of the helper 
type (CD4+). This finding is confirmed by work that shows that oestradiol 
causes a decrease in the number and proportion of intermediate T-cells of the 
CD4+/CD8+ population, with a proportional increase in the percentage of the 
less mature CD4-/CD8- T-cells, and to a lesser extent the mature CD4+ and 
CD8+ subsets (Screpanti et al, 1989). It is possible that CD4+CD8+ T-cells 
express higher concentrations of oestrogen receptors than the less mature T-cells 
and are more severely affected by oestrogen treatment. Perhaps, treatment with 
oestradiol interferes with the progressive maturation of immature T-cells over the 
period of treatment; oestradiol might also promote the maturation of T-cells from 1ý 
the CD4+CD8+ to the CD4+ or CD8+ populations. Oestrogen treatment blocks 
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T-cell development in the thymus of Balb/c mice although oestrogen deprivation 
by oophorectomy does not enhance the process (Rijhsinghani el al, 1996b). 
There is much evidence, therefore, that oestradiol causes changes in the thymus 
and that oestrogen receptors are present in thymocytes as well as in the 
reticuloepithelial cells in this tissue. 
Several observations suggest that immunological dimorphism develops 
during sexual maturation. In male hamsters, depression of immunity occurs 
when testosterone levels are increasing at puberty (Blazovec and Orsini, 1976). 
in human females there is a significant increase in the circulating levels of 
immunoglobulin G as oestrogen levels start to rise (Stoica et al, 1978-, Weetman 
et al, 1981). This is a period when juvenile arthritis, more common in females 
than in males, also develops (Aarow et al, 1985). Such dimorphism may be 
established early during the development of T-cells in the thymus and may be a 
result of the difference in the thymic microenvironment due to the different 
effects of the male and female sex hormones. Gonadectomy results in different 
effects on the thymus in 30-day and 75-day-old male and female rats (Leposavic 
ef al, 1996). Differences between the sexes are found in the size and total 
thymocyte yield of the thymus regardless of age or treatment, while gonadectomy 
at 30 days (though not at 75 days) results in increases in thymic weight in both 
sexes. At 30 days, the females in the control group have a higher percentage of 
CD4-/CD8- thyMocytes than do gonadectomised females, while the opposite 
effect is found in males. Gonadectomy at this age, however, results in an 
increase in both sexes of the CD4+CD8- subset. The difference in response to 
gonadectorny between the sexes at 30 days suggests that these two subsets of T- 
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cells may differ in their age-related sensitivities to local sex hormone action. 
Altematively, altered sex hormone availability after gondectomy could effect 
changes in the reticuloepithelial. cells in the thymus and on their release of thymic 
hormones. 
If differences in immune responsiveness exist between males and females 
and these differences are due to the different hormone environments in males and 
females, the role of sex hormone receptors must be crucial in the development of 
this phenomenon. Studies in humans, guinea pigs, mice and rats, confirm the 
presence of oestrogen receptors in the thymus (Nilsson et al, 1990,:, Screpanti el 
al, 1982, Kawashima et al, 1992). 
Concentrations of available free oestradiol are low in perinatal and 
neonatal rats, due to the presence in the blood of immature rats of a protein 
called alphafetoprotein that binds oestrogens (see Figure 2.11 ). This binding of 
oestradiol by alphafetoprotein is reflected in the low level of the free fraction of 
the hormone and is of biological significance in brain and uterus development. 
Alphafetoprotein is secreted by the foetal liver, decays slowly after birth and is 
undetectable after 28 days (Nunez ef al, 1971, Greenstein ef al, 1978, 
Greenstein, 1992). Testosterone levels are high in male rats during the early 
post-natal period (Weisz and Ward, 1980) and could be aromatised in the thymus 
as well as in the brain to oestradiol. Differences in the male and female brain as 
well as in the thymus may be due, in some part, to differences in the 
microenviromnent of these tissues during the early post-natal period. 
The present study was undertaken in order to investigate differences in 
the oestrogen receptors in brain and thymus of male and female 
Wistar rats 
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between the ages of 5 and 30 days. Levels of circulating oestradiol are known to 
be low at the start of this period of development, but start to nse by 22 days 
(Greenstein, 1992). Nevertheless, the free fraction of oestradiol in serum was 
also measured in order to confirm its value in these animals. 
4.2: Materials and Methods 
4,2.1 - Animals 
Male and female Wistar rats were purchased from Bantin and Kingman, 
as before, and were allowed to settle for 48 hours before sacrifice. The age 
groups studied were 5 days, 18 days, and 30 days. Animals to be sacrificed at 5 
and 18 days were kept with their litter mates and mother in one cage (56 x 38 x 
20 cm); those rats to be used at 30 days had been weaned (at 21 days) before 
delivery from the supplier and were housed 5 per cage (56 x 38 x 20 cm). All 
animals were housed in the Biological Services Facility in the Rayne Institute, St. 
Thomas's Hospital under conditions of controlled lighting and temperature (fights 
on 08-OOh-20.00h-, lights off 20: 00h-08: 00h-, 19-200C). and were allowed free 
access to BK rodent diet which is steroid free, and to tap water. These ages 
were chosen as the thymus was still growing, the brain was undergoing 
development, and the production of oestradiol in the ovaries, while increasing, 
was still well below adult levels (Greenstein, 1978). 
4.2.2- Chemicals 
Chen-ticals used for this study are given in Section 2.1.1-2.1.5. 
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4.2.3- Methods 
4.2.3.1: Serum was prepared by the method given in Section 2.2.2. 
4.2.3.2: Cytosols from brain, thymus and uterus were prepared by the 
method given in Section 2.2.3. 
4.2.3.3. Steroids for binding studies were prepared by the method given in 
Section 2.2.4. 
.33 4.2.3.4. H-oestradiol- 170 ('H-E2) and H-moxestrol were each prepared 
at a concentration of 5xl 0-7 M and stored at 4'C. 
4.2.3.5-. Unlabelled moxestrol and unlabelled oestradiol-17P were prepared in 
the same way as their tritiated counterparts at a concentration of 5xIO-5 
M and stored at 4'C. 
4.2.4. Assay of cytosols from the brain, thymus and uterus for steroid -receptor 
binding activity. 
4.2.4.1 - Incubation of the cytosol. 
Cytosols, prepared from the three different age groups of male and 
female Wistar rats, were stored at -70T and were assayed within two months of 
their preparation by the methods described in Section 2.2.4. Briefly, 60ýil cytosol 
was incubated with 60ýtl 'H-moxestrol in final concentrations in the incubate 
ranging from 2.5 x 10-9M to 3.1 x 10-10 M in the presence or absence of a 100- 
fold excess of unlabelled moxestrol. These incubations were performed in 96- 
well polypropylene round-bottomed plates, which were sealed and placed in an 
agitating water bath for lhr at 25T. Aliquots of the total of tritlated and 
unlabelled moxestrol (60ýtl) were also incubated in order to establish the total 
125 
steroid added to each of the incubation samples. The samples were cooled to 
2'C before separation of bound and free moxestrol was carried out. 
4.2.4.2-. Separation of bound and free moxestrol 
Columns of Sephadex LH20 were prepared as described in Section 
2.2.4.3. The columns were filled to 9 cm with Sephadex LH-20 and were cooled 
for I hr in a waterbath maintained at 0.5-2.0'C. When the sample had cooled to 
2.0'C after incubation, 100 ýtl was applied to each column and washed in 
immediately with 200ýtl of Buffer 2. The samples remained on the columns for 
I hr, the time established (see Section 2.4) for equilibration of the bound and ftee 
steroid to take place. Each column was eluted with 700ýtl Buffer 2 and the 
equivalent volume of eluate was collected into scintillation vials. Up to 94 
columns (12 samples) could be operated at one time. Scintillation fluid (10ml) 
was added to each vial and, following overnight extraction, the radioactivity was 
counted as before. 
4.2.4.3- Construction of Scatchard Plots 
Scatchard analysis (Section 2.2-5.4) on the data was using the computer 
programme given in Appendix A. Regression analysis was used to obtain a 
measure of the slope and the coefficient of correlation for each Scatchard plot 
obtained. 
4.2.5- Measurement of the free fraction of oestradiol in serum of female and 
male Wistar rats at 5,18 and 30 days 
Measurement of the free-fraction of oestradiol in serum was done by the 
method of Greenstein et al (1987) (Section 2.5). Graphs were constructed using 
sený-Iogarithrnic graph paper in order to estimate the alphafetoprotein-bound 
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3H-oestradiol eluted (between fractions 4 and 9) and the free `H-oestradiol eluted 
(between fractions 15 and 21). The free fraction was then estimated from these 
data. 
4.2.6- Statistical Analyses 
Statistical analyses of the results obtained in this set of experiments were 
undertaken as described in Section 2.6. The analysis tested for signIficant 
differences in body and tissue weight, binding affinity of the oestrogen receptor 
fo r3 H-moxestrol and for the concentration of oestrogen receptors between the 
sexes and the three age groups. 
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4.3: Results 
4.3.1 - Body weights of female and male Wistar rats at 5,18 and 30 days. 
The body weights of female and male Wistar rats in the different age groups are 
shown in Figure 4.1. Between the ages of 5,18 and 30 days, the body and 
tissue weights of male and female Wistar rats increased. There were no 
differences in body weight between males and females at 5 days or at 18 days 
(p>0.05). By 30 days, however, male rats were heavier than female rats of the 
same age group (p<0.05). 
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Figure 4.1: Body weights (g) of female and male Wistar rats at 5,18 and 30 
days. Bars represent the mean ± SEM of 9-10 observations/group. ( *Males 
differ from females of the same age group, p<0.05, Two-way ANOVA. ) 
* 
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4.3.2- Tissue weights of female and male Wistar rats at 5,18 and 30 davs. 
4,3.2.1: Uterus 
The weight of the uterus in the three different age groups is shown in 
Figure 4.2. The weight of the uterus increased between 5,18, and 30 days 
(p<0.05). Between 5 and 30 days the rise appeared to be exponential. 
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Figure 4.2: Uterus weights in Wistar rats at 5,18 and 30 days. Bars represent 
the mean ± SEM of 9-10 observations/group. (*Differs from the females of the 
other groups, P<0.05; Kruskal-Wallis One-Way ANOVA on Ranks, Dunn's 
Multiple All Pairwise Comparison). 
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4.3.2.2- Thymus 
Thymus weights of female and male Wistar rats are shown in Figure 4.3. 
The thymus in both sexes was heavier at 18 days and at 30 days than at each 
earlier age (. p<0.05 in each case). There was no sex difference in the weight of 
this tissue between males and females within any of the age groups (p> 0.05). 
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Figure 4.3: Thymus weight in female and male Wistar rats at 5,18 and 30 days. 
Bars represent the mean ± SEM of 9-10 observations/group. (*Differs from 
other age groups, p<0.05; Kruskal-Wallis One-Way ANOVA on Ranks, Dunn's 
Multiple All Pairwise Comparison). 
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4.3.3 The tissue-to-body weight ratio in uterus and thymus in female and male 
Wistar rats at 5,18 and 30 days. 
The ratio of tissue weight to body weight is shown in Table 4.1. The 
ratio for the uterus did not alter between 5 and 18 days (p>0.05). Bv 30 davs, 
however, it had increased significantly over the value found in the two vounger 
age groups (p<0.05). The thymus weight-to-body weight ratio was similar in 
males and females at 5 and 19 days (p>0.05), but increased in both sexes 
between these ages (. P<0.05). At 30 days, the relative weight of thymus differed 
between the sexes (_p<0.05). In females, the relative weight of thymus showed 
no significant differences at 30 days compared with 18 days (p>0.05). However, 
in males at 30 days, the relative weight of the thymus was signIficantly lower than 
in females at 30 days (, p<0.05) and than in males at 18 days (p<0.05). 
Table 4.1: The relationship of tissue weight (mg x 104 ) and body weight (g) 
(mean ± SEM) in Wistar rats at 5,18 and 30 days. 6-10 observations/group-, 
(, *Males differ from females within the age group and from males at 18 davs), 
p<0.05,, Kruskal-Wallis One-Way ANOVA on Ranks, Dunn's Multiple All 
Pairwise Compafison). 
Sex Tissue 5 days 18 days 30 days 
Female Uterus 9.4±0.9 8.7±1.0 14.6±2.3 
Female Thymus 24.9±1.6 54.8±2.3 43.4-ý- 1.5 
Male Thymus 28.1±1.7 55.2±3.0 3 4.6±1.2 
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4.3.4- Determination of the concentration of cytosolic oestrogen receptors in 
uterus, hypothalamus, cortex and thymus 
4.3.4.1: Uterus 
The concentration of oestrogen receptors (E2R) in the uterus of Wistar rats is 
shown in Figure 4.4. The concentration of oestrogen receptors in the uterus 
approximately doubled between each of the age groups and was significantly 
different in all three age groups (p<0.05). 
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Figure 4.4: Concentration of cytosolic oestrogen receptors (EM), (fTnole/mg 
protein) in the uterus of Wistar rats at 5,18 and 30 days. Bars represent the 
mean ± SEM of 5-10 observations/group. (*Differs between females in the three 
age groups, p<0.05; Kruskal-Wallis One-Way ANOVA on Ranks,, Dunn's 
Multiple All Pairwise Comparison). 
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4.3.4.2- Hypothalamus 
The concentration of oestrogen receptors in the hypothalamus of female 
and male Wistar rats is shown in Figure 4.5. In females,, there was a progressive 
decrease with age in the concentration of oestrogen receptors in the 
hypothalamus (, p<0.05). There were higher concentrations (approXimately 
double) of binding sites in the hypothalamus of 5-day-old females than in males 
of the same age group (p<0.05). However, at 18 and 30 days, there were no 
significant differences in the concentration of oestrogen receptors in 
hypothalamus between the sexes (p>0.05). 
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Figure 4.5: Concentration of cytosolic oestrogen receptors (EM), (fmole/mg 
protein) in the hypothalamus of female and male Wistar rats at 5,18 and 30 days. 
Bars represent the mean ± SEM of 5-10 observations/group. (*Differs between 
males and females at 5 days, and between females in all age groups, p<0.05,, 
Kruskal-Wallis One-Way ANOVA on Ranks, Dunn's Multiple All Pairwise 
Compafison). 
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4.3-4.3 -. Cortex 
The concentration of oestrogen receptors in the cortex of female and 
male Wistar rats is shown in Figure 4.6. In cortex, there were no differences in 
concentration of oestrogen receptors in 5-day-old and in 18-day-old rats 
(p>0.05). By 30 days, however, no binding sites were detectable in either sex. 
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Figure 4.6: Concentration of cytosolic oestrogen receptors (EM), (fi-nole/mg 
protein) in the cortex of female and male Wistar rats at 5,18 and 30 days. Bars 
represent the mean ± SEM of 5-10 observations/group. nd = not detectable. 
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4.3.4.4: Thymus 
The concentration of oestrogen receptors in the thymus of female and 
male Wistar rats is shown in Figure 4.7. In thymus, the concentration of binding 
sites was sin-fflar in both sexes and in all three age groups (p>0.05) with the 
exception of 5-day-old females. In this group, the concentration of binding sites 
was not only greater than in males of the same age group, but also higher than in 
females in any of the other groups (. p<0.05). 
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Figure 4.7: Concentration of cytosolic oestrogen receptors (EM), (fmole/mg 
protein) in the thymus of female and male Wistar rats at 5,18 and 30 days. Bars 
represent the mean ± SEM of 5-10 observations/group. (*Differs between males 
and females of the same age group, p<0.05,, Kruskal-Wallis One-way ANOVA 
on Ranks, Dunn's Multiple All Pairwise Comparison). 
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4.3.5. Measurement of the molar dissociation constants of the oestrogen 
receptor (Kd) in uterus, hypothalamus, cortex and thymus. 
Molar dissociation constants (Kd) were calculated by Scatchard plots as 
described in Section 2.2.5.4. In all tissues, and under the conditions of the 
experiments, binding isotherms yielded linear Scatchard plots, and the results 
(Table 4.2) were consistent with the presence of a high-affinity binding receptor 
for the ligand. (Figure 4.8). 
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Figure 4.8: Examples of Scatchard analysis of moxestrol binding to immature 
male and female rat cortex, hypothalamus, thymus and uterus cy-tosols. 
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No significant differences were found in the value of apparent affinitV of 
the oestrogen receptor for 3 H-moxestrol in any of the tissues examined (p>0.05). 
The value of the dissociation constant in all the tissues was of the order of 10-9 M 
(Table 4.2). In cortex,, the binding constant was the same as in other tissues in 
rats of 5 and 18 days (p>0.05). By 30 days, however, no binding was detectable 
in this tissue in either male or female rats. 
Table 4.2: Molar dissociation constant (Kd) of cytosolic oestrogen receptor 
in uterus, hypothalamus cortex and thymus of male and female wistar rats at 
18 and 30 days old mean ± SEM, number of observations 6-10, (Kruskal-Wallis 
One-way Analysis of Variance on Ranks, Dunn's All Pairwise Multiple 
Compafison Method) n. d. = not detectable by this method. 
Sex Tissue 5 days 
Kd x 10-9 M 
18 days 
Kd x 10-9 M 
30 days 
Kd x 10-9 M 
Female 
I 
Uterus 2.53±0.75 1.31±0.18 2.23±0.32 
Female Hypothalamus 4.52±1.17 2.16±0.19 2.75±0.68 
Male Hypothalamus 3.33±0.44 2.46±1.17 3.82±1.06 
Female Cortex 2.55±0.62 2.22±0.27 n. d. 
Male Cortex 1.44±0.36 3.06±1.84 n. d. 
Female Thymus 2.20±0.51 1.89-+0.83 3.24+-0.57 
Male Thymus 1.71±0.39 1.79±0.58 2.62-+0.41 
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4.3.6-. The free fraction of oestradiol in the serum of female and male Wistar rats 
at 5,18 and 30 days 
The results of the measurement of the free fraction of oestradiol in the 
serum of Wistar rats at 5,18 and 30 days are shown in Figure 4.9. The free 
fraction of oestradiol in the serum was low at 5 and 18 days (less than 1.8% of 
alphafetoprotein-bound oestradiol) but had fisen by 30 days to sirnilar levels in 
both sexes of 6.25%, which is the level found in adult rats. At 30 davs, 
alphafetoprotein levels are low as the carrier protein is synthesised by the foetus 
during the prenatal period and is gradually metabolised in the neonate. 
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Figure 4.9. The free fraction of oestradiol in serum of female and male Wistar 
rats at 5,18 and 30 days. Bars represent the mean ± SEM of 5-10 observations 
per age and sex group. 
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4.4: Discussion 
The aims of this study were to examine the binding characteristics of the 
cytosolic oestrogen receptor in the uterus, two brain regions, (the hypothalamus 
and the cortex), and the thymus of immature female and male rats and to 
establish whether there were sin-filarities or differences in its concentration and 
dissociation constant in these tissues Such findings could have physiological 
significance. 
The three age groups chosen for this developmental study were identified 
as being appropriate for a number of reasons. Among the many changes taking 
place during this stage of development are several that appear to be dependent 
upon oestrogen. The uterus reaches its potential for reproduction during this 
period (Greene and Press, 1984. ). Sexual differentiation of the central nervous 
system in rats, as in most mammalian species, results, in part, from gender 
differences in gonadal hormone environment in the brain during the perinatal 
period (Keefer and Holderregger, 1985, O'Keefe and Handa, 1990, reviewed by 
Pilgrim and Hutchison, 1994. ). The free fraction of circulating oestradiol is low 
at 5 days and begins to rise at about 20 days as puberty approaches, reaching 
adult levels at 30 days (Greenstein, 1992). There is much evidence that 
involution of the thymus is related to increasing concentrations of sex hormones 
with approaching puberty (Chiodi, 1940, Grossman, 1984-, Greenstein, 1986). 
Moxestrol, a synthetic oestrogen, was used for determining the binding 
characteristics of the oestrogen receptor in the three age groups. The dissociation 
constant of the oestrogen receptor for oestradiol is lower (0.16 x 10-9M) than 
for 
moxestrol (0.73 x 10-9M) in some rat tissues However , in 
Scatchard analyses 
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that compared the binding characteristics of these two ligands, the same 
concentration of oestrogen receptors was found although the Kd value differed 
somewhat (Dahlberg, 1982; Kuhn-Velten et al, 1984). Moxestrol, unlike 
oestradiol, does not bind to alphafetoprotein. In immature rats, the high level of 
alphafetoprotein could interfere with the binding assays (Gerlach el al, 19833, 
Pulg-Duran et al, 1979). Since the objective of this work was to compare the Kd 
and concentration of the cytosolic oestrogen receptor in immature rats, 
moxestrol was the more suitable agonist than oestradiol for this purpose. 
4.4.1 -. Body and tissue weights 
Between the age of 5 and 30 days, Wistar rats increased in weight. At 5 
days, males and females had similar body weights and the increase in weight 
between this age and 18 days was similar in both sexes. However, 30-dav-old 
males were heavier than females of the same age by which time, ftee oestrogen 
levels were rising in both sexes (see Figure 4.9). Oestrogen is necessary for bone 
maturation and in the pre-pubertal growth spurt in males and females (reviewed 
by Lee and Witchel, 1997). In rats, there is synergism between growth hormone 
and testosterone and this finding may account, in part, for the weight difference 
found between males and females (Zachmann, 1992). 
Uterus weight increased progressively in each of the age groups (Figure 
4.2) although the tissue-to-body weight ratio of this tissue did not change 
between the ages of 5 and 18 days (Table 4.1). By 30 days, however, the tissue- 
to-body weight ratio of the uterus was significantly greater (p<0.05) than at the 
earlier ages in response to the increasing availability of oestrogen in circulation. 
The increased uterus weights were similar to the changes found by Brovvn et al 
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( 1994) in their study of pubertal development of oestrogen receptors. During 
this period, oestrogen receptor mRNA is present in the uterine stroma and 
increases from day I to day 14 of postnatal life. It is not present at birth in the 
lurninal epithelium and does not become abundant in this tissue until postnatal 
day 7. However, in the developing uterus, the oestrogen receptor is abundant in 
the glandular epithelium of the uterus by postnatal day 21 (Fishman et al, 1996). 
The weight of the thymus also increased progressively with age and the 
increase was similar in both sexes. In both sexes the ratio of tissue-to-bodv 
weight increased from 5 to 18 days. In females, the value of the tissue-to-bodv 
weight ratio at 30 days was similar to its value at 18 days. In males at 30 davs, 
however,, the ratio of thymus to body weight was significantly less than in 
females of the same age. Wise and Klindt (1995) made a similar finding when 
considefing the thymus of developing male and female cattle. In rats, oestrogen 
levels rise between 24 and 30 days in both sexes (Figure 4.9) and this response 
could slow the rate of thymus growth compared to the overall body weight gain 
in the males (Table 4.1) which is mainly directed by growth hormone. It is well- 
known that oestradiol administration causes thymic atrophy in rodents (Chiodi, 
1940, Dougherty, 1952. ) and the thymus at this age may be responding to the 
increasing levels of free oestradiol in circulation. The effects of increasing 
testosterone may also be among several causes of thymic regression at this period 
of development and could explain the difference observed between males and 
females by 30 days. Greenstein et al (1988a) showed that orchiedectomv 
increased the tissue-to-body weight ratio of thymus in 10-week-old rats, while 
testosterone administration blocks the regenerative effect. It is also possible that 
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in the thymus, aromatase activity in males may convert circulating testosterone to 
oestradiol. 
4.4.2: Receptor studies: oestrogen receptor concentration 
Uterus 
The determination of the concentration of cytosolic oestrogen receptors 
in Wistar rats showed that in uterus there was a progressive increase with age in 
the number of receptors per mg of protein (p<0.05) (Figure 4.4). At 30 days, the 
concentration of cytosolic oestrogen receptors in the uterus of Wistar rats was 
half the value found by Grossman el al (I 979a) in Sprague-Dawley rats of the 
same age but was higher than the value found in 55-60-day-old Sprague-Dawley 
rats by Hagenfeldt and Eriksson (11988). Dhaher showed that cytosolic 
oestrogen receptor concentration differed between autoimmune-prone and non- 
autoimmune-prone mice. The difference between the results of Grossman's 
study and the results found in this study may be due to strain differences or to the 
different methods used in the two studies. Results of other research groups 
whose results are shown in Table 4.3. 
During this period, the concentrations of free oestradiol are rising as 
alphafetoprotein, the molecule that sequesters maternal oestrogen In the blood of 
new-born mammals, disappears from the circulation (Greenstein, 1992, Keel and 
Ise Abney, 1984). Between 5 and 30 days, the ovaries in rats, begin to synthes' 
and release oestradiol and this increase is associated with increased growth of the 
uterus and of cytosolic oestrogen receptor concentration in this tissue (Gorski el 
al, 1968). 
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Table 4.3: Concentration of oestrogen receptors in uterus from different 
species of rodent. 
Authors Tissue Animals Oestrogen 
receptor 
concentration 
(mean± SE-NI) 
(fmoles/mg 
protein) 
Dhaher, 199. ). Uterus 21 -day-old-Balb/c 112+25 
mice 
Dhaher, 1992 Uterus 21 -day-old-NIRL- 556±78 
Ipr/Ipr mice 
Grossman et al, 1979a Uterus 30-day-old 531+25 
Sprague-Dawley 
rats 
Hagenfeldt and Eriksson, Uterus 55-60-day-old 1233 ±8 
1988 Sprague-Dawley 
rats 
Hypothalamus 
The concentrations of cytosolic oestrogen receptors in the hypothalamus 
of males were similar in all the age groups (Figure 4.5). In females, there was a 
significant decrease in the concentration of oestrogen receptors between 5,18 
and 30 days although at 18 and 30 days there were no differences between the 
sexes. At 5 days, the concentration of receptors in females was approximately 
double and significantly higher than the value found in males of the same age. A 
comparison of the results obtained here and those of other groups is shown in 
Table 4A. 
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Table 4.4: Concentration of oestrogen receptors in hypothalamus of dIfferent 
strains of rats reported by other groups. 
Authors Tissue Animal Oestrogen receptor 
concentration 
(fmoles/mg protein) 
(mean± SEM) 
This study hypothalamus Wistar rats 
males _5 days 7.31±1.10 
female 5 days 14.08±1.96 
males 18 days 8.43±2.52 
females 18 days 8.47±0.93 
males 30 days 5.41±0.65 
females 30 days 4.63±0.99 
Brown et al, 1994 preoptic area of 30-day-old female 20 
the Sprague Dawlc, % rats 
, pothalamus 
hy 
Brown et A 1994 hypothalamus 30-day-old female 25 
Sprague Da,, vley rats 
O'Keefe J and Handa R_ 1990 hypothalamus 5-day-old Sprague- 30 
Dawley rats (male 
and female pooled) 
O'Keefe and Handa, 1990 hypothalamus 18-day-old Sprague- 20 
Dawlev rats ( male 
and female pooled) 
O'Keefe and Handa , 
1990 hypothalamus 30-day-old Sprague- 20 
Dawley rats ( male 
and female pooled) 
Kuhnemann et al, 1994 hypothalamic Wistar rats 
ventro-medial 5 days males 18 
nucleus 5 days females 28 
10 days males 8 
10 days females 20 
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The present study differed in some respects from the results of Brown et 
al (1994) and O'Keefe and Handa (1990). The higher concentration of 
hypothalamic oestrogen receptors in Sprague-Dawley rats that Brown ef al 
(1994) reported may be due to strain differences with respect to the Wistar rats 
used in the present study. The different techniques used in Brown's studv 
(autoradiography) could also account, in part, for the different results obtained 
for 30-day-old rats. O'Keefe and Handa (1990), using binding techniques, found 
a slightly higher concentration of cytosolic receptors in the hypothalamus of 5- 
day-old rats compared with older age groups and no sex differences in any of the 
age groups studied. Results of their study showed higher concentrations of 
oestrogen receptor in the hypothalamus than the results of the present study and 
the difference could be due to the different strain (Sprague-Dawley) rat used. On 
the other hand, results of the present study were in agreement with those of 
Kuhnemann el al (1994), who detected higher concentrations of oestrogen 
receptors in 5-day-old female Wistar rats than in males of the same age group, 
with the sex difference still present at 10 days. By 18 days, in the Wistar rats 
used in the present study, no sex differences in hypothalamic oestrogen receptor 
concentrations were detected. 
Changes over time of oestrogen receptor concentration in hypothalamus 
could be due to a number of factors. The decrease in oestrogen receptor 
concentration in females between 5 and 30 days could be due to the increasing 
availability of oestradiol as alphafetoprotein concentrations decrease and as the 
ovaries begin to synthesise and release oestradiol. A consequence of increased 
oestradiol would be binding of the receptor and subsequent translocatIon to the 
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nucleus and hence a reduction in cytosolic receptor concentration 'would be 
observed. Alternatively, the binding of receptor could down-regulate receptor 
synthesis and lead to reduced cytosolic receptor concentrations as replenishment 
of receptors declined. In males, on the other hand, locally synthesised oestradiol, 
by conversion from testosterone, is available at 5 days. Binding of oestradiol in 
males to the oestrogen receptor and to the subsequent translocation of the bound 
receptor to the nucleus would result in a decrease in cytosolic oestrogen 
receptors in males at 5 days. Measurement of the nuclear receptors as well as of 
cytosolic receptors by autoradiography or by inimunohistochernistrv could 
identify whether the hormone-receptor complex was bound to the DNA in the 
nucleus. There are higher concentrations of oestrogen receptor mRNA and of 
the nuclear oestrogen receptor itself in the hypothalamus of 5-day-old male rats 
than in females of the same age (Adcock and Greenstein, 1986). Moreover, in 
female rats, treated at 5 days with oestradiol, the concentration of oestrogen 
receptor mRNA is the same as in males, the nuclear oestrogen receptor 
concentration also rises to the same level as in males at 5 days and treatment of 
neonate females with testosterone produces the same result (Adcock and 
Greenstein, 1986). Higher concentrations of nuclear receptors could be due to 
the presence of high concentrations of oestradiol, aromatized from testosterone 
in the hypothalamus in rats of this age. Translocation of receptor-bound 
oestradiol from cytosol to nucleus in hypothalamus of males in the present study 
could explain the higher concentrations of (untranslocated) cytosolic receptors 
found in the hypothalamus of 5-day-old female rats compared with the males. As 
circulating oestradiol concentrations rise in females during the period up to 30 
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days, the cytosolic receptor levels would fall, if translocation to the nucleus 
occurred, to levels similar to those found in males. 
Treatment of female rats at 5 days with dihydrotestosterone, which is not 
convertible to oestradiol, does not produce the same increase in oestrogen 
receptor mRNA in 5-day-old females as does oestradiol or testosterone treatment 
(Greenstein el al, 1988a) and this finding suggests that oestradiol treatment 
enhances the synthesis of oestrogen receptor mRNA. Treatment of pre-pubertal 
female rats with alphafetoprotein delays vaginal opening and reduces the number 
of nuclear oestrogen receptors in the hypothalamus and the preoptic area as well 
as in the uterus (Greenstein, 1992). This finding of lower concentrations of 
nuclear receptor when oestradiol is not available would be consistent with a role 
for oestradiol in the translocation of hormone-bound receptor from the cytosol to 
the nucleus of the cell. The higher concentrations of oestrogen receptors in the 
hypothalamus of 5-day-old females in the present study could suggest that in 
neonate males and females, oestrogen receptors were present in the cytosols, but 
that in males, circulating testosterone was converted to oestrogen in some cellils, 
through the activity of aromatase. At 5 days females had little free circulating 
oestradiol and therefore their tissues were not exposed to oestradiol at the same 
concentrations as were those of the males until a slighter later age (18-30 days) 
when the ovaries began to synthesise and release oestradiol. 
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Cortex 
The concentration of receptors in cortex cytosols was similar in both 
sexes at 5 and 18 days (Figure 4.6). There did appear to be a slight reduction of 
receptor concentrations between 5 and 18 days, but the difference did not reach 
levels of statistical significance. 
Kuhnemann el al (1994), using quantitative in vitro autoradiography and 
Wistar rats, reported sin-filar results to the present study of brain cortex cytosolic 
receptor concentration at 5 and 10 days with no differences between the sexes in 
cortical oestrogen receptors. O'Keefe and Handa (1990), using binding assays, 
similar to the techniques used for this present study also reported similar results 
of an age-dependent trend to decreased oestrogen receptor concentration in 
cortex, with no sex differences and no receptors detectable by 30 days in either 
sex. These results could suggest that in cortex, increasing concentrations of 
available oestradiol were bound to cytosolic receptors which were translocated 
to the nucleus. Brown el al (. 1994. ) reported increased concentrations of nuclear 
oestrogen receptor and concomitant decreased cytosolic receptors in various 
brain areas of rats at puberty and/or after adn-ýnistration of oestradiol. This 
finding could explain the observation of the disappearance of detectable 
oestrogen receptors in the cortex in the present study. High concentrations of 
oestrogen receptor mRNA have been detected in the cortex of adult rats using in 
situ hybridisation techniques(Pelletier et al, 1988). Loss of cytosolic receptor in 
the cortex could, therefore, have been due to altered post -trans] ati onal 
processing of oestrogen receptor m. RNA or to the development of receptor- 
degrading enzymes in this brain area following the early postnatal period. The 
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sex difference between males and females in the hypothalamus was not shown in 
the cortex and this result could be indicative of the presence and acti-vity of 
aromatase in the hypothalamus, but not in the cortex. Beyer el al (1994) found 
significantly higher concentrations of aromatase-immunoreactlVltv in the 
hypothalamus of developing male mice than in the females. Moreover thev found 
little aromatase immuno-reactivity in the cortex and no sex differences in this 
area of the brain. It is possible that no oestrogen receptors are present in the 
brain cortex after the early postnatal period (Table 4.5. ). 
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Table 4.5: Concentration of cytosolic oestrogen receptors in brain cortex and 
amygdala tissue at different ages (days) in various strains and species of rodent. 
(nd = not detectable). 
Mean oestrogen 
Author Tissue Sex and age receptor 
Animal concentration 
(fmoles/mg 
protein) 
This study Cortex Female ýI 10.5 
Wistar rats Male 5 8.5 
Female 18 6.0 
Male 18 6.0 
Female 30 nd 
Male 30 nd 
Kuhnemann et al, 1994 cortical male 5 17 
amygdala female 5 17 
Wistar rat male 10 8 
female 10 12 
Brown et al, 1994 amygdala female 30 4 
Sprague- 
Dawley rat 
O'Keefe and Handa, 1990 cortex male and female 
Sprague- pooled 5 20 
Dawley rats 
O'Keefe and Handa. 1990 cortex male and female 
Sprague- pooled 18 2 
Dawley rats 
O'Keefe and Handa, 1990 cortex male and female 
Sprague- pooled 30 nd 
Dawley rats 
Shughrue et al, 1990 cortex age 1-8 increase 
perinatal age 8-24 decrease 
mice 
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Thymus 
The concentration of oestrogen receptors measured in thymus cylosols bý- 
other research groups is shown in Table 4.6. The concentration of oestrogen 
receptors measured in thymus cytosols from male and female rats at 30 davs 
were similar to those reported by Grossman el al, (1979b) in the thvmus of adult 
male Sprague-Dawley rats and in cattle. These values were a little lower than the 
concentration (. 22.2finole/mg protein) found by Brodie el al (1980) in the thyrnus 
of rats of the same sex, age and strain as those studied by Grossman et al 
(. 1979b). Using enzyme immunoassay techniques, Kawashima ef al (19c)2) 
reported higher levels for whole thymus in mice. In the present study, 
significantly higher concentrations of cytosolic oestrogen receptors were found in 
thymus of 5-day-old females (22.7 fmoles/mg) than in females of the older age 
groups and in males of all the age groups investigated. Grossman el al (1979a) 
found no sex differences at these ages. The result reported here for thymus 
showed the same trend as in the hypothalamus for the same age group of females 
and might reflect similar mechanisms of translocation to the nucleus and/or 
down-regulation of oestrogen receptor synthesis in this tissue. 
The nucroenvironment of the hypothalamus and thymus differs in many 
ways. Nevertheless, these tissues may be similar with respect to their ability to 
convert testosterone to oestradiol and to differ in this respect from the cortex, in 
which there was no evidence of sex differences in oestrogen receptor activity at 
any age. Different nerve growth and other growth factors may be produced 
locally in the hypothalamus and thymus and may interact with oestradiol and the 
oestrogen receptor in analogous ways to give locally relevant responses. In the 
151 
developing basal forebrain, oestrogen receptors co-localise with nerve groýýih 
factor receptors (Toran-Allerand el al,, 1992) and oestrogen- sensitive neurons 
express m. RNAs for neurotrophins and their receptors during development 
(Miranda el al, 1994). Oestradiol, available through aromatization in prenatal 
and perinatal. thymus tissue in male rats, may in the presence of thymic factors 
(interleukins or thymic hormones) or other neurosterolds direct thymic 
development. These pathways would be unavailable to females at this age 
because of the low concentration of available oestradiol at this early, critical 
period of development. 
Different or similar mechanisms in males and females could be producing 
the same end results i. e., higher concentrations of cytosolic oestrogen receptors 
in hypothalamic and thymic tissue in females than in males at 5 days (Figures 4.5 
and 4.7). The higher levels of oestrogen in males, produced through 
aromatization of testosterone to oestradiol, could lead to occupancy of the 
receptors and a lowering of cytosolic receptor concentration available for 
measurement. Oestrogen-bound receptors would be translocated into the cell 
nucleus and become tightly associated with DNA. This could account for the 
lower concentration of oestrogen receptors in hypothalamic and thymic cytosols. 
Moreover, as oestrogen classically downregulates its own receptor in the adult 
brain (Shughrue et al, 1990), the higher levels in males resulting from 
aromatization of testosterone could have a similar effect in the hypothalamus and 
thymus of male rats as young as 5 days when testosterone concentrations are 
high. In females, increasing availability of oestradiol, synthesised and released by 
the developing ovaries and circulating in the blood, could interact with the 
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receptors in hypothalamus and thymus at 18 and 30 days in a similar manner to 
that found in males of all three age groups studied. The thymus tissue-to-body 
weight ratio was greater in females than in males at 30 days. This result could 
support the conclusion that males at this age were exposed to oestrogen, formed 
in the thymus from aromatization of testosterone, for a longer period and that 
oestrogens cause thymic involution (Forsberg, 1995). This explanation is 
unlikely, however, as the absolute weight of the thymus in both sexes increased 
over the period. Moreover increased bone and body mass in males may be 
independent of thymic development. 
Oestrogen treatment is known to alter T-cell development in the thymus 
in mice and results in a decrease in the number of CD4+/CD8+ cells and an 
increase in the proportion of CD4+ helper T-cells (Rýjhslnghani el al, 1996b). 
This change in the ratio of immature to mature T-cells could be due to the 
interaction of oestradiol with reticuloepithelial cells and/or with the T-cells 
themselves. Thymosin-04 is synthesised and released bV the thymus and this 
hormone has long been known to be important in a number of immune functions 
(Low ef al, 1981) as well as in a number of interactions with the hypothalamus 
and its release of luteinizing hormone-releasing hormone (Rebar el al, 198 1 ). 
Moreover, oestrogen therapy depresses thyrnosin-P4 concentrations in women 
(Suh et al, 1985). There is some evidence that the oestrogen receptor can bind 
to the DNA independently of the presence of oestrogen itself (Gorski el al, 
1993). 
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Table 4.6: Concentration of oestrogen receptors (mean ± SENI) in thvmus in 
various strains and species of rodent. 
Authors Animal Sex and age Oestrogen 
receptor 
concentration 
(fmoles/mg 
protein) 
Present study Wistar rats Female, 5 days 22.76±2.37 
Male, 5 days 9.26±1.68 
Female, 18 days 8.89±1.218 
Male, 18 days 10.81±0.95 
Female, 30 days 6.41±0.37 
Male, 30 days 9.21±0.86 
Grossman et al,, Sprague-Dawley Male, 1-2 months 10.15±0.39 
1979b rats 
Brodie et al, 1980 Sprague-Dawley Male, adult 2 12 --ý- 4.0 
rats 
Grossman et al, Cattle (strain not Male, adult 6.57±0.048 
1979a given) 
Grossman et al, Rats (strain not Male, adult 6.06±0.365 
1979a given) Female, adult 5.60±0.308 
Kawashima et al, C57 BL/6NJcl mice Female, adult 24.1±2.9 
1992 
Athreva et al, 1989 NZB mice Male, adult 19.3±1.8 
Female,, adult I 7.3±- 1.2 
NZW Male, adult 16.7 ±21. -1 
Female, adult 17.2±1.9 
NZB/NZW FI Male, adult 14.7± 1.5 
Female, adult 17.3±1.1 
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4.4.3- Receptor studies- dissociation constant 
The Scatchard analysis obtained using cYtosols from uterus, 
thymus and hypothalamus and cortex yielded straight lines (Figure 4.8). The 
shape of the plots was consistent with the presence of one class of specific. high- 
affinity binding site in all the tissues investigated under the experimental 
conditions used (Figure 2.5). The Kd values obtained for oestrogen receptor 
were of the order of Ix 10-9 to 5x 10-9 M for the tissues exan-ýined (Table 4.7), 
No statistical differences were found between the values in males and females of 
all three age groups in any of the tissues examined. The values of the 
dissociation constant of the oestrogen receptor in the tissues examined were 
similar to results reported by other groups in some instances, but differed from 
those reported in other cases. The values found in the present study were similar 
to those found by Danel (1983) and Dhaher (1992). In these two studies, as in 
the present study, radiolabelled and unlabelled moxestrol were the ligands used 
to assess total and non-specific binding to the oestrogen receptor and gel 
filtration was used to separate the bound and free hormone. Differences in the 
results of the present study from those in Table 4.7 could reflect the different 
ligands employed or the different methods used to separate the bound and free 
steroid. Species differences could also account, in part, for the differences in Kd 
but as the similanties to the present study were found in tissues from humans 
(Danel, 1987) and mice (Dhaher, 1992), this explanation seems less likelv than in 
the difference in the methodologies employed. However, Dhaher's results for the 
dissociation constant of the oestrogen receptor for moxestrol in the thymus of 
immature MRL mice was one order of magnitude lower than the result found for 
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Balb/c mice in the same study. Athreya (1989) also found lower dissociation 
constants for the oestrogen receptor in the thymus of NZW/NZB F1 mice. The 
lower affinity of the receptor in the thymus may be significant in these 
autoimmune prone strains of mice. Wistar rats are not autoimmune-prone and in 
this strain, the dissociation constant of the oestrogen receptor for moxestrol in 
thymus cytosols was similar to the value found in non-autoirnmune-prone Balb/c 
mice (Dhaher, 1992). By 30 days, there was an apparent loss of receptor affinity 
and/or cytosolic receptor in the cortex. One possible explanation for the 
difference is that, at this age, oestrogen levels were rising in females and males 
and could be occupying receptors that were then translocated into the cell 
nucleus where, tightly bound to DNA, they were no longer detectable in the 
cytosols from the cortex under the conditions used. 
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Table 4.7: Molar dissociation constants (Kd) of the cytosolic oestrogen 
receptor determined in various tissues using different experimental methods 
Mean 
Kd (x 10-9M) 
Author Tissue Animals (see key for 
method) 
Present studv uterus immature Wistar rats 1.31-4.52 
hy 
. pothalamus (a. I (see Table 4.2) cortex 
thymus 
Brodie et al, 1980 thymus adult Sprague-Dawley Oý43 
rats (c, 5) 
Dahlberg et al, 1982 skeletal muscle adult rat, 0.73 
strain unspecified (C. 1) 
Grossman el al, thvmus adult Sprague-Dawley 0.25 
1979b rats ( c. 5. ) 
O'Keefe and Handa, hippocampus immature 0.14-0.55 
1990 Sprague-Dawley rats (a, 2) 
Yuan et al, 1995 hippocampus adult Sprague-Dawley 0.643 
rats (b, 3) 
Athrcya et al, 1989 thymus NZB, NZW, 0,09-0.15 
NZB/NZW FI mice (c, 4) 
Dhaher, 1992 uterus immature Balb/c mice 4.56 
hypothalamus 7.09 
thymus 10.9 
(a, 1) 
Key: a= gel filtration, b= quantitative autoradiography. c= dextran-coated charcoal: 
d= enzyme-linked immunoassay, I= moxestrol and 
3 H-moxestrol-, 2= moxestrol and 
3 H-oestradiol, 3= diethylstilbestrol and II P-methoxy-16(x_ [12511 iodo-estradioL 
3 
4= diethylstilbestrol and H4ethylstilbestrOl, 5= oestradiol and 
'H-oestradiol' 
diethylstilbestrol and 16(x- [12511 oestradiol. 
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Table 4.7: (continued) Molar dissociation constants (Kd) of the cvtosolic 
oestrogen receptor determined in various tIssues using dIfferent experimental 
methods. 
Mean 
Author Tissue Animal Kd (x 10-9M) 
(see key for 
method) 
Dhaher, 1992 uterus MRL-Ipr/lpr mice 2.33 
hypothalamus 0.58 
thymus 0.79 
Sholl. and Kim, 1989 brain fetal rhesus monkeys 0.46 
(a, 
Danel et al, 1983 thymus human 2.4 
(a. I) 
Nilsson et al, 1990 thymus humans aged 142 0.27 
years (d, 5) 
Weusten et al, 1986 blood monocytes humans aged 1-48 0.1-0.64 
and thymocvtes years (c. 6) 
Key: a= gel filtration, b= quantitative autoradiography c= dextran-coated charcoaL 
d= enzyme-linked immunoassay, I= moxestrol and 3 H-moxestrol, 2= moxcstrol and 
3 H-ocstradiol., 3= diethylstilbestrol and ilp-methox-v-16(X-["ýlliodo-estradiol. 
4= cliethylstilbestrol and 3 H-diethylstilbestrol, 5= oestradiol and 3 H-ocstradiol. 
diethylstilbestrol and l6cc- [125 floestradiol. 
The results of the receptor studies presented here showed similarities and 
differences compared with the results of other workers. Moxestrol was used as 
the ligand in order to permit measurement of receptor binding in immature rats. 
This approach was necessary because moxestrol unlike oestradiol does not bind 
to alphafetoprotein present in the blood of immature rodents. The dissociation 
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constant of moxestrol for the oestrogen receptor (Kd of the order of I O-Nl) in 
the present study was largely similar to the value found bv other workers. On the 
other hand this value differed from the value found by other groups for the 
binding of oestradiol to the oestradiol receptor (Kd of the order of I 0-'OM) 
indicating the higher affinity of the receptor for oestradiol than for moxestrol. 
The affinity of different steroids for the oestrogen receptor differs (see Chapter 
3) and there is no reason for the affinity of the receptor to be the same for 
moxestrol and oestradiol. Nevertheless,, the results for the measurement of the 
concentration of oestrogen receptors in the various tissues gave a similar pattern, 
of lowered cytosolic oestrogen receptor concentration in brain and thymus with 
increasing age, to results found by other research groups (Tables 4.4,4.5,4-6) 
whether the ligand used was moxestrol or oestradiol. 
4.4.4: Free fraction of oestradiol in serum 
The free fraction of oestradiol in serum rose in males and females 
between 5 and 18 days from the low level of 1.8 % of the alphafetoprotein-bound 
fraction to its adult value of 6.25% (Figure 4.9). This rise could have resulted in 
the decreases in cytosolic oestrogen receptor concentration in the hypothalamus 
and thymus in females at 18 and 30 days compared with the concentration at 5 
days in these tissues (Figures 4.5 and 4.7). In males, the concentration of 
cytosolic oestrogen receptor in these two tissues was the same in all three age 
groups, perhaps because locally synthesised oestradiol was present earlier in 
males. It is possible that, in females, the concentrations of cylosolic oestrogen 
receptors were higher in the hypothalamus and thy-mus because the receptors 
were not translocated to the nucleus as they may have been in males, in kýhom 
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the receptor can bind locally aromatised oestradiol and be translocated to the 
nucleus of the cell. Once bound to a steroid response element on the DNA- the 
receptor dimer can couple with another dimer (or other transcription factor) to 
create a more stable complex and sufficient residence time at the gene to 
influence gene transcription (O'Malley and Tsai, 1993). Moreover, the exposure 
of tissues to oestradiol could have lead to the down-regulation of oestrogen 
receptor synthesis and consequent lack of replenishment of the cytosolic 
receptors. 
There is a clear need to measure, in the future, the nuclear receptor 
concentration in the tissues examined in this study. An estimation of the location 
within each tissue and within cells in the tissues could be made by 
autoradiography or by immuncytochemistry. Moreover, binding studies could 
also identify the nuclear DNA-bound receptor in the brain and thymus. 
Additional studies should address the question of aromatase activity in the cortex 
and in the thymus. Further studies should also be done in order to measure and 
compare the expression of the alpha and beta subtypes of the oestrogen receptor 
in the thymus. Differences between the expression of the sub-types might 
contribute to the selective action of oestradiol agonists or antagonists in this 
tissue. Exposure to differential oestradiol concentrations in thymus of 
developing males and females might contribute to establishment of autoimmune 
susceptibility which is known to be higher for many autoimmune diseases in 
females than in males 
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Conclusion 
The development of the weight of the uterus and thvmus and the 
oestrogen-binding characteristics of oestrogen receptors in all the tissues 
examined in this study showed some similarities and some differences. 
The thymus of male and female rats increased in weight between 5,18 
and 30 days. However, in females, the thymus tissue-to-body weight ratio at ) 30 
days was greater than in males at this age (Table 4.1). 
The dissociation constant of 
3 
H-moxestrol for the oestrogen receptor 
was in the 10-9M range and was similar in all tissues examined in all three age 
groups. 
There were considerable variations in the tissues with respect to 
oestrogen receptor concentrations. Receptor concentrations in the uterus 
increased dramatically with age. There were no sex or age differences in 
receptor concentrations in the thymus, with the exception of its value in females 
at 5 days, in which it was significantly greater than in males of the same age. A 
similar result was found in the hypothalamus. In the cortex, no differences were 
found in the concentration of oestrogen receptor in males and females at 5 and 
18 days but, by 30 days, no oestrogen receptor was detectable in this tissue in 
either sex. 
Increasing levels of endogenous free oestrogens in both sexes could have 
contributed to these developmental changes and the differences observed. 
Moreover, the aromatization of testosterone to oestradiol in males could have 
resulted in some of the differences that were found in weight and In oestro(yen 
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receptor concentrations between the tissues in males and females in the three a-ge 
groups. In order to test the hypothesis that oestradiol-binding to its receptor 
might be playing a part in sex-related differences in weight-gain patterns and 
cytosolic oestrogen receptor concentrations during the development of the 
uterus, brain and thymus, further experiments were carried out on immature male 
and female Wistar rats using an aromatase inhibitor, 4-hydroxyandro st enedi one 
(. 4-OHA), clorniphene (CC) an oestrogen antagonist and oestradiol. The results 
of these studies are presented in Chapter 5. 
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Chapterfive 
Effects of oestrogen receptor antagonists and aromatase 
inhibitors on oestrogen receptors in uterus, brain, and thymus of 
immature rats 
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5.1 Introduction 
Greater knowledge and understanding of oestrogen interaction with its 
receptor has important implications for early development as well as for human 
reproduction and disease processes. The results of the study described in 
Chapter 4 revealed some differences in cytosolic oestrogen receptor binding 
characteristics in the uterus of the three age groups and between the sexes and 
different age groups in the brain and thymus. In order to investigate these 
findings further, two compounds were used in this present study: - clomiphene 
citrate and 4-hydroxyandrostenedione. Clorniphene citrate is a partial oestrogen 
ago, onist/antagonist and was used in order to investigate the effects it might have 
on oestrogen receptor binding characteristics (concentration and dissociation 
constant) in both sexes. 4-hydroxyandrostenedione is an aromatase inhibitor and 
was used to study the effect that the inhibitor would have in males when the 
conversion of testosterone to oestradiol was inhibited. 
1.1 -. Clomiphene citrate 
In 1940 the William S. Merle Company began to synthesise a group of 
chloroethylene compounds. Clorniphene citrate (CC), a compound in this group 
(Figure 5.1), was itself first synthesised in 1956 and tested in 1960 for 
oestrogenicity and gonadotrophin inhibition as well as for anti-fertility properties. 
Clinical trials for its use for ovulation induction in animals were conducted from 
I 1961 and the compound was approved for human use as an anti-infertility 
drug 
by prescription in 1967 (reviewed by Dickey and Holtkamp, 1996). 
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Figure 5.1: Structure of clomiphene citrate. 
CC is a non-steroidal racemic mixture of cis (38%) and frans (62%) 
isomers. The cis-isomer (Zuclomiphene) is n-fildly oestrogenic as well as anti- 
oestrogenic, while the trans-isomer (enclorrýphene) is purely anti -oest rogenic. 
CC is a competitive antagonist of oestradiol for the cytoplasmic oestrogen 
receptor in women where it acts at the level of the complex formed in the nucleus 
between the oestradiol-bound receptor and the DNA (Clarke and Markaverich, 
1988). As a result of the antagonism of the oestrogen receptor in the 
hypothalamus, gonadotrophin-releasing hormone secretion is increased and there 
is an additional effect of increased sensitivity of the pituitary to this releasing 
factor (Hsueh el al, 1978). As a result, secretion of follicle stimulating hormone 
and luteinizing hormone is increased and, therefore, an increase in follicular 
oestrogen synthesis occurs. Additionally, CC may have a direct effect on the 
ovary, making it more sensitive to pituitary gonadotrophin (Dickey el al. 1965). 
It is the drug of first choice for women suffering from anovulation and for 
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ovulating women with inadequate follicular or luteal function (Fritz et al, 199 1 ). 
The mechanism of action of CC in stimulating ovulation in humans appears to be 
interference with oestrogen receptor replenishment in the hypothalamus. The 
resulting lower concentration of the oestrogen receptor in the hypothalamus 
alters the pattern of gonadotrophin release and results in enhanced follicular 
development (Dickey el al, 1996). In small mammals, with short oestrus cycles, 
CC is contraceptive because the effects of both isomers are present throughout 
the cycle, while in humans, with long cycles, the effects of the anti -Oestrogeni c 
isomer are short-lived and the effects of the isomer with oestrogen agonist 
properties are dorMnant. In studies undertaken with rats, however, CC protects 
ovariectomised rats against osteoporosis (Beale el al, 1984) and against the loss 
of cancellous bone although it had no effect on cortical bone histomorphometry 
(Jimenez et al, 1997). Thus, in rats, the compound shows oestrogenic properties 
in bone in contrast to its antagonistic activity in reproduction. 
The effects of CC upon the rat thymus during development are not 
known. In the study reported here CC was adnunistered alone and in 
combination with oestradiol in order to determine whether in the uterus, 
hypothalamus, cortex and thymus of male and female Wistar rats between 15 and 
30 days CC might compete with oestradiol for the oestrogen receptor. 
5.1.2- 4-Hydroxyandrostenedione 
Differentiation of the male brain is associated with the activity of an 
enzyme complex (aromatase) localised in certain brain areas such as the preoptic, 
the hypothalamus, and the limbic system (Lauber et al, 1994; Roselli and 
Resko, 
1993; Shinoda, 1994). The enzyme appears to be confined to neurones and 
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absent from glial cells (Abe-Donomae el al, 1994). The complex consists of P- 
450 (arom), a specific form of cytochrome P-450 and the flavoproteln NADPH- 
cytochrome P-450 reductase (Means et al, 1989). Activity of the enzyme, 
leading to the conversion of testosterone to oestradiol, is a feature of both 
ovafian and pefipheral oestrogen biosynthesis. In pre-menarchal and post- 
menopausal females, the bulk of circulating oestrogen derives from peripheral 
conversion of testosterone by aromatase, predominantly in adipose tissue, in 
females of reproductive age, the ovaries are the source of circulating oestrogen 
by aromatization of precursor testosterone in the granulosa cells. In males, the 
testes are the source of testosterone (Funder, 1993). 
The relationship between aromatase activity and brain development has 
been well established in sexual differentiation of the brain and in behaviour 
(Hutchison and Steimer, 1984; Hutchison, 1993). Moreover, studies using 
inhibitors of the enzyme have demonstrated that, in the male, several brain areas 
contain receptors that bind oestradiol, which has been locally produced through 
aromatization of testosterone (Clancy and Michael, 1994)- These areas include 
for example, the lateral septum, medial preoptic area, and sub-divisions of the 
hypothalamus, arnygdala and bed nucleus of the stria terminalis. The role of 
aromatase in thymus development has been less documented, although several 
effects resulting from its inhibition have been shown in this tissue 
(Greenstein el 
al, 1992; Greenstein el al, 1993). 
Aromatase inhibitors include steroidal compounds, for example, 1,4,6- 
androstatriene-3,17-dione (ATD) and 4-hydroxy-androstene-3,17-dione 
(4- 
OHA), as well as non-steroidal compounds, such as 
167 
tetrahydroiniidazo-[1,5-ct]-pyridin-5-yl)benzonitfile monohydrochlofide (CGS 
16949A, Fadrazole) (Brodie et al, 1987). In the present study 4-OHA, (Figure 
5.2), was chosen because it had been used previously in this laboratory and had 
been shown to effect changes in rat thymus structure (Greenstein el al, 1992). 4- 
OHA is a potent and selective inhibitor of aromatase that inactivates the enzyme 
by irreversible combination (acts as a 'suicide inhibitor') with the enzyme at its 
active site (Brodie et al, 1979; France el al, 1987). Aromatase inhibition has 
been shown to lead to a decrease in oestrogen receptor concentration in the 
uterus of ovariectornized rats and in mammary tumours of rats, as well as a 
decrease in oestrogen concentration in vivo (Coombes el al, 1987). Clancv and 
Nfichael (1994) showed that the lateral septum, medial preoptic area, certain 
subdivisions of the hypothalamus, amygdala, and bed nucleus of the stna 
terminalis, were all areas of the male rat brain that contained oestrogen receptors. 
Using an aromatase inhibitor these studies showed that with the exception of the 
lateral septum, the other areas bind oestrogens that have been synthesized locally 
by the activity of aromatase on circulating testosterone. 
0 
0 
OH 
Figure 5.2: Structure of 4-OHA. 
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The aim of the experiments in which 15 day-old rats were treated with 
CC, 4-OHA, oestradiol (E2), or CC+E2 was to establish whether-. 
a) the oestrogen receptor in the thymus and brain of animals of this age 
group could be manipulated with CC,, a partial agonist/antagonist of oestradiol. 
4-OHA, a compound that inhibits the aromatization of testosterone to 
oestradiol, affects the Kd of the receptor and its concentration in these tissues. 
CC was used as an agonist/antagonist to the oestrogen receptor in order 
to assess whether it had similar or different effects in the tissues examined. 
4-OHA was used in order to assess whether the interaction of oestrogen 
receptors in the tissues examined might be produced locally from aromatization 
of circulating testosterone in males. CC, 4-OHA, CC +E2 or E2 alone were 
implanted into 15-day-old male and female Wistar rats. Body and tissue weights, 
as well as oestrogen receptor binding and concentration, were estimated in 
uterus, hypothalamus, cortex and thymus after sacrifice at 30 days. The age 
chosen for administration of the compounds was 15 days. At this age the free 
oestradiol concentration in the blood is still low because the hormone is bound to 
alphafetoprotein. Unbound oestradiol concentrations begin to rise with 
approaching puberty, and as alphafetoprotein concentrations decrease the free 
hormone becomes available to the tissues (Greenstein, 1992). Administration of 
CC, E2, CC+E2 and 4-OHA at 15 days, would allow the time necessary for 
active plasma levels of the drug to be established before the rise in the oestradiol 
concentrations. Moreover, the thymus is growing rapidly during this period and 
drug effects might be more clearly demonstrated than at other ages. 
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5.2: Materials and Methods 
5.2.1 -. Animals 
Male and female Wistar rats (12-days-old) were purchased from Bantin 
and Kingman as before. The animals were allowed to settle for 48 hours before 
treatment at 15 days and were housed with their mother in one cage (56 x 38 x 
20 cm) in the Biological Services Facility in the Rayne Institute, St. Thomas's 
Hospital under conditions of controlled lighting and temperature (lights on 
08-00-22: 00; lights off 22-00-08: 00,19-20T) until weaning at 21 days. They 
were allowed free access to steroid-free BK rodent diet and tap water. At 21 
days, the mother was anaesthetised and sacrificed and littermates were housed 
together until sacrifice at 30 days. 
5.2.2- Preparation of implants 
5.2.2.1 Materials 
Clomiphene citrate. ) 
I -[p(P-diethylaminoethoxy)phenyl]- 1,2- 
diphenylchloroethylene (CQ oestradiol- 170 were purchased from Si igma 
Chemical Co, Poole, Dorset, LJK. 4-Hydroxy-4-androstene-3,17-dione. ) (4- 
OHA) was obtained from Innovative Research of America; Ohio, USA. Silastic 
medical grade tubing (0.335cm ID x 0.465cm OD. )-, Silastic medical adhesive, 
Silicone Type, were products of Dow Coming Corp, Michigan, USA. 
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5.2.2.2- Doses 
Implants were prepared one day before use as follo"'s. Silastic tubing 
was cut into lengths approximately I cm and the pieces were weighed and each 
was filled with the steroids to be used. After re-weighing, the pieces of tubing 
were sealed with Silastic, brand medical adhesive. The implants were stored at 
40C until used. The amount of steroid placed in the implants is given in Table 5.1 
below 
Table 5.1 Steroids used for implantation into 15 day old male and female 
Wistar rats. 
Steroid Amount used / mg 
cc 25 
E2 5 
CC + E2 25+5 
OHA 25 
The control group were implanted with empty Silastic tubing. 
5.2.3- Implantation procedure 
The animals were anaesthetised as described in Section 2.2.1 and were 
weighed. An incision was made mýid-way along the dorsal surface of the rat 
through the skin. The implant was introduced subcutaneously and the wound was 
closed with stainless-steel clips which were left in place The animals were then 
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returned to their mother. Their weight was recorded again at sacrifice at 30 
days. 
5.2.4- Preparation of tissues 
At 30 days, the animals were anaesthetised weighed and sacrificed, blood 
was collected, the tissues were dissected and cytosol preparations carried out 
within two weeks (Sections 2.2.1 - 2.2.3). 
5.2.5-. Assay of cytosols prepared from animals treated with CC, 4-OFLA,, E-2. or 
CC+E2. 
Assays were performed on all the cytosols in the same wav as described 
previously within two months of their preparation and stored at -700C (Section 
2.2.4). Care was taken to assay cytosols from different tissues and different 
treatment groups on the same day. The results were analysed as before by 
Scatchard analysis to estimate the binding constant of the cytosolic oestrogen 
receptor and its concentration (Section 2.2.4). 
5.2.6. The free fraction of oestradiol in serum 
Estimation of the free fraction of oestradiol in serum was made as 
described earlier (Section 2.5). 
5.2.7-. Statistical Analyses 
Statistical analyses of the results of this set of experiments were 
undertaken as described earlier (Section 2.6). 
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5.3 Results 
5.3.1: Body and tissue weights of male and female Wistar rats at 30 davs after 
treatment with CC,, E2, CC+E2 or 4-OHA. 
5.3.1.1 -. Body weight 
The body weight of male and female Wistar rats in the control and 
treatment groups are given in Figures 5.3 and 5.4 respectively. Untreated and 
CC-treated males were heavier (p<0.05) than their female counterparts. Within 
the female groups, animals treated with E2 or with CC+E2 were significantly 
lighter (p<0.05) following the treatment than untreated and CC-treated female. 
Females treated with 4-OHA were similar in body weight (p>0.05) to all the 
other female groups although their body weight was intermediate between that of 
the other female groups. Males treated with E2, or CC+E2 were all lighter 
(p<0.05) than untreated and CC-treated males. Males treated with 4-OHA, like 
the females of this group, were intermediate in weight between the other groups 
of males, but not significantly different from any of the other male groups. 
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Figure 5.3: Body weights of 30-day-old female Wistar rats in the control 
group and in the groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. 
Bars represent the mean ± SEM of 6-10 observations/group. (*Differs from 
control CC and 4-OHA groups, p<0.05, Two-Way ANOVA). 
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Figure 5.4: Body weights of 30-day-old male Wistar rats at in the control 
group and in the groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. 
Bars represent the mean ± SEM of 6- 10 observations/group; (*Differs from 
control and CC groups, p<0.05; Two-way ANOVA). 
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5.3.1.2: Tissue weight 
The uterus and thymus weight of female Wistar rats in the control and treatment 
groups are shown in Figures 5.5a and 5.5b respectively. Results for the weight 
of the thymus of males, and the results showing differences between the sexes are 
shown in Figures 5.6 and 5.7. The uterus of females treated with E2 or with 
CC+E2 was significantly heavier than in females of the other groups (p<0.05). 
The uterus of females treated with CC or with 4-OHA appeared to increase in 
weight compared with the controls but neither reached levels of statistical 
significance. 
However, the thymus of males and females decreased in weight as a 
result of treatment with E2 or CC+E2. Treatment with 4-OHA led to an 
increase in the weight of this tissue in males (p<0.05) and to a slight, but not 
significant, increase in its weight in females. 
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Figures 5.5a; b: Uterus (5.5a) and thymus weight (5.5b) of 30-day-old female 
Wistar rats in the control group and in the groups treated at 15 days with CC, 
E2, CC+E2 or 4-OHA. Bars represent the mean ± SEM of 6- 10 
observations/group. (*Differs within the tissue from females of the control or 
other treatment groups, p<0.05; Kruskal-Wallis One-Way ANOVA on Ranks; 
Dunn's Multiple All Pairwise Comparison). 
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Figure 5.6: Thymus weight of 30-day-old male Wistar rats in the control 
group and in the groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. 
Bars represent the mean ± SEM of 6-10 observations/group. (*Differs from 
males of the control or other treatment groups, p<0.05; Kruskal-Wallis One-Way 
ANOVA on Ranks; Dunn's Multiple All Pairwise Comparison). 
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Figure 5.7: Thymus weights of 30-day old female and male Wistar rats in the 
control group and in the groups treated at 15 days with CC, E2. CC+E2 or 4- 
OHA. Bars represent the mean ± SEM of 6-10 observations/group. (Data 
repeated from figures 5.6, b and 5.7) 
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5.3.1.3. The relationship between tissue weight and body weight 
The relationship between tissue weight and body weight in uterus and 
thymus of female and male rats in the control and treatment groups are shou, n in 
Table 5.2. 
The weight of the uterus relative to body weight increased in females 
treated with E2 or with CC+E2 (p<0.05), but there was no significant difference 
from the controls in animals treated with CC or with 4-OHA. (p>0.05). 
The tissue weight relative to body weight of the thymus in females treated 
with CC or with 4-ORA did not differ from the value in females in the control 
group (p>0.05), but those treated with E2 or with CC+E2 had decreased thymus 
weight relative to body weight (p<0.05). As with the females, the tissue to body 
weight ratio of males treated with CC did not differ from its value in the control 
group of males (p>0.05). In both the control and CC groups of males, however, 
its value was less than in corresponding groups of females (p<0.05). In males 
treated with 4-OHA the relative weight of thymus to body weight was similar to 
the value found in females of the control, CC, and 4-OHA groups, but it was 
significantly heavier than in the thymus of the control group of males. The 
relative weight of the thymus in males treated with E2 was lower than in either 
the control or CC treated males (p<0.05) and it was also lower than in the 4- 
OHA treated males (p<0.01). 
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Table 5.2: The tissue-to-body weight ratio (mean ± SEM) in female and male 
Wistar rats, 6-10 per group- (*Differs from control groups within a tissue and 
sex, p<0.05; Kruskal-Wallis One-Way ANOVA on Ranks- Dunn's Multiple All 
Pairwise Comparison). 
Sex Tissue Control 
(X 104) 
cc 
(X 104) 
E2 
(XIO 
CC+E2 I 4-OHA 
(XI04 I (X 104) 
Female Uterus 13.91: 1.1 17.2±2.3 26.5±2.3* 29.5±2.3* 17.9±1. ) 
Female Thymus 44.1±2.5 42.0±5.7 27.6±2.4* 34.8±2.7* 48.9±3.6 
Male Thymus 32.6±1.8 37.4±2.6 24.6±1.9* 30.0±3.6 
I 
I 
43.7±2.0* 
179 
5.3.2- The concentrations of cytosolic oestrogen receptors in uterus, 
hypothalamus, cortex and thymus of male and female Wistar rats at 30 days, after 
15 days treatment with CC, 4-OHA, E2 or CC+E2. 
5.3.2.1: Uterus 
The concentration of oestrogen receptors in the uterus In control 
and treated Wistar rats are shown in Figure 5.8. The concentration of oestrogen 
receptors in the uterus of animals treated at 15 days with CC or 4-OHA did not 
differ from the value in the control group (p>0.05). No receptors were 
detectable in females treated with E2 or CC+E2. 
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Figure 5.8: Concentration (finole/mg protein) of cytosolic oestrogen 
receptors in the uterus of 30-day-old female Wistar rats in the control group and 
in the groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. Bars represent 
the mean ± SEM of 5-9 observations/group; nd, not detectable. 
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5.3.2.2-. Hypothalamus 
The concentration of oestrogen receptors in the hypothalamus in control 
and treated female and male Wistar rats are shown in Figure 5.9. No differences 
were found in concentration of the oestrogen receptor in the hypothalamus 
between males and females in the control, or CC-treated groups (p>0.05). Males 
treated with 4-OHA had significantly higher levels of oestrogen receptors in the 
hypothalamus than did females of the same treatment group (p<0.05) or than 
males and females of the control or CC treatment groups (p<0.05). No receptors 
were detectable in either sex in this tissue after treatment with E2 or with 
CC+E2. 
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Figure 5.9: Concentration (fmole/mg protein) of cytosolic oestrogen 
receptors in the hypothalamus of 30-day-old female and male Wistar rats the 
control group and in the groups treated at 15 days with CC, E2, CC+E2 or 4- 
OHA. Bars represent the mean ± SEM of 5-9 observations/group. nd, not 
detectable. (*Differs from other groups, p<0.05, Kruskal-Wallis One-Way 
ANOVA on Ranks; Dunn's Multiple All Pairwise Comparison). 
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5.3-2.3 - Cortex 
No cytosolic oestrogen receptors were detectable in the female and male 
Wistar rats in the control or treated groups 
found in 30-day-old rats in the earlier study. 
5.3.2.4-. Thymus 
This result was the same as that 
The results of the determination of the concentration of oestrogen 
receptors in the thymus in control and treated female and male Wistar rats are 
shown in Figure 5.10 and Figure 5.11 respectively. Treatment of females and 
males with E2 and CC+E2 resulted in a lowering of receptor concentration in the 
thymus to a level below the detection limit. CC also lowered the receptor 
concentration in females (p<0.05) though not in males. In males, 4-OHA 
treatment led to an increase in oestrogen receptor concentration in the thymus 
compared with the level in males of the control and other treated groups 
(p<0.05). 
182 
14 
1 
-T- Cýý 12 
12 10 cl 
on 8! 
06 
4 
2 
I 
nd nd 0 L- ---I- - ----- - ----- -ý 
I- 
Control cc E2 CC+E2 4-OHA 
Treatments 
Figure 5.10: Concentration (ftnole/mg protein) of cytosolic oestrogen 
receptors in the thymus of female Wistar rats at 30 days in the control group and 
in groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. Bars represent the 
mean ± SEM of 5-9 observations/group. nd, not detectable. (*Differs from 
females of the other groups, p<0.05; Kruskal-Wallis One-Way ANOVA on 
Ranks, Dunn's Multiple All Pairwise Comparison). 
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Figure 5.11: Concentration (fmole/mg protein) of cytosolic oestrogen 
receptors in the thymus of male Wistar rats at 30 days in the control group and 
in 
groups treated at 15 days with CC, E2, CC+E2 or 4-OHA. Bars represent the 
mean ± SEM of 5-9 observations/group. nd, not detectable. 
(*Differs from 
males of the other groups, p<0.05; Kruskal-Wallis One-Way ANOVA on 
Ranks., 
Dunn's Multiple All Pairwise Comparison). 
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5.3.3: The molar dissociation constant of the oestrogen receptor in uterus. 
hypothalamus, cortex and thymus after treatment with CC, E2, CC+E2 or 4- 
OHA. 
Results of the measurement of the dissociation constant of the oestrogen 
receptors are shown in Table 5.3. The dissociation constant of the oestrogen 
receptors was in the nanomolar range 00-9M) in all tissues. There was no 
significant difference in its value between males and females in any of the 
treatment or control groups (p>0.05). In experiments, when animals had been 
treated with E2 or CC+E2, no receptors were detectable. 
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Table 5.3: Values of the molar dissociation constants (Kd, x of 
cytosolic oestrogen receptors in the uterus, hypothalamus, cortex and thvmus of 
female and male Wistar rats at 30 days in the control group and in groups treated 
at 15 days with CC, E2, CC+E2 or 4-ORA. The values represent the mean + 
SEM of 5-9 observations per group. nd, binding not detectable. (No significant 
differences in the values, p>0.05, Kruskal-Wallis One Way ANOVA on Ranksl 
Dunn's Multiple All-Pairwise Comparison). 
Sex Tissue Control 
KdxIO-9M 
cc 
KdxIO-9M 
E2 
KdxIO-9M 
CC + E2 
KdxlO-9M 
4-OHA 
UxIO-ý)m 
Female Uterus 2.72+-0.63 1.96±0.57 3.27-+0.63 2.4 8 ±0.6 -3) 1.5-3 ±0.6 3' 
Female Hypothalamus 3.65±0.57 3.73±0.57 nd nd 3.29±0.6() 
Male Hypothalamus 4.03±1.88 3.29±1.65 nd nd 4.8-')'± 1 .56 
Female Cortex nd nd nd nd nd 
Male Cortex nd nd nd nd nd 
Female Thymus 2.37±0.57 2.04±0.55 nd nd 1.96-+0.55 
Male Thymus 2.60±0.89 2.02±1.12 nd nd 3.44±1.0() 
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5.3.4- The free fraction of oestradiol in the serum of female and male Wistar 
rats at 30 days after treatment with CC, E2 CC+E2 or 4-OHA. 
The results of the measurement of E2 in the serum of female and male 
Wistar rats at 30 days after treatment with CC, E2 CC+E2 or 4-OHA are shokvn 
in Table 5.4. There was a small, but significant, increase in the free fraction of 
oestradiol in the serum of E2 and CC+E2 treated male (9 percent increase) and 
female (12 percent increase) rats compared with the control groups (p<0.05). 
Table 5.4: The free-fraction of oestradiol (mean percentage±SEM of 6- 10 
observations) in the serum of female and male Wistar rats at 30 davs after 
treatment with CC, E2, CC+E2 or 4-OHA. (*Differs within each sex from the 
control or other treatment groups, p<0.05-, Kruskal-Wallis One-Way ANOVA on 
Ranks; Dunn's Multiple All Pairwise Comparison). 
Sex Control cc E2. I CC+EA. 4-OHA 
Female 5.12±0.3 5.12±0.3 5.72±0.2* 5.51-+0.2* 5.39±0.4 
Male 5.46±0.2 5.331±0.4 5.92±0.2* 5.96±. 0.6* 1 
5.19±0.2 
A summary of the results obtained at 30 days following the administration 
Of CC,, E2, CC+E2 or 4-OHA to female and male Wistar rats at 15 
days is shown 
in Table 5.5. 
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5-4: Discussion 
5.4.1: Body, tissue and tissue weight related to body weight in female and male 
Wistar rats treated with CC,, E2. CC+E2 or 4-OHA. 
Body weight 
Treatment of male and female rats at 15 days with E2 and CC-E2 was 
associated with lower body weight at 30 days, although the males in all groups 
were heavier than females in the corresponding groups. This result with E2 and 
with CC+E2 was not unexpected as E2 has been shown previously to inhibit 
body growth in developing female rats (Jansson et al, 1985). The conclusion 
that reduced body weight was due to the treatment is supported by the finding 
that the free fraction of oestradiol in serum was higher in the groups treated with 
E2 and CC+E. Alphafetoprotein concentrations fall during the period from 23 to 
30 days, so there could have been higher concentrations of free oestradiol 
available to all the tissues. 
E2 treatment could possibly have resulted in decreased body weight in 
both sexes through an effect on growth hormone. In adult female rats, the 
growth hormone content of the pituitary is lower than in males and, when male 
rats are treated with EZ, the growth honnone content of the pitultapy decreases 
to the same level as in females (reviewed by Zachman, 1992). There is evidence 
that growth hormone and testosterone act synergistically in human males to 
promote growth. The lower weight of the 30-day-old male and female rats 
treated with E2 or CC+E2 could have been mediated through interactions of E2 
with growth hormone. Lack of E2, or insensitivity to its potential effects, leads 
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to prolonged growth because E2 is a potent stimulator of bone maturation (Lee, 
1997) and in the absence of the hormone the bones continue to -gTo"- without 
developing into mature bone. 
The effects of treatment of CC+E2 are likely to have been due to E2 
because treatment with CC alone had no effect on body welght. These effects 
might have resulted from the dose of CC given or because CC had no interaction 
with any other growth factors. As a racemic mixture of the two Isomers of CC 
were given, the anti-oestrogenic properties of the enclomiphene isomer may have 
predorninated over the nfildly oestrogenic property of the zuclonUphene isomer 
of the drug over this period of time (Dickey and Holtkamp, 1996). When E2 and 
CC were given together, however, E2 effects on body weight seemed to 
predominate in that the body weight of male and female animals showed a low 
weight gain pattern similar to that observed in animals treated with E2 alone. 
This result differs from that of Forsberg (1995) who found that body weight was 
significantly decreased in neonatal NMRI mice treated with CC. This difference 
could be due to dose and/or species differences in response to the drug. 
Administration of 4-OHA had no significant effect on body weight of 
either female or male rats. 4-OHA treatment increases the weight of tissues such 
as the thymus in immature and ageing rats (Greenstein ef al, 1992). However, 
there was no evidence in those studies that administration of 4-OHA at the 
concentration used in the present study, or given as implants, altered overall body 
weight. It is possible that other hormones, such as growth hormone or its 
releasing factors, play a more important role in the overall body growth 
during 
the first 30 days and that other regulatory pathways not involving testosterone 
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are more closely associated with body growth during this complex stage of 
development. 
Tissue weigh. 
If oestradiol was associated, at least in part with, decreased overall body 
weight in male and female rats, what was the effect of oestradiol on tissue 'A-eight 
in rats in the first 30 days of postnatal development? 
Uterus 
The uterus increased in weight after treatment with E2 and with CC+E2, 
a result that is in agreement with the result found by Young el al (1991) in 
ovariecton-ýised adult female rats treated with E2 or with CC. Their studv 
showed that E2 restored the weight of the uterus to levels comparable with the 
intact group and that CC had a smaller effect on this tissue. It is likely that the 
large increase in uterus weight observed in 30-day-old rats treated with CC+E2 
at 15 days was due to the oestrogen effect rather than to CC. There was no 
significant difference between the weight of the uterus in rats treated with the 
combination CC+E2 or with E2 alone although the CC+E2 and E2 groups were 
heavier than other groups. The same result was found in the uterus tissue to 
body weight ratio, with no significant differences between the control group and 
the groups treated with CC or with 4-OHA. In the groups treated with E2 or 
with CC+E2, the tissue-to-body weight ratio was significantly increased from 
13.9 x 10-4 (control) to 26.5 x 10-4 (E2) and 29.5 x 101 (CC+E2). 
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Thymus 
The thymus, in contrast to the uterus, showed a marked decrease in 
weight and in tissue-to-body weight ratio in males and females as a result of 
treatment with E2 or CC+E2. It is well known that both testosterone and 
oestradiol cause thymic atrophy (Grossman, 1984) and the present result ,. vas in 
agreement with previous studies of the effects of steroid hormones on this tissue. C) 
Oestradiol or diethystilbestrol treatment of gonadectornised Sprague-Dawlev rats 
causes inhibition of thymus growth (Windmill el al, 1993), an observation that is 
in accordance with the results of the present study. Martin el al (1994) observed 
histological and ultrastructural changes in adult rat thymus after oestradiol 
treatment. Their analysis confirmed lymphocyte depletion in both conical and 
medullary regions of the thymus as well as profound modifications in the 
epithelial component of this tissue. They also found increased vascular 
permeability in treated animals and this alteration could result in changes in 
lymphoid traffic into and out of the thymus. These effects may also contnbute at 
an early developmental stage to observed differences in thymus structure and 
immune function in males and females. 
CC had no effect on thymus weight or on the tissue/to body weight ratio. 
The use of a series of different doses of CC might have clarified whether this 
drug can cause atrophy or its reversal in the thymus. That steroid hormones can 
alter thymus architecture is well known, but the potential for CC to act as an 
agonist or antagonist of E2 needs further elucidation to determine if the 
drug has 
any effect on rat thymus at this age. 
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In males treated with 4-OHA there was an increase in thymus weight and 
in the thymus-to-body weight ratio. The values reached in male thymus weight 
and in the thymus-to-body weight ratio were similar to those found in females of 
the same treatment group. However, the tissue-to-body weight ratio of thymus 
in males treated with 4-ORA was higher than in the male control group. 
Between 15 and 30 days postnatally, testosterone levels are high (Wachi el al, 
1973) and, although bound to plasma proteins, this hormone is available to the 
tissues (Manni et al, 1985). It is possible that in the thymus, irreversible binding 
of 4-OHA to the active site of aromatase (Wei Yue and Brodie, 1997), prevented 
the conversion of testosterone to oestradiol and thus reduced thymic regression 
during the period of treatment. In females, little testosterone is present 
compared with males and, therefore, the effects of an aromatase InhIbItor would 
be minimised. 
While the action of oestradiol on the uterus in neonatal and in adult rats is 
well documented (Sheehan et al, 1981, Woodman, 1997), its specific effects on 
the epithelial and lymphocyte cell Populations of the thymus are less well 
established and need further investigation. Nevertheless, the results of this stu& 
were in agreement with the work of others on the effects of oestradiol treatment 
on uterus and showed that the thymus was also responsive to E2 at this age. The 
results of this study also suggest that testosterone rnight have been aromatized to 
E2 in the thymus of males in this age group and hence have caused 
developmental changes in the structure of this tissue. 
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5.4.2- Effects on the concentration of cytosolic oestrogen receptor 
Uterus 
The concentration of the oestrogen receptor in uterus cytosols of E'-' and 
CC+E2-treated rats decreased compared with the control group. This result ývas 
not surprising as E2 alone, or in combination with CC, could have occupied 
cytosolic oestrogen receptors and been translocated into the nucleus from where 
it would not have been recovered. CC treatment alone did not alter the 
concentration of receptors that were detected in the uterus, and this result 
suggests that CC had neither agonist nor antagonist activity in the uterus at the 
concentration used. CC treatment in adult female rats can be oestrogenic or anti- 
oestrogenic depending upon the dose and isomers used. CC (the racemic 
mixture) is mildlv oestrogenic in the uterus of adult ovariectomised female rats 
and results in cytoplasmic oestrogen receptor concentrations similar to those 
found in E2-treated ovariectornised females. Zuclomiphene, the cis isomer, is 
strongly anti-oestrogenic and treatment results in a much lower concentration of 
cvtosolic oestrogen receptors and concomitant decrease in cytosolic 
progesterone receptor concentration (Young el al, 199 1 ). 
Treatment with 4-014A had no effect on cytosolic oestrogen receptor 
concentration in uterus. Treatment of adult intact Sprague-Dawley rats with 4- 
OHA results in a reduction in the concentration of free plasma oestrogen J. 11 v/ . vo 
and may also inhibit the synthesis of oestrogen receptors in the uterus (Zhou and 
Brodie, 1995). However, in the immature female rats used in the present studN,, 
little testosterone is likely to be available for aromatization to oestradiol. This 
may explain why the result found in the present study differed 
from that of Zhou 
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and Brodie (1995) i. e. the difference might be related to the different age of the 
rats used in which ovarian synthesis of oestradiol was inhibited bv 4-OHA. In 
the uterus, oestradiol has the effect of increasing the expression of its receptor. 
Hypothalamus 
E2 and CC+E2 treatment resulted in a decreased oestrogen receptor 
concentration in the hypothalamus to a level that was undetectable by the 
methods used. These results suggest that the receptors might have been 
occupied by E2 and translocated to the nucleus. Oestrogen receptor mRNA 
synthesis decreases in the hypothalamus of ovanectomised rats following E-' 
treatment (Lauber ef al, 1991) and this result would suggest, that in this present 
study, E2 administration at 15 days down-regulates the synthesis of the 
oestrogen receptor in the hypothalamus. 
The response in the hypothalamus to 4-OHA treatment differed between 
males and females in that 4-OHA increased the concentration of oestrogen 
receptor in males, but had no effect in females. 4-OHA treatment of females in 
this age group, where E2 levels are low, may have had no effect on oestrogen 
receptor concentration because there was little testosterone present. In male 
rats, however, the concentration of oestrogen receptor in the hvpothalamus 
increased after treatment with 4-OHA, a result that is in agreement with studies 
by Clancy el al (1995). This result could have been due to inhibition by 4-OHA 
of local synthesis of oestradiol from testosterone via aromatase. 4-OHA 
treatment could also have lead to decreased rate of translocation of oestradiol- 
bound receptor from the cytosol to the nucleus. In the control group, 
however, 
no differences were observed between male and females. This 
finding would 
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argue against the role of aromatization in oestrogen receptor differences bemeen 
males and females. Usingi/7 vitro autoradiography techniques, Kuhnemann et al 
(1994) found higher concentrations Of cYtosolic oestrogen receptor in the 
hypothalamus of female Wistar rats at 10 days than in males but, in other studies 
in 30-day-old rats, no sex differences were detected (see Table 4.5). As males 
have higher levels of aromatase activity in the brain (MacLusky el al, 1985) the 
fact that in this study no sex differences were found in the control group could 
have been due to the increasing concentrations of free oestradiol in both sexes 
between 15 and 30 days. 
The recent discovery of a second oestrogen receptor (ERP) (Kulper el al, 
1996) could account for some observed tissue-specific effects of oestrogens. In 
the rat hypothalamus, there is differential distribution of ER(x, the classical 
oestrogen receptor (Shughme ef al, 1996), and ERP and this finding may lead to 
further elucidation of the role of oestrogens in the developing hypothalamus. In 
the present study, no account was taken of the possible differential tissue 
distribution of the two forms of the oestrogen receptor. In the present study, no 
distinction was made between the sub-types of the cytosolic oestrogen receptor 
and the measurements made are likely to have included both sub-types. 
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In the cortex, no oestrogen receptors were detectable in the control or 
treated animals. This result could be due in both sexes to the increasing levels of 
free oestradiol with consequent down-regulation in the 
brain of oestrogen 
receptors, or to translocation of oestrogen receptors to the nucleus 
ftom the 
cytosol. Brain aromatase activity is confined to those areas such as 
the 
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hypothalamus that are associated with reproduction (Hutchison el al. 1994). The 
lack of detectable oestrogen receptors in the cortex is unlikely. therefore, to be 
due to aromatization of testosterone in males, Other studies of the cortex shww 
similar findings, that is, high levels of oestrogen receptor during the early 
postnatal pefiod and no detectable oestrogen receptor in rats b-,,, 330 davs 
(O'Keefe and Handa 1990, -) Keefer and Holdregger, 1985. Yokosuka el al, 1995). 
E2 enhances cortical myelination (Curry and Heim, 1966) and these findings 
supports a developmental role in both sexes for E2 at an early, if limited, stage of 
development. 
Thymus 
The concentration of oestrogen receptors in thymus cytosols of female, 
though not of male, rats decreased after treatment with CC; no receptors were 
detectable after treatment with E2 or CC+E2 in either sex, receptor 
concentrations did not change in females, but rose in males, after treatment with 
4-OHA. 
The result in females treated with CC is suggestive of oestrogen 
antagonist activity in this group. E2 levels are low in females at this age and the 
lowering of the oestrogen receptor concentration suggests that the CC-bound 
receptors could have been translocated into the nucleus of the cell. No reduction 
of oestrogen receptor concentrations was found in males, perhaps because locally 
formed E2 at this age may have been bound to the receptor with greater affinIt.. 
than that of CC. Thynuc weight did not change and the functional effect of CC 
treatment may differ from the thymic weight reduction effects and reduced 
receptor concentration effects of E2 and testosterone (Greenstein el al, 
1991), It 
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has been well -established that CC is a useful drug for the treatment of infertility 
in women (Dickey and HoItkamp, 1996), can prevent bone loss in 
ovariecton-fized rats and can reduce procarbazine-induced infertility in male rats 
(Weisseberg et al, 1995). Little is known, however of the effects of CC on the 
thymus or on immune function. In two reports, CC used for induction of 
ovulation in women has been associated with the development of systemic lupus 
erythyrnatosus (Ben-Chetrit and Ben-Chetfit, 1994, - Canvin and Capell, 1995). 
Further studies of the effects of CC in adult rats,, and in an animal model of 
autoirnmune disease, could perhaps reveal whether the binding of CC to the 
oestrogen receptor in the thymus is associated with the development of 
autoimmune disease. Postmenopausal oestrogen therapy has been associated 
with higher risks of development of systemic lupus erythymatosus (Sanchez- 
Guerrero et al, 1995) and the CC effect could be mediated through mechanisms 
similar to those of oestradiol in the development of this condition. 
Treatment with E2 and with CC+E2 caused the concentrations of 
oestrogen receptors to decrease in both sexes to a level at which they were 
undetectable in the assay system being used. This result differed from the results 
of Kawashima el al (1992) who found oestrogen receptor concentration raised in 
thymus cytosols from adult ovariectomised E2-treated female mice compared 
with the controls. There is no obvious reason why these results should be 
different in rats and mice. The effect may have been due to a different dose of 
E2 or to treatment at a different developmental stage in the thymus. Oestrogen 
receptors are present in the thymulin-producing cells in the adult 
female rat 
thymus (Kawashima et al, 1991) and many other thymic factors are produced 
by 
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the reticulo-epithelial cells of the thymus (Low el al. 1981. Dardenne et al, 1974. 
Grossman ef al, 1982). Moreover, oestrogens regulate thýmk INTnphocyte 
function via thymic factors, and oestrogen receptors are localised in the lymphold 
fraction of the thymus (Danel el al, 1983, Kawashima el al, 1992). The effect of 
E2 and CC+E2 treatment in the present study could have been due to 
translocation of receptor to the nucleus and/or to down-regulation of receptor 
synthesis. 
4-OHA treatment led to an increase in thymus cytosolic oestrogen 
receptors in males, but not in females. This finding is in agreement with the 
results of Greenstein el al (1993) who found that aromatase inhibition with 4- 
OHA may have contributed to the observed increase in thymic cytosolic 
oestrogen receptors. In males, high concentrations of testosterone are present 
between 5 and 30 days, and are converted to oestradiol Wa the aromatase 
pathway. When 4-OHA is admirustered to males, it combines irreversibly With 
aromatase and the conversion of testosterone to oestradiol is inhibited. Similar 
work using a different aromatase inhibitor, 1,4,6-androstatrlene-3,17-dione 
(. ATD), gave the same result, an increase in oestrogen receptors in thymus 
cytosols of male rats (Greenstein et al, 1993). 
5.4.3. - Effects on the molar dissociation constant (Kd) 
The molar dissociation constant of the oestrogen receptor for E2 did not 
change as a result of any of the treatments. This result suggests that none of the 
treatments applied (with the exception of E2 or CC+E2) acted as oestrogen 
agonists in that there was no lowering of the apparent affinity of the receptor for 
oestradiol. The effects of CC treatments vary considerably from oestrogenic to 
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anti- oestrogenic depending upon the dose used and the end-organ (Young et al, 
1991). The concentration of CC in the present study mav have been at 
insufficient doses and use of a range of doses of the pure cis and trans isomers 
might have led to a more conclusive result about the effects of this drup , on the 
tissues examined. In the immature females in the study described here, xý ith little 
endogenous oestrogens present, CC may have acted as a weak oestrogen agonist 
in the thymus, but had no effect at the concentration used in other tissues or in 
males in which testosterone which is aromatizable to oestradiol, was present. 
The results of the present study did not take account of the recent 
discovery of the second (beta) form of the oestrogen receptor. If there are 
differences between the distribution of the alpha and beta forms in the brain and 
thymus or between males and females in these tissues, they could be significant 
during the development of these tissues. The development of thymic epithelial 
cells (and other oestrogen-sensitive thymic cells) could be altered between males 
and females as a result of differences between expression of the two sub-types of 
the receptor and/or differences between the sexes in the exposure to oestradiol in 
the thymus during the early perinatal period. 
In summajy: 
The effects of treatment of female and male Wistar rats at 15 days with 
E2, CC, CC+E2, or 4-OHA varied depending upon the tissue (summarized in 
Table 5.5). The effect of E2 on body weight and tissue weight as well as on 
oestrogen receptor concentration in the uterus, hypothalamus, 
brain cortex and 
thymus cytosols showed some similanties between the sexes 
in response to this 
treatment as well as some differences 4-OHA also had 
differential effects in the 
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two sexes. These findings may have some relevance to different de-.., elopmental 
pathways in the tissues examined. They might suggest possible 1-kays of 
manipulating the microenvironment of the thymus or of ameliorating the 
iatrogenic effects on immune function of infertility treatments Nvhich alter 
oestrogen or oestrogen receptor concentrations. Autolmmune diseases such as 
systemic lupus erythymatosus may develop against a particular genetic and/or 
envirom-nental background. It is possible that against such a background (present 
possibly in autoimmune-prone experimental animals) low oestradiol or CC levels 
could cause a temporary manifestation of disease while high levels could induce 
the full-blown symptoms to develop. If thymus structure and function can be 
manipulated by administration of oestradiol or its inhibitors, this alteration could 
have important implications for the treatment of diseases that result ftom the 
breakdown of immunological self-tolerance. 
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Chapter six 
Final discussion and conclusion 
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The studies undertaken in this project addressed the following questions 
I. Is the cytosolic oestrogen receptor in the thymus of immature female 
Wistar rats similar to or different from the receptor in the uterus where its ligand 
binding specificities are well-established9 
2. Do the binding characteristics (Kd and concentration) of mosolic 
oestrogen receptors in the thymus differ from those found in the uterus and brain 
and do they differ between the sexes and at 5 18, and 30 days in Wistar rats" 
3. If differences exist, could they be due to differential exposure to 
oestradiol in the two sexes at different ages and could manipulation of oestradiol 
concentrations in this age group modify oestrogen receptor binding in the tissues 
studied? 
Gel filtration was chosen as the most appropriate method for determining 
the specificity of the cytosolic oestrogen receptor in the uterus and thymus and 
for measuring its dissociation constant in these tissues and in the brain although it 
is less sensitive than some molecular biological methods for determination of 
cytosolic oestrogen receptor concentrations. Although time-consuming and 
needing relatively large sample volumes, the relatively high sensitivity of this 
method nevertheless, made it most appropriate to estimate oestrogen receptor 
concentration and to determine the dissociation constant of the receptor. 
The cytosolic oestrogen receptor had similar ligand specificities in the 
thymus of females and in the uterus with the exception of the higher affinity of 
the receptor in thymus for corticosterone compared with its affirdty 
for this 
compound in the uterus. This difference could be significant because of the well- 
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known atrophic effects on the thymus of stress, mediated Wa the 
hypothalarnic/pituitary axis and raised glucocorticoids in many mammals 
(reviewed by Spagneto and Gorospe, 1997). The observed differences could 
have been due to other factors such as growth factors or thyniic hormones 
present in the thymus. Additional factors could have been genetically determined 
molecular variation of the oestrogen receptor structure and/or differential post- 
translational modification of the oestrogen receptor protein in this tissue. 
Moreover, there could be differences in the ratio of expressed ERct and ERO 
sub-types in the thymus. In the rat there are differences between the relative 
expression of the two sub-types in various tissues (reviewed by Kulper el al, 
1997). Studies of the relative distribution, affinities and specificities of the two 
sub-types have not been studied in the thymus thus far. The results are consistent 
with the hypothesis that the rat thymus in this age group does possess high- 
affinity receptors for oestradiol. 
Oestrogen receptors have been well-characterised in the uterus and brain 
of developing rats and there are clear differences in these tissues in its 
distribution and concentrations. In the present studies, sex and age differences 
were found in cytosolic oestrogen receptor concentrations in the thymus as well 
as in the uterus and brain. Females, at 5 days, had higher concentrations of 
receptors in thymus than did males of the same age, a result which was sinular to 
the pattern found in the hypothalamus, though not in cortex. Moreover, thymus 
weight relative to body weight was lower in males than in females 
by 30 days. 
These results suggest that in males, during this period when circulating 
testosterone concentrations are high, oestradiol, locally-formed 
from testosterone 
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in the thymus and hypothalamus, may be contributing to the two-fold loýýer 
concentration of cytosolic oestrogen receptors found in males compared ýýIth 
females at 5 days. Thus in males, the difference from females in testosterone 
secretion and aromatase activity during the perinatal period and conversion of 
this hormone to oestradiol in hypothalamus and in thymus could have 
developmental significance in the organisation of these two tIssues and in adult 
responsiveness to oestradiol. Moreover, in the thymus, the difference could, 
when combined with other factors, genetic or environmental, lead to differential 
development of autoirnmune diseases in males and females. 
Because free oestradiol concentrations in the serum did not begin to rise 
until after 18 days in both sexes, it was decided to treat animals at 15 days in 
order to give the compounds, CC, E2, CC+E2 and 4-OHA, time to be absorbed. 
Oestradiol. treatment caused thymic atrophy in both sexes, a result that was 
consistent with previous studies and differed from the effect of increase in the 
weight of the uterus. On the other hand, administration of an aromatase inhibitor 
was associated with an increase in thymus weight in males, though not in 
females. This result suggests that in males, aromatization of testosterone to 
oestradiol inhibited thymus growth by 30 days. By this age in the control group, 
the weight of the thymus relative to body weight was lower in males than in 
females. As cytosolic oestrogen receptors were undetectable as a result of 
treatment with oestradiol, with or without clomiphene, in both sexes, it is 
possible that cytosolic oestrogen receptors were translocated into the nucleus 
and became undetectable by the methods used. Aromatization of testosterone to 
oestradiol in the thymus of males might have been occurring and could 
ha,,,, e 
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resulted in the higher concentrations of oestrogen receptors in males, though not 
in females, after treatment with the aromatase InMbitor. In the control males, 
receptors could have been translocated to the nucleus., after aromatase inhibition 
the unbound receptors might have remained in the cytosol. It is also possible 
that, in the thymus, oestradiol formed either locally through arornatization or 
after treatment with oestradiol down-regulates the synthesis of oestradiol 
receptors and hence their replenishment in the cytosol. 
The different effects of the drugs in cytosols from uterus, hypothalamus, 
cerebral cortex and thymus could have been due to structural differences in the 
receptor in these tissues. This question could be addressed in the future by 
sequencing the oestrogen receptor gene in the different tissues in order to look 
for differences in the nucleotide sequences that would alter the amino acid 
sequence of the receptor. The finding that the receptor had a higher affinity in 
the thymus than in the uterus for corticosterone might be explained by such a 
difference, despite the similar affinity shown in both tissues for oestradiol. In the 
rat, the tissue distribution and level of ERcc and ERP mRNA expression differs in 
that the concentration of the ERa is moderate to high in uterus, testis, pituitary, 
ovary, kidney, epididymis and adrenals. The concentration of ERP of the 
receptor is moderate to high in prostate, ovary, lung, bladder, brain and uterus 
(Kuiper et al, 1996). The two sub-types could also exert tissue specific effects if 
they are able to transactivate different oestrogen response elements on DNA. 
Moreover., the ERcc and ERP can also mediate gene transcription Wa an AP I 
enhancer site with different effects being observed dependent on 
ligand and 
receptor sub-type. The discovery of the ERP form of the oestrogen receptor 
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may have some significance for this study if the two forms of this hormone 
receptor perform different physiological roles in the different tissues or in 
different cell types within the same tissue. The two forms of the receptor show 
only 55 percent homology in the ligand binding domain and this difference could 
be associated with the higher affinity for corticosterone of the cytosolic receptor 
in the thymus compared with I lochemical I the uterus. Alternatively, given the bi 
richness of the thymic microenvironment, there could also be soluble products 
such as growth hormone or thymic hormones that might enhance the binding of 
corticosterone to the oestrogen receptor. These effects could be mediated by 
post-translational modification ligand-binding site of the receptor by thymic 
factors. 
The question of whether oestrogen receptors were being translocated to 
the nucleus in response to the various treatments could be addressed by using gel 
filtration techniques to measure nuclear receptors. Studies previously undertaken 
in this laboratory (Greenstein, 1992) showed that cytosolic oestrogen receptor 
concentrations decrease in the hypothalamus and uterus with a concomitant rise 
in nuclear receptor concentrations after oestradiol administration. If this pattern 
is due to translocation of the receptor from cytosol to nucleus and to the tight 
binding of the receptor to the DNA, the same effect may be present in the 
thymus. 
Histology, using immunocytochernistry or autoradiography techniques, 
could be used to localise nuclear receptors to specific areas within the tissues 
exaýnined. Reverse transcript ase-polymermase chain-reaction techniques could 
identify cells synthesising mRNA for the receptor. Studies could 
be done at 
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closer age intervals than 15 and 30 days and might reveal more clearl,, - the stues 
at which differences arose. Treatment with a series of different doses of 
clomiphene and/or separate use of the two different isomers might also establish 
whether treatment with this drug could modulate the response of thymic cells to 
oestradiol. Clorniphene treatment in the present studies did lower the 
concentration of oestrogen receptors in the thymus of female rats, presumably as 
a weakly competitive antagonist, as no change was observed in the binding 
constant in this treatment group. Castration of males at 5 days and/or treatment 
with oestradiol together with 4-OHA might also clarify the role of aromatase in 
the development of the hypothalamus and thymus. 
Functional differences that relate to the immune responsiveness (for 
example, mixed lymphocyte reaction or responsiveness to nutogens) of treated 
rats need to be examined and compared with these parameters in untreated 
animals. Moreover, an examination of the interaction of sex hormones with 
other hormones such as growth hormone and glucocorticoids might reveal effects 
on T-cell differentiation in the thymus, for example, by altering the ratios of T- 
cell subsets emerging. Several studies have shown that the ERct and ERP differ 
in their specificity and tissue distribution in many areas of the brain as well as in 
tissues such as the ovaries, uterus, prostate, kidney, adrenal, bladder and 
lung 
(see Chapter 4, Section 1). it would seem timely to study the distribution and 
specificity of the two oestrogen receptor sub-types in the thymus. 
Differences 
between histocompatible Fischer 344 and Lewis rats have been shown in their 
diumal and stress corticosterone levels and in the 
binding of the TyPe 11 
glucocorticoid receptors in the thymus The difference 
in the affinity of the 
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oestrogen receptor for corticosterone found in the present studv might be 
associated with the ratio of ER(x and ERO in the thymus and, moreover, there 
could be differences between different strains of immune-prone and control 
strains of animals. The present studies suggest that the specificity of the 
cytosolic oestrogen receptor in the thymus closely resembles the receptor in the 
uterus but there was a notable difference in the affinity of the oestrogen receptor 
in the thymus for corticosterone compared with the uterus. 
Differences in receptor concentrations, but not in affinity for oestradiol, 
were found between different age groups and sexes. Moreover, tissue weights 
and cytosolic oestrogen receptor concentrations were, in some tissues, 
differentially altered in treated males and females. The mechanisms for these 
differences may vary in detail between the tissues examined. Nevertheless, sex 
differences in the thymus, as in the brain, could be related to differential exposure 
of males and females to oestradiol at an early stage of postnatal development. 
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APPENDIX A 
Program for the Hewlett Packard HP48SX programmable calculator 
(reproduced by kind permission of Dr B. D. Greenstein). The calculator can be 
used in conjunction with a small Hewlett-Packard infra-red printer, the HP 
82240B 
The program relies on the fact that the non-specific binding of the ligand is purek 
a function of the amount of added radioactivity, and directly proportional to it 
Therefore only one incubation is needed where the radioactive steroid (usualk, in 
the highest concentration used is diluted by a 100-fold excess of unlabelled 
steroid.. The program asks for the cpm relating to the total radioactivity used in 
the incubation in which non-specific binding (NSB) is assessed, and for the cpm 
bound. It calculates the NSB and stores the value. It then asks for the various 
cpm of the total bound radioactivity in each of the other incubations in which 
there is no unlabelled steroid, and proceeds to calculate and plots the Scatchards 
obtained. The program asks for the correction factor which converts all cpm to 
molar concentrations, and then proceeds to print the Kd, the binding capacity and 
correlation coefficient. 
SCAT 
<<LBN SPIN TEST CALC 
A aR PRO REG 
LBL 
<< "ENTER DATE, SPACE TISSUE" 
440.5 BEEP 
'4: DATE 
: TISSUE: " f 10 
) V) INPUT OBJ--> PRST 
CLEAR 
NSPIN 
<<CLE, PPAR' PURGE 
'ZPAR'PURGE 450.5 BEEP 
"ENTER nonspecific 
BOUND, TOTAL" 
": nonspBOUND: 
: nonspTOTAL: - 
(101 V) INPUT OBJ--) 
PRST DUP 'NST' STO DROP 
DUP'NSB'STO CLEAR 
TEST 
<<440.5 BEEP 
"ENTTER BOUND, TOTAL" 
ý": BOUND: 
: TOTAUl 10 
v) INPUT OBJ-> PRST 
DUP'T'STO DROP DUP 
'BT'STO CLEAR 
CALC 
<<'BT'-NSB*T/NlST'4NU-lvl 
-SPBOL'ND"-->T, A, G DUTBSP' 
STO'T-BSP'*N'LT\1'FRE' 
244 
--)TAG DUP'F'STO'BSPIF' 
--ý N-UM'BoverF' --) TAG DUT 
'BF'STO PRST 3 DROPN 
ARR 
<<BSP BF 2 4ARRY E-- 
PRO 
<<440.5 BEEP 
"MORE? 
PRESS I ENTER ELSE 
PRESS 0 ENTER" 
j ": ENTER CHOICE: -Vj 
INPUT OBJ44 x 
IF 'x= = I' 
THEN CLEAR TEST CALC 
ARR PRO 
ELSE CLEAR 
"PARAMETERS" PRI CLEAR 
END 
REG 
<< "ENTER CORR. FACTOR" 
440.5 BEEP ý": CORF: )V 
.1 
INPUT OBJ* VFYCF CORF 
PRI CLEAR "PLOTTING" PRI 
CLEAR CR I XCOL 2 
YCOL LINFIT SCATRPLOT 
PRLCD LR CORR 0 PREDX 
'N'4TAG DUP DTAG'N' 
STO ROT DUT'SLOPE^ STO 
'l/SLOPE*CORF'-4', NLAl VKD' 
-->T-AG'N*CORF'--)NtT-M 
'NMOLAR14TAG PRST CLEAR 
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